gene_id	gene_short_name	cell_group	marker_score	mean_expression	fraction_expressing	specificity	pseudo_R2	marker_test_p_value	marker_test_q_value	gene_ID	uniprot	uversion	up_evalue	cel	cel_evalue	dmel	dmel_evalue	spur_acc	spur_evalue	Reviewed	Entry.Name	Protein.names	Gene.Names	Organism	Length	Gene.Ontology..biological.process.	Gene.Ontology..GO.	Gene.Ontology.IDs
LOC105329534	uncharacterized LOC105329534	10	0.244618740974806	4.3723264553448304	0.605882352941176	0.403739669570068	0.210154384315135	9.48701685472259e-42	5.0765786150969e-36	uncharacterized LOC105329534	Q9ESN6	1	2.21e-8	C12C8.3a.2	6.15e-4	anne-PI	4.6	XP_787393.2	2.98e-6	reviewed	TRIM2_MOUSE	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (Neural activity-related RING finger protein) (RING-type E3 ubiquitin transferase TRIM2)	Trim2 Kiaa0517 Narf	Mus musculus (Mouse)	744	cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]	cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017022; GO:0043161; GO:0043523; GO:0061630; GO:1990830
LOC105337374	Uncharacterized protein C2orf50	11	0.534222155422196	18.3096425468308	1	0.534222155422196	0.75488392675334	2.57310008974733e-61	1.37688644282451e-55	Uncharacterized protein C2orf50	Q96LR7	1	1.13e-15	F41A4.1.1	2.2	Vps13B-PA	4.7	XP_030830022.1	1.66e-20	reviewed	CB050_HUMAN	Uncharacterized protein C2orf50	C2orf50	Homo sapiens (Human)	162			
LOC105331844	uncharacterized LOC105331844	6	0.58666280736464	6.83748447643418	0.924528301886792	0.634553648782161	0.711276871099773	4.24151145833905e-222	2.26966671344889e-216	uncharacterized LOC105331844	Q6BNG2	2	0.005	F32B5.8a.1	1.1	RluA-1-PC	5.1	XP_030835828.1	3.4	reviewed	DPOE_DEBHA	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A)	POL2 DEHA2E22000g	Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) (Yeast) (Torulaspora hansenii)	2226	DNA repair [GO:0006281]; DNA replication [GO:0006260]	epsilon DNA polymerase complex [GO:0008622]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; DNA replication [GO:0006260]	GO:0000166; GO:0003677; GO:0003887; GO:0006260; GO:0006281; GO:0008270; GO:0008622; GO:0051539
LOC105317489	serine-rich adhesin for platelets	9	0.641024131415347	2.71368222768513	0.938628158844765	0.682937247700197	0.721546617794654	4.07516596235348e-190	2.18065390778305e-184	serine-rich adhesin for platelets	Q8FUI7	2	0.59	T02C5.5b.1	1.6	CG7879-PB	0.86	XP_030849397.1	0.19	reviewed	CRGA_COREF	Cell division protein CrgA	crgA CE0031	Corynebacterium efficiens (strain DSM 44549 / YS-314 / AJ 12310 / JCM 11189 / NBRC 100395)	90	cell cycle [GO:0007049]; cell division [GO:0051301]	integral component of plasma membrane [GO:0005887]; cell cycle [GO:0007049]; cell division [GO:0051301]	GO:0005887; GO:0007049; GO:0051301
LOC105325141	uncharacterized LOC105325141	9	0.642420297562834	1.88285445776095	0.768953068592058	0.835447992605188	0.61955406923815	5.3915363672754e-163	2.88505424242e-157	uncharacterized LOC105325141	Q6C0K9	1	1.3	K09B11.9a.1	7.1	Cyt-c-p-PB	4.7	XP_030836234.1	0.86	reviewed	BYE1_YARLI	Transcription factor BYE1	BYE1 YALI0F23815g	Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica)	822	regulation of mRNA 3'-end processing [GO:0031440]; transcription antitermination [GO:0031564]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II complex recruiting activity [GO:0001139]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of mRNA 3'-end processing [GO:0031440]; transcription antitermination [GO:0031564]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]	GO:0000977; GO:0001139; GO:0005634; GO:0006351; GO:0006362; GO:0006368; GO:0031440; GO:0031564; GO:0046872
LOC105334990	uncharacterized LOC105334990_ncRNA	11	0.550813647005653	14.0365794107182	0.808510638297872	0.68126951077015	0.518051118079165	1.52005648995404e-42	8.13394388226328e-37	uncharacterized LOC105334990_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105334984	radial spoke head 14 homolog	11	0.52845371549665	7.72699890089184	0.936170212765957	0.564484650644149	0.61090025213828	6.74985885664685e-50	3.61190347306258e-44	radial spoke head 14 homolog	Q9D3W1	1	4.65e-101	Y71H2B.10c.1	0.003	p120ctn-PA	0.006	XP_785178.2	4.55e-158	reviewed	RSP14_MOUSE	Radial spoke head 14 homolog (Rhabdoid tumor deletion region protein 1)	Rsph14 Rtdr1	Mus musculus (Mouse)	341			
LOC105327784	cholecystokinin receptor type A	9	0.676435772289071	1.70011607950492	0.783393501805054	0.863468704719229	0.615967600730867	4.81058701375367e-162	2.5741835957557e-156	cholecystokinin receptor type A	P70031	1	1.86e-8	T05A1.1b.1	6.15e-9	sNPF-R-PB	2.12e-6	XP_003725989.2	1.33e-16	reviewed	CCKAR_XENLA	Cholecystokinin receptor (CCK-XLR)	cckar	Xenopus laevis (African clawed frog)	453		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021
LOC105322769	contactin	2	0.258338072344533	3.59995280064188	0.776664552948637	0.332625032729694	0.237278716198244	8.37719000286967e-243	4.48270138805558e-237	contactin	Q9VN14	2	2.14e-177	C33F10.5d.1	6.05e-72	Cont-PA	1.27e-170	XP_030829353.1	2.73e-92	reviewed	CONT_DROME	Contactin	Cont CG1084	Drosophila melanogaster (Fruit fly)	1390	axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991]	GO:0005886; GO:0005918; GO:0007156; GO:0007411; GO:0008366; GO:0019991; GO:0021682; GO:0030424; GO:0031225; GO:0045197; GO:0060857; GO:0061343; GO:0070593; GO:0098632
LOC105325951	uncharacterized LOC105325951	6	0.387462852635864	4.32774932863399	0.795148247978437	0.487283790942053	0.457819747603807	2.65296306461529e-142	1.41962175958016e-136	uncharacterized LOC105325951	O35607	1	6.75e-107	F29C4.1a.1	1.59e-37	wit-PA	8.5e-100	XP_790983.2	1.12e-117	reviewed	BMPR2_MOUSE	Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (BRK-3) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II)	Bmpr2	Mus musculus (Mouse)	1038	anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell body [GO:0044297]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; phosphatase activator activity [GO:0019211]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activator activity [GO:0030546]; transforming growth factor beta receptor activity [GO:0005024]; anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412]	GO:0001568; GO:0001649; GO:0001707; GO:0001893; GO:0001935; GO:0001938; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003148; GO:0003151; GO:0003176; GO:0003177; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0004674; GO:0005024; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0005905; GO:0005912; GO:0006468; GO:0007178; GO:0009267; GO:0009925; GO:0009952; GO:0009986; GO:0010595; GO:0010634; GO:0010862; GO:0014069; GO:0014916; GO:0016324; GO:0019211; GO:0019838; GO:0030166; GO:0030308; GO:0030424; GO:0030425; GO:0030501; GO:0030509; GO:0030513; GO:0030546; GO:0036122; GO:0042127; GO:0043025; GO:0043235; GO:0043539; GO:0044297; GO:0045296; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048286; GO:0048662; GO:0048842; GO:0051148; GO:0060173; GO:0060350; GO:0060391; GO:0060412; GO:0060413; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0061626; GO:0071363; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:1990782; GO:2000279
LOC105325948	transient receptor potential cation channel subfamily M member-like 2	3	0.524882610571117	9.98874339849292	0.92615596963423	0.566732416332003	0.595889682785641	0	0	transient receptor potential cation channel subfamily M member-like 2	A7T1N0	1	1.02e-97	ZK512.3.1	1.34e-59	Trpm-PJ	5.4e-34	XP_030829334.1	8.19e-84	reviewed	TMP2L_NEMVE	Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2)	TRPM2 v1g248535	Nematostella vectensis (Starlet sea anemone)	1551	calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ADP-ribose diphosphatase activity [GO:0047631]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; sodium ion transmembrane transport [GO:0035725]	GO:0005261; GO:0005886; GO:0005887; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0098655; GO:0099604
LOC105332280	uncharacterized LOC105332280	7	0.467283907878058	5.18379911867933	0.564864864864865	0.82724902351618	0.36057677922465	6.41279885329504e-112	3.431539968789e-106	uncharacterized LOC105332280	B4MQJ1	2	9.68e-15	F57B1.1.1	2.8	qvr-PB	3.19e-14	XP_030848427.1	0.011	reviewed	QVR_DROWI	Protein quiver (Protein sleepless)	qvr sss GK19387	Drosophila willistoni (Fruit fly)	161	negative regulation of acetylcholine-gated cation channel activity [GO:1903049]; negative regulation of membrane potential [GO:0045837]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]	anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; negative regulation of acetylcholine-gated cation channel activity [GO:1903049]; negative regulation of membrane potential [GO:0045837]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]	GO:0005886; GO:0009897; GO:0030431; GO:0031225; GO:0032222; GO:0034235; GO:0045187; GO:0045837; GO:0045938; GO:0048511; GO:1903049; GO:1903818
LOC105318289	centrosome and spindle pole-associated protein 1	11	0.531936760096108	22.6047003059134	1	0.531936760096108	0.789699289837829	4.42421282783551e-64	2.3674316778774e-58	centrosome and spindle pole-associated protein 1	B2RX88	2	0.007	F47D12.4c.2	1.5	CG15563-PA	4.16e-4	XP_001195971.3	5.07e-16	reviewed	CSPP1_MOUSE	Centrosome and spindle pole associated protein 1	Cspp1 Cspp	Mus musculus (Mouse)	1205	positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467]	GO:0000922; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0032467; GO:0034451; GO:0051781
LOC105346986	trichohyalin	5	0.59680895421899	11.3230105897197	0.719919110212336	0.828994460284524	0.462075280964652	7.87852854082035e-236	4.2158636504213e-230	trichohyalin	Q7M3Y3	2	1.19e-35	W03F8.1.2	5.33e-24	wupA-PB	2.81e-11	XP_030845572.1	9.73e-11	reviewed	TNNI_CHLNI	Troponin I (TnI)		Chlamys nipponensis akazara (Akazara scallop) (Japanese scallop)	292		troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872]	GO:0003779; GO:0005861; GO:0046872
LOC105347950	uncharacterized LOC105347950	6	0.4949946308568	5.28652447778732	0.873315363881402	0.566799407555163	0.626641089399927	2.787489525328e-195	1.49160794491922e-189	uncharacterized LOC105347950	A6LLK6	1	2.4	ZK112.7.1	3	CG42749-PB	4.45e-48	XP_030832622.1	2	reviewed	GATB_THEM4	Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B (Asp/Glu-ADT subunit B) (EC 6.3.5.-)	gatB Tmel_0946	Thermosipho melanesiensis (strain DSM 12029 / CIP 104789 / BI429)	476	translation [GO:0006412]	asparaginyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050566]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; translation [GO:0006412]	GO:0005524; GO:0006412; GO:0050566; GO:0050567
LOC105339970	uncharacterized LOC105339970	10	0.249032976969996	10.0106813983802	0.888235294117647	0.280368252217876	0.377866199919673	6.45711923117352e-74	3.4552561575548e-68	uncharacterized LOC105339970	A8F3J8	1	0.39	F41A4.1.1	0.47	CG42346-PD	4.8	XP_030854963.1	0.96	reviewed	ATPF_PSELT	ATP synthase subunit b (ATP synthase F(0) sector subunit b) (ATPase subunit I) (F-type ATPase subunit b) (F-ATPase subunit b)	atpF Tlet_0162	Pseudothermotoga lettingae (strain ATCC BAA-301 / DSM 14385 / NBRC 107922 / TMO) (Thermotoga lettingae)	162		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]	GO:0005886; GO:0016021; GO:0045263; GO:0046933
LOC105339977	uncharacterized LOC105339977	10	0.256508983556801	16.5111006868697	0.952941176470588	0.269176093855902	0.444481219781607	9.48889343277682e-87	5.07758278702634e-81	uncharacterized LOC105339977	Q07E01	1	2.4	D2092.4.1	2.7	kek4-PC	1.6		NA	reviewed	MET_ORNAN	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	MET	Ornithorhynchus anatinus (Duckbill platypus)	1382	cell migration [GO:0016477]; liver development [GO:0001889]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; phagocytosis [GO:0006909]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein kinase B signaling [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	basal plasma membrane [GO:0009925]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; hepatocyte growth factor receptor activity [GO:0005008]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; liver development [GO:0001889]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; phagocytosis [GO:0006909]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein kinase B signaling [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	GO:0001889; GO:0004714; GO:0005008; GO:0005524; GO:0005887; GO:0006909; GO:0007169; GO:0007399; GO:0009925; GO:0016477; GO:0017154; GO:0030182; GO:0031016; GO:0033674; GO:0043235; GO:0050918; GO:0051897; GO:0071526; GO:2001028
LOC105332609	uncharacterized LOC105332609_ncRNA	10	0.35531234112812	13.7171940692435	0.905882352941176	0.392227909037535	0.456826661288504	3.93611050899801e-89	2.10624422224891e-83	uncharacterized LOC105332609_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105332606	transcription factor GATA-4	14	0.440326817554531	19.0968712996271	0.956521739130435	0.460341672897919	0.471332986638064	2.38147367226207e-23	1.27434561381681e-17	transcription factor GATA-4	Q91677	1	1.42e-86	W09C2.1b.1	4.89e-47	pnr-PD	5.74e-63	NP_001005725.1	2.14e-68	reviewed	GATA4_XENLA	Transcription factor GATA-4 (GATA-binding factor 4) (xGATA-4)	gata4	Xenopus laevis (African clawed frog)	392	cardiac muscle tissue development [GO:0048738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; cardiac muscle tissue development [GO:0048738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]	GO:0000976; GO:0000981; GO:0003677; GO:0005634; GO:0008270; GO:0045893; GO:0045944; GO:0048738
LOC105332606	transcription factor GATA-4	6	0.289801647237211	10.9112371776625	0.973045822102426	0.297829393698076	0.617521327976	2.1110161139768e-192	1.1296216107179e-186	transcription factor GATA-4	Q91677	1	1.42e-86	W09C2.1b.1	4.89e-47	pnr-PD	5.74e-63	NP_001005725.1	2.14e-68	reviewed	GATA4_XENLA	Transcription factor GATA-4 (GATA-binding factor 4) (xGATA-4)	gata4	Xenopus laevis (African clawed frog)	392	cardiac muscle tissue development [GO:0048738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; cardiac muscle tissue development [GO:0048738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]	GO:0000976; GO:0000981; GO:0003677; GO:0005634; GO:0008270; GO:0045893; GO:0045944; GO:0048738
LOC105319359	myb-like protein X	14	0.226614969360122	180.542730325012	1	0.226614969360122	0.505432771291293	6.31424497199765e-25	3.37880299847572e-19	myb-like protein X		NA	NA	Y54F10AL.1a.1	1.2		NA	XP_030847674.1	0.44	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105322006	protein unc-45 homolog B	5	0.349704311229436	4.51153643137855	0.787664307381193	0.443976333512082	0.355550559887773	9.94807073521859e-181	5.32329223498135e-175	protein unc-45 homolog B	D7REX8	1	0	F30H5.1.1	4.63e-162	unc-45-PB	0	XP_797752.4	0	reviewed	UN45B_XENTR	Protein unc-45 homolog B (Unc-45B)	unc45b cmya4	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	927	cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]	A band [GO:0031672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]	GO:0002088; GO:0005737; GO:0005829; GO:0007517; GO:0030018; GO:0030154; GO:0031672; GO:0048471; GO:0051879; GO:0061077
LOC105333225	T-box brain protein 1	4	0.280635276673895	2.20729685874058	0.37207488299532	0.754244076930678	0.169765424453528	2.38029004589144e-96	1.27371224587688e-90	T-box brain protein 1	Q64336	2	1.91e-91	F21H11.3.2	6.33e-55	byn-PC	1.92e-60	XP_791266.2	1.23e-90	reviewed	TBR1_MOUSE	T-box brain protein 1 (T-brain-1) (TBR-1) (TES-56)	Tbr1	Mus musculus (Mouse)	681	amygdala development [GO:0021764]; cell fate specification [GO:0001708]; cerebral cortex development [GO:0021987]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; conditioned taste aversion [GO:0001661]; gene expression [GO:0010467]; hindbrain development [GO:0030902]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axon guidance [GO:1902667]; regulation of gene expression [GO:0010468]; regulation of neuron projection development [GO:0010975]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]	nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; amygdala development [GO:0021764]; cell fate specification [GO:0001708]; cerebral cortex development [GO:0021987]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; conditioned taste aversion [GO:0001661]; gene expression [GO:0010467]; hindbrain development [GO:0030902]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axon guidance [GO:1902667]; regulation of gene expression [GO:0010468]; regulation of neuron projection development [GO:0010975]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]	GO:0000978; GO:0000981; GO:0001228; GO:0001661; GO:0001708; GO:0003677; GO:0003700; GO:0005634; GO:0006338; GO:0006357; GO:0010092; GO:0010467; GO:0010468; GO:0010975; GO:0016575; GO:0019901; GO:0021764; GO:0021902; GO:0021987; GO:0030182; GO:0030902; GO:0031490; GO:0045892; GO:0045944; GO:1902667
LOC105323125	uncharacterized LOC105323125	2	0.169134083762156	4.62051793839916	0.865948002536462	0.195316674057498	0.192254711103105	5.20441336296564e-196	2.78492322582982e-190	uncharacterized LOC105323125	Q5SW96	3	0.005	F46C5.8.2	4.7	CG14968-PA	3.85e-24	XP_003724780.2	6.8e-10	reviewed	ARH_HUMAN	Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein)	LDLRAP1 ARH	Homo sapiens (Human)	308	amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]	axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]	GO:0001540; GO:0001784; GO:0005546; GO:0005769; GO:0005829; GO:0005883; GO:0005886; GO:0006898; GO:0008203; GO:0009898; GO:0009925; GO:0030159; GO:0030276; GO:0030301; GO:0030424; GO:0030669; GO:0031623; GO:0034383; GO:0035591; GO:0035612; GO:0035615; GO:0035650; GO:0042632; GO:0042982; GO:0043393; GO:0048260; GO:0050750; GO:0055037; GO:0071345; GO:0090118; GO:0090205; GO:1903076; GO:1904707; GO:1905581; GO:1905602
LOC105330942	uncharacterized LOC105330942	13	0.381887442683043	3.01659457038931	0.827586206896552	0.461447326575344	0.288231160377201	1.78747168420615e-17	9.56490397992184e-12	uncharacterized LOC105330942	Q06002	3	0.022	F36H1.3.1	2.4		NA	XP_030843518.1	0.19	reviewed	BFSP1_BOVIN	Filensin (Beaded filament structural protein 1) [Cleaved into: Filensin C-terminal fragment; Filensin N-terminal fragment]	BFSP1	Bos taurus (Bovine)	757	cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886]; structural constituent of eye lens [GO:0005212]; cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]	GO:0005212; GO:0005737; GO:0005882; GO:0005886; GO:0005938; GO:0045109; GO:0048469; GO:0070307
LOC105332654	zinc finger protein 1-like	10	0.482167091315583	18.2157376688396	0.929411764705882	0.518787376731956	0.567593100551028	1.46192704704194e-110	7.82288858288521e-105	zinc finger protein 1-like	G5EBU4	1	1.06e-45	F28F9.1.1	9.38e-47	zfh1-PA	1.63e-40	XP_799337.3	2.47e-36	reviewed	ZAG1_CAEEL	Zinc finger E-box-binding homeobox protein zag-1 (Zinc finger involved in axon guidance 1) (ZAG-1)	zag-1 F28F9.1	Caenorhabditis elegans	596	anatomical structure development [GO:0048856]; axon guidance [GO:0007411]; dendrite development [GO:0016358]; larval development [GO:0002164]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; positive regulation of axon extension [GO:0045773]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure development [GO:0048856]; axon guidance [GO:0007411]; dendrite development [GO:0016358]; larval development [GO:0002164]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; positive regulation of axon extension [GO:0045773]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0000122; GO:0000978; GO:0000981; GO:0002164; GO:0005634; GO:0006357; GO:0007411; GO:0016358; GO:0045664; GO:0045773; GO:0046872; GO:0048665; GO:0048856
LOC105344648	elongation of very long chain fatty acids protein 4	12	0.678285954259707	75.2787702664086	1	0.678285954259707	0	1	1	elongation of very long chain fatty acids protein 4	Q3S8M4	1	1.05e-111	F56H11.3.1	1.14e-18	CG31522-PF	9.37e-68	XP_030845097.1	2.18e-106	reviewed	ELOV4_MACMU	Elongation of very long chain fatty acids protein 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4)	ELOVL4	Macaca mulatta (Rhesus macaque)	314	fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]	GO:0005783; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102756
LOC105344649	elongation of very long chain fatty acids protein 4	12	0.688660554832525	16.6188024164641	1	0.688660554832525	0.894424062441463	8.41951726957217e-55	4.50535104708623e-49	elongation of very long chain fatty acids protein 4	Q9EQC4	2	1.59e-90	F56H11.4a.1	6.4e-20	CG31522-PF	2.72e-76	XP_030845095.1	4.71e-106	reviewed	ELOV4_MOUSE	Elongation of very long chain fatty acids protein 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4)	Elovl4	Mus musculus (Mouse)	312	fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]	GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102756
LOC105344655	uncharacterized LOC105344655	9	0.639450191350876	1.26213413614616	0.848375451263538	0.75373490640082	0.640964202386958	1.13000657091924e-168	6.04675556151453e-163	uncharacterized LOC105344655	B0UJ78	1	1.8	Y45F10D.13a.1	1.5	ksr-PD	4.9	XP_800040.1	1.6	reviewed	PURA_METS4	Adenylosuccinate synthetase (AMPSase) (AdSS) (EC 6.3.4.4) (IMP--aspartate ligase)	purA M446_6845	Methylobacterium sp. (strain 4-46)	430	'de novo' AMP biosynthetic process [GO:0044208]	cytoplasm [GO:0005737]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; 'de novo' AMP biosynthetic process [GO:0044208]	GO:0000287; GO:0004019; GO:0005525; GO:0005737; GO:0044208
LOC105334171	two pore potassium channel protein sup-9	7	0.613407043117056	8.89250871564744	0.708108108108108	0.866261854783628	0.515854632159181	3.39069371846254e-160	1.81438733429905e-154	two pore potassium channel protein sup-9	O17185	2	2.25e-122	F34D6.3.1	1.98e-123	Task6-PE	6.87e-118	XP_030830349.1	3.1e-60	reviewed	SUP9_CAEEL	Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38)	sup-9 F34D6.3	Caenorhabditis elegans	329	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322]	integral component of plasma membrane [GO:0005887]; muscle cell projection membrane [GO:0036195]; striated muscle dense body [GO:0055120]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322]	GO:0005267; GO:0005887; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0030322; GO:0036195; GO:0055120; GO:0071805
LOC105337692	uncharacterized LOC105337692	2	0.272688964249193	13.2647725254404	0.871147748890298	0.313022635478947	0.22789128013431	5.29207989520261e-233	2.83183428856208e-227	uncharacterized LOC105337692	C4JTH6	1	1.2	T05F1.4.1	5.7	RhoGAP18B-PD	2.9	XP_030830981.1	0.01	reviewed	UTP25_UNCRE	U3 small nucleolar RNA-associated protein 25 (U3 snoRNA-associated protein 25) (U three protein 25)	UTP25 UREG_05765	Uncinocarpus reesii (strain UAMH 1704)	715	rRNA processing [GO:0006364]	nucleolus [GO:0005730]; U3 snoRNA binding [GO:0034511]; rRNA processing [GO:0006364]	GO:0005730; GO:0006364; GO:0034511
LOC105318857	uncharacterized LOC105318857	6	0.550483426649229	5.78464396058166	0.808625336927224	0.680764504289547	0.596517644277927	8.87380634821402e-186	4.74844476738011e-180	uncharacterized LOC105318857	Q9PTU3	1	0.99	C27A2.6.1	0.38		NA	XP_030851525.1	3.2	reviewed	XPO2_PAGMA	Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter)	cse1l cas xpo2	Pagrus major (Red sea bream) (Chrysophrys major)	971	intracellular protein transport [GO:0006886]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; small GTPase binding [GO:0031267]; intracellular protein transport [GO:0006886]	GO:0005634; GO:0005737; GO:0006886; GO:0031267
LOC105348570	troponin T, skeletal muscle	5	0.754692391670973	36.4302114041897	0.906976744186047	0.832096739534663	0.681320707594537	0	0	troponin T, skeletal muscle	Q9XZ71	1	1.48e-30	T22E5.5.2	2.67e-26	up-PT	1.53e-23	XP_030834105.1	5.38e-5	reviewed	TNNT_PERAM	Troponin T (TnT)	TNT	Periplaneta americana (American cockroach) (Blatta americana)	384	regulation of muscle contraction [GO:0006937]	troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937]	GO:0005861; GO:0006937
LOC105330366	calpain-9	4	0.192336943541642	0.485148946312252	0.297191887675507	0.647181001628306	0.134053200939051	2.68965554248779e-76	1.43925619802956e-70	calpain-9	O14815	1	2.97e-145	Y77E11A.11a.2	2e-115	CalpB-PB	2.14e-134	XP_030855129.1	5.24e-130	reviewed	CAN9_HUMAN	Calpain-9 (EC 3.4.22.-) (Digestive tract-specific calpain) (New calpain 4) (nCL-4) (Protein CG36)	CAPN9 NCL4	Homo sapiens (Human)	690	digestion [GO:0007586]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007586
LOC105333627	tetraspanin-9	13	0.376450048388719	2.5008242279971	0.931034482758621	0.404335237158254	0.310843692094323	1.00183622021453e-18	5.36090576126558e-13	tetraspanin-9	Q0VC33	1	3.23e-26	F33C8.3.1	4.69e-19	Tsp96F-PC	1.46e-17	XP_030845566.1	8.18e-37	reviewed	TSN11_BOVIN	Tetraspanin-11 (Tspan-11)	TSPAN11	Bos taurus (Bovine)	253	cell migration [GO:0016477]	integral component of plasma membrane [GO:0005887]; cell migration [GO:0016477]	GO:0005887; GO:0016477
LOC105333630	33 kDa inner dynein arm light chain, axonemal	11	0.558414868911307	23.043431368467	1	0.558414868911307	0.73547354515572	8.93662102478023e-60	4.7820574033281e-54	33 kDa inner dynein arm light chain, axonemal	Q26630	1	2.9e-159	F41G4.1.1	7.43e-52	Dnali1-PA	3.37e-84	NP_999680.1	4.23e-160	reviewed	IDLC_STRPU	33 kDa inner dynein arm light chain, axonemal (p33)		Strongylocentrotus purpuratus (Purple sea urchin)	260		axoneme [GO:0005930]; dynein complex [GO:0030286]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]	GO:0005930; GO:0030175; GO:0030286; GO:0045504
LOC105333051	ALX homeobox protein 1	5	0.374056998474528	12.8532352982486	0.448938321536906	0.833203539394837	0.237765923643758	1.21026499116485e-120	6.47622478892241e-115	ALX homeobox protein 1	Q15699	2	9.83e-53	R08B4.2.1	3.2e-28	Pph13-PA	1.39e-27	XP_030844644.1	9.74e-59	reviewed	ALX1_HUMAN	ALX homeobox protein 1 (Cartilage homeoprotein 1) (CART-1)	ALX1 CART1	Homo sapiens (Human)	326	embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell migration [GO:0001755]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell migration [GO:0001755]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001755; GO:0005634; GO:0005654; GO:0005794; GO:0006357; GO:0010718; GO:0016604; GO:0045892; GO:0045893; GO:0045944; GO:0048704; GO:1990837
LOC105319166	ras and EF-hand domain-containing protein homolog	2	0.170080541729595	2.91645209726798	0.67292327203551106	0.252748788454175	0.131701349711824	6.67803050732314e-134	3.57346754871267e-128	ras and EF-hand domain-containing protein homolog	A1A600	2	1.57e-65	4R79.2b.1	1.97e-69	Rab8-PC	2.12e-45	XP_030833265.1	1.09e-91	reviewed	EFC4A_DANRE	EF-hand calcium-binding domain-containing protein 4A (Calcium release-activated channel regulator 2B)	cracr2b efcab4a zgc:158448	Danio rerio (Zebrafish) (Brachydanio rerio)	390	store-operated calcium entry [GO:0002115]	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; store-operated calcium entry [GO:0002115]	GO:0002115; GO:0005509; GO:0005737
LOC105345833	guanine deaminase	4	0.312049358371945	6.10953568297093	0.650546021840874	0.479672994523781	0.23220467552109	1.24846706960652e-131	6.68064716683008e-126	guanine deaminase	Q5RAV9	1	1.69e-156	F38E11.3.1	1.41e-12	DhpD-PA	2.42e-114	XP_030855907.1	3.03e-141	reviewed	GUAD_PONAB	Guanine deaminase (Guanase) (Guanine aminase) (EC 3.5.4.3) (Guanine aminohydrolase) (GAH)	GDA	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	454	guanine catabolic process [GO:0006147]	guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270]; guanine catabolic process [GO:0006147]	GO:0006147; GO:0008270; GO:0008892
LOC105343207	uncharacterized LOC105343207	12	0.725563963112812	11.767919580647	0.9375	0.773934893987	0.763239962859524	5.55414885701307e-47	2.97206948657855e-41	uncharacterized LOC105343207	Q9GL77	1	1.6	R02E4.2.1	8.79e-4	tok-PC	0.19	XP_030830839.1	1.51e-5	reviewed	S4A4_BOVIN	Electrogenic sodium bicarbonate cotransporter 1 (Sodium bicarbonate cotransporter) (Solute carrier family 4 member 4)	SLC4A4 NBC NBCE1	Bos taurus (Bovine)	1079	bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]	GO:0005452; GO:0005886; GO:0006814; GO:0008510; GO:0015701; GO:0016021; GO:0016323; GO:0022857; GO:0050801; GO:0051453; GO:0055085
LOC105341857	APOBEC1 complementation factor	3	0.385027886882728	3.79318758841041	0.884057971014493	0.435523347457512	0.494882829841264	2.92636204009721e-298	1.56591973855234e-292	APOBEC1 complementation factor	Q9NQ94	1	0	F58D5.1a.2	1.52e-82	Syp-PC	2.21e-105	XP_781163.3	1.82e-162	reviewed	A1CF_HUMAN	APOBEC1 complementation factor (APOBEC1-stimulating protein)	A1CF ACF ASP	Homo sapiens (Human)	594	cytidine to uridine editing [GO:0016554]; embryo implantation [GO:0007566]; mRNA localization resulting in post-transcriptional regulation of gene expression [GO:0010609]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA demethylation [GO:1901537]; protein stabilization [GO:0050821]	apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; cytidine to uridine editing [GO:0016554]; embryo implantation [GO:0007566]; mRNA localization resulting in post-transcriptional regulation of gene expression [GO:0010609]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA demethylation [GO:1901537]; protein stabilization [GO:0050821]	GO:0003723; GO:0003727; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006397; GO:0007566; GO:0010609; GO:0016554; GO:0016556; GO:0030895; GO:0045293; GO:0050821; GO:1901537; GO:2000623
LOC105347381	uncharacterized LOC105347381	1	0.603457645964072	210.832450977889	0.900550389068134	0.670098701071591	0.199953632898906	1.82679043958414e-183	9.77530178544987e-178	uncharacterized LOC105347381	P00625	2	0.89	F45C12.2.1	3		NA	XP_795812.2	0.078	reviewed	PA2A1_OVOOK	Acidic phospholipase A2 DE-I (svPA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A2 Ook-E6) (Phospholipase A2 PLA2-01)		Ovophis okinavensis (Ryukyu Island pit viper) (Trimeresurus okinavensis)	139	arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]	extracellular region [GO:0005576]; host extracellular space [GO:0043655]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; toxin activity [GO:0090729]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]	GO:0004623; GO:0005509; GO:0005576; GO:0006644; GO:0016042; GO:0043655; GO:0050482; GO:0090729
LOC105347378	uncharacterized LOC105347378	1	0.54347271698928	104.858260712832	0.830138546213703	0.654677125243831	0.193221509042039	3.19164263325481e-177	1.70787350619572e-171	uncharacterized LOC105347378	Q6BMF6	2	1.8	Y102A5B.2b.1	1.8		NA	XP_003725656.2	4	reviewed	DPH2_DEBHA	2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2)	DPH2 DEHA2F05830g	Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) (Yeast) (Torulaspora hansenii)	588	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; 2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	GO:0005737; GO:0017183; GO:0032991; GO:0051539; GO:0090560
LOC105320596	myoneurin	5	0.393846982528017	6.65892328034415	0.79474216380182	0.495565732468459	0.381372119117826	5.11477569103205e-194	2.73695739047678e-188	myoneurin	G5ED84	1	5.04e-8	W02G9.2b.1	3.45e-9	CG15097-PC	1.83e-4	XP_030836723.1	1.08e-15	reviewed	KLHL8_CAEEL	Kelch-like protein 8	kel-8 W02G9.2	Caenorhabditis elegans	690	protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	anchoring junction [GO:0070161]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	GO:0006511; GO:0014069; GO:0016567; GO:0031463; GO:0043005; GO:0043025; GO:0070161
LOC105320586	sodium/hydrogen exchanger 9B2	13	0.410915195923567	2.22539071247775	0.896551724137931	0.458328487760902	0.367730876457827	7.16743568932037e-22	3.83535217684085e-16	sodium/hydrogen exchanger 9B2	Q5BKR2	2	1.36e-113	F41E7.1.1	1.48e-40	Nha1-PB	3.54e-87	XP_030835794.1	3.35e-144	reviewed	SL9B2_MOUSE	Sodium/hydrogen exchanger 9B2 (NHA-oc) (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Soditlum/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2)	Slc9b2 Nha2 Nhedc2	Mus musculus (Mouse)	547	clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]	anchoring junction [GO:0070161]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]	GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0030317; GO:0030672; GO:0031966; GO:0042802; GO:0061178; GO:0070161; GO:0072583; GO:0097228; GO:0097708; GO:2001206
LOC105342897	DNA-binding protein RFX6	6	0.332794579601583	2.63967793834702	0.881401617250674	0.377574278385894	0.544460536759859	2.08446038821278e-169	1.11541142941577e-163	DNA-binding protein RFX6	Q5RJA1	2	0	F33H1.1b.1	2.23e-32	Rfx-PI	3.39e-68	XP_790469.2	0	reviewed	RFX6_DANRE	DNA-binding protein RFX6 (Regulatory factor X 6)	rfx6 si:dkeyp-93d12.2	Danio rerio (Zebrafish) (Brachydanio rerio)	848	endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]	nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]	GO:0000976; GO:0000978; GO:0000981; GO:0003309; GO:0003310; GO:0003311; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0045893; GO:0045944; GO:0050796; GO:0090104
LOC105317153	uncharacterized LOC105317153	3	0.358537398245159	0.798677568527219	0.538302277432712	0.666052166740045	0.280735020738663	2.00988761242623e-167	1.07550694051017e-161	uncharacterized LOC105317153	O06743	1	0.003	T24A6.20.1	6.2e-12	san-PA	7.6	XP_030849959.1	1.91e-12	reviewed	YITH_BACSU	Uncharacterized N-acetyltransferase YitH (EC 2.3.1.-)	yitH BSU10990	Bacillus subtilis (strain 168)	282		N-acetyltransferase activity [GO:0008080]	GO:0008080
LOC105341161	protein FAM234A	3	0.404375330073116	1.26026515113319	0.657004830917875	0.615483039155405	0.39908400834484	3.2640413824914e-239	1.74661465610221e-233	protein FAM234A	A2RU67	1	1.52e-28	F20A1.9.1	6.9	CG6184-PE	1.62e-52	XP_030833671.1	2.44e-56	reviewed	F234B_HUMAN	Protein FAM234B	FAM234B KIAA1467	Homo sapiens (Human)	622		cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	GO:0005794; GO:0005856; GO:0016021
LOC105342289	ETS-related transcription factor Elf-2	9	0.626490127195515	3.00660398721109	0.924187725631769	0.677881895442022	0.691912539923896	3.22612122964593e-182	1.72632327895338e-176	ETS-related transcription factor Elf-2	Q99607	1	6.42e-9	C42D8.4a.1	1.23e-8	Ets98B-PB	3.17e-9	NP_999699.1	1.56e-9	reviewed	ELF4_HUMAN	ETS-related transcription factor Elf-4 (E74-like factor 4) (Myeloid Elf-1-like factor)	ELF4 ELFR MEF	Homo sapiens (Human)	663	cell differentiation [GO:0030154]; innate immune response [GO:0045087]; natural killer cell proliferation [GO:0001787]; NK T cell proliferation [GO:0001866]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; natural killer cell proliferation [GO:0001787]; NK T cell proliferation [GO:0001866]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001787; GO:0001866; GO:0005634; GO:0005654; GO:0006357; GO:0016604; GO:0016605; GO:0030154; GO:0045087; GO:0045893; GO:0045944; GO:1990837
LOC105324617	zinc finger protein 473 homolog	14	0.24198920015344	9.08172207306485	0.956521739130435	0.252988709251323	0.213003323042211	2.26577315714123e-11	1.21243334257153e-5	zinc finger protein 473 homolog	A3KN32	1	1.13e-45	Y55F3AM.14.2	3.71e-34	CG12299-PA	1.85e-41	XP_030833948.1	1.81e-44	reviewed	ZNF34_BOVIN	Zinc finger protein 34	ZNF34	Bos taurus (Bovine)	543	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872
LOC105324593	uncharacterized LOC105324593	12	0.73957823769892	11.9596889603121	0.9375	0.788883453545515	0.769213711662266	2.44766883444735e-47	1.30976717466345e-41	uncharacterized LOC105324593	Q5E9J9	1	0.38	K02B12.1.1	3	Atg17-PC	2.9	XP_030834364.1	8.8	reviewed	STRAA_BOVIN	STE20-related kinase adapter protein alpha (STRAD alpha) (STE20-related adapter protein)	STRADA LYK5 STRAD	Bos taurus (Bovine)	373	activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; protein export from nucleus [GO:0006611]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; serine/threonine protein kinase complex [GO:1902554]; ATP binding [GO:0005524]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activator activity [GO:0043539]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; protein export from nucleus [GO:0006611]; protein phosphorylation [GO:0006468]	GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006611; GO:0007049; GO:0030295; GO:0032147; GO:0043539; GO:1902554
LOC105326681	U1 small nuclear ribonucleoprotein A	7	0.491020849132834	24.2439136529689	0.883783783783784	0.555589339997396	0.460435690167498	6.66339276881965e-143	3.56563477773755e-137	U1 small nuclear ribonucleoprotein A	Q01617	4	1.24e-62	F46A9.6.3	1.06e-29	cpo-PY	2.21e-60	XP_030828402.1	3.12e-100	reviewed	CPO_DROME	Protein couch potato	cpo CG43738	Drosophila melanogaster (Fruit fly)	606	chemical synaptic transmission [GO:0007268]; dormancy process [GO:0022611]; regulation of hemocyte proliferation [GO:0035206]	nucleus [GO:0005634]; synapse [GO:0045202]; mRNA binding [GO:0003729]; chemical synaptic transmission [GO:0007268]; dormancy process [GO:0022611]; regulation of hemocyte proliferation [GO:0035206]	GO:0003729; GO:0005634; GO:0007268; GO:0022611; GO:0035206; GO:0045202
LOC105342498	acidic leucine-rich nuclear phosphoprotein 32 family member A	14	0.198293545678817	23.3598808088412	1	0.198293545678817	0.23853515391833	1.46489398494575e-12	7.83876490496348e-7	acidic leucine-rich nuclear phosphoprotein 32 family member A	Q28XE2	2	1.35e-64	T19H12.2.1	3.91e-25	Mapmodulin-PA	2.84e-52	XP_011672921.1	1.75e-48	reviewed	AN32A_DROPS	Acidic leucine-rich nuclear phosphoprotein 32 family member A	Anp32a Mapmodulin GA19125	Drosophila pseudoobscura pseudoobscura (Fruit fly)	263	nucleocytoplasmic transport [GO:0006913]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nucleocytoplasmic transport [GO:0006913]	GO:0005634; GO:0005737; GO:0005783; GO:0006913; GO:0048471
LOC105320214	uncharacterized LOC105320214	1	0.407176701281568	6.89987864035491	0.88176124501803	0.461776590411662	0.420888942607751	0	0	uncharacterized LOC105320214	Q501P1	1	0.013	K03H1.5.1	0.025	CG9095-PA	0.007	XP_030845903.1	0.001	reviewed	FBLN7_MOUSE	Fibulin-7 (FIBL-7) (Protein TM14)	Fbln7 Tm14	Mus musculus (Mouse)	440	cell adhesion [GO:0007155]; positive regulation of biomineralization [GO:0110151]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; positive regulation of biomineralization [GO:0110151]	GO:0005509; GO:0005615; GO:0007155; GO:0008201; GO:0031012; GO:0043395; GO:0110151
LOC105334677	uncharacterized LOC105334677	7	0.388731210769643	1.92691454878773	0.483783783783784	0.803522614440043	0.301574918056596	1.02276530976936e-93	5.47289899380062e-88	uncharacterized LOC105334677	O60320	4	1.41e-5	F43D9.1.1	0.33	CG13921-PB	8.15e-9	XP_001183561.3	8.99e-6	reviewed	F1891_HUMAN	Protein FAM189A1 (Transmembrane protein 228)	FAM189A1 KIAA0574 TMEM228	Homo sapiens (Human)	539		integral component of membrane [GO:0016021]	GO:0016021
LOC105326722	glycine-rich cell wall structural protein	13	0.440777288050635	5.75547528031557	0.862068965517241	0.511301654138736	0.409128355256371	3.69942820173945e-24	1.97959362617639e-18	glycine-rich cell wall structural protein	Q9QZ04	2	1.07e-4	Y53H1C.2c.1	2.12e-6		NA	XP_030831660.1	0.008	reviewed	MAGL2_MOUSE	MAGE-like protein 2 (Protein nS7)	Magel2	Mus musculus (Mouse)	1284	Arp2/3 complex-mediated actin nucleation [GO:0034314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of actin nucleation [GO:0051127]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; retrograde transport, endosome to Golgi [GO:0042147]; rhythmic process [GO:0048511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nucleus [GO:0005634]; retromer complex [GO:0030904]; ubiquitin-protein transferase activity [GO:0004842]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of actin nucleation [GO:0051127]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; retrograde transport, endosome to Golgi [GO:0042147]; rhythmic process [GO:0048511]	GO:0000122; GO:0004842; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0030904; GO:0034314; GO:0042147; GO:0042752; GO:0045892; GO:0048511; GO:0051127; GO:0070534
LOC105323913	valine-rich protein-like	13	0.450794204571882	8.82682638916184	1	0.450794204571882	0.454924944904322	1.09359700832311e-26	5.85192507929762e-21	valine-rich protein-like	H2A0K6	1	1.97e-37	B0491.8c.1	0.63		NA	XP_030833450.1	0.6	reviewed	VRP_PINMG	Valine-rich protein (Alveoline-like protein)		Margaritifera margaritifera (Freshwater pearl mussel)	238		extracellular region [GO:0005576]	GO:0005576
LOC105326721	mantle protein	13	0.453647641673423	9.72327705576231	1	0.453647641673423	0.430935491778297	2.31025156617192e-25	1.23623409507112e-19	mantle protein	P86948	1	3.54e-42	F26A3.8a.1	3.1	CG11970-PB	0.29	XP_030846345.1	2.2	reviewed	MP_PINMA	Mantle protein (MP)		Pinctada maxima (Silver-lipped pearl oyster) (White-lipped pearl oyster)	260		extracellular region [GO:0005576]	GO:0005576
LOC105319410	PE-PGRS family protein PE_PGRS16	13	0.457740204866655	5.06418754090772	1	0.457740204866655	0.387025932147878	6.15411797033618e-23	3.29311775887065e-17	PE-PGRS family protein PE_PGRS16	Q9I7U4	3	5.1	F32A5.1b.1	1.2	CG15040-PA	1.9	XP_030833604.1	2.5	reviewed	TITIN_DROME	Titin (D-Titin) (Kettin)	sls titin CG1915	Drosophila melanogaster (Fruit fly)	18141	cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522]	GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0016203; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0040011; GO:0045214; GO:0051301
LOC105333510	spermatogenesis-associated protein 17	11	0.506506268216983	10.1010266645631	0.957446808510638	0.529017657915516	0.616224875846055	2.5551010124785e-50	1.36725499258534e-44	spermatogenesis-associated protein 17	Q96L03	1	1.05e-80	T05C1.4a.1	0.041	CG18063-PE	5.03e-5	XP_030855284.1	3.57e-127	reviewed	SPT17_HUMAN	Spermatogenesis-associated protein 17	SPATA17	Homo sapiens (Human)	361		cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]	GO:0005516; GO:0005737
LOC105327632	deleted in malignant brain tumors 1 protein	13	0.387991554200653	1.87292635266494	0.931034482758621	0.416731669326627	0.357745512625401	2.5541348511884e-21	1.36673799194972e-15	deleted in malignant brain tumors 1 protein	Q9UGM3	2	5.07e-159	C06B8.7.1	1.85e-5	teq-PD	3.81e-20	XP_030853316.1	0	reviewed	DMBT1_HUMAN	Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)	DMBT1 GP340	Homo sapiens (Human)	2413	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of bacterial lipoprotein [GO:0042494]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; extracellular matrix binding [GO:0050840]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of bacterial lipoprotein [GO:0042494]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0006952; GO:0015031; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042494; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0050840; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399
LOC105326272	probable serine/threonine-protein kinase kinX	5	0.349156671725885	2.40543808391166	0.57633973710819	0.605817453222632	0.270104439409999	4.69277091490658e-137	2.51113925873383e-131	probable serine/threonine-protein kinase kinX	O88799	1	0.46	C56G2.1d.1	1.1	CG43233-PA	1.8	XP_030840729.1	2.51e-23	reviewed	ZAN_MOUSE	Zonadhesin	Zan	Mus musculus (Mouse)	5376	binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; regulation of binding of sperm to zona pellucida [GO:2000359]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix binding [GO:0050840]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; regulation of binding of sperm to zona pellucida [GO:2000359]	GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0016021; GO:0031012; GO:0050840; GO:2000359
LOC105321527	peptidyl-prolyl cis-trans isomerase B	5	0.537803434776347	17.7709326864213	0.86046511627907	0.625014802577916	0.481678333654127	4.73503022180596e-246	2.53375255193014e-240	peptidyl-prolyl cis-trans isomerase B	P23284	2	6.39e-73	F31C3.1.2	9.46e-69	CG2852-PD	2.29e-68	XP_030829796.1	1.12e-70	reviewed	PPIB_HUMAN	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)	PPIB CYPB	Homo sapiens (Human)	216	bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral process [GO:0044794]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral process [GO:0044794]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]	GO:0000413; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006457; GO:0016018; GO:0016020; GO:0030593; GO:0032991; GO:0034663; GO:0040018; GO:0042470; GO:0043231; GO:0044794; GO:0044829; GO:0048471; GO:0050821; GO:0051082; GO:0060348; GO:0061077; GO:0070062; GO:0070063
LOC105321539	uncharacterized LOC105321539	8	0.63334602411402	7.93571812187449	0.867924528301887	0.729724766913979	0.62283666802111	1.08061062840334e-177	5.78243392143654e-172	uncharacterized LOC105321539	F4HRS2	2	0.59	Y27F2A.7.1	1.3	inaC-PA	0.35	XP_030835572.1	0.5	reviewed	SWTIE_ARATH	Protein SWEETIE	SWEETIE At1g67140 F5A8.5	Arabidopsis thaliana (Mouse-ear cress)	2222	carbohydrate metabolic process [GO:0005975]; ethylene biosynthetic process [GO:0009693]; regulation of ethylene biosynthetic process [GO:0010364]; regulation of leaf senescence [GO:1900055]; starch metabolic process [GO:0005982]; trehalose metabolic process [GO:0005991]	carbohydrate metabolic process [GO:0005975]; ethylene biosynthetic process [GO:0009693]; regulation of ethylene biosynthetic process [GO:0010364]; regulation of leaf senescence [GO:1900055]; starch metabolic process [GO:0005982]; trehalose metabolic process [GO:0005991]	GO:0005975; GO:0005982; GO:0005991; GO:0009693; GO:0010364; GO:1900055
LOC105318190	silk gland factor 1	6	0.37518653327013	3.98964681747136	0.954177897574124	0.393203965658808	0.635947830481242	3.19761434688599e-198	1.71106901793347e-192	silk gland factor 1	O42097	1	1.38e-90	F38A6.1b.1	5.3e-57	fkh-PD	7.27e-73	NP_001073010.1	7.17e-95	reviewed	FOXA2_ORYLA	Hepatocyte nuclear factor 3-beta (HNF-3-beta) (HNF-3B) (Forkhead box protein A2) (Me-HNF3B)	foxa2 hnf3b	Oryzias latipes (Japanese rice fish) (Japanese killifish)	415	anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; system development [GO:0048731]	nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; system development [GO:0048731]	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0019904; GO:0030154; GO:0048731
LOC105349024	helicase-like transcription factor	8	0.361989791461269	1.92900614785901	0.518867924528302	0.697653052634446	0.312166371874993	4.35199161836782e-89	2.32878553092157e-83	helicase-like transcription factor	Q14527	2	0	F54E12.2.2	1.52e-60	lds-PA	1.14e-60	XP_030837525.1	0	reviewed	HLTF_HUMAN	Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (DNA-binding protein/plasminogen activator inhibitor 1 regulator) (HIP116) (RING finger protein 80) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3)	HLTF HIP116A RNF80 SMARCA3 SNF2L3 ZBU1	Homo sapiens (Human)	1009	DNA repair [GO:0006281]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767]	GO:0003677; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006281; GO:0008094; GO:0008270; GO:0016020; GO:0016363; GO:0016567; GO:0016818; GO:0031625; GO:0042789; GO:0045944; GO:0050767; GO:0061630; GO:0090575; GO:0140658
LOC105320106	follistatin-related protein 3	2	0.204743079745997	3.78132989753299	0.57425491439442	0.356536922216694	0.138683882851784	5.12513593943439e-141	2.74250124227886e-135	follistatin-related protein 3	O95633	1	4.22e-9	F41G3.12.1	2.77e-6	CG32354-PA	7.97e-4	XP_783040.4	1.13e-9	reviewed	FSTL3_HUMAN	Follistatin-related protein 3 (Follistatin-like protein 3) (Follistatin-related gene protein)	FSTL3 FLRG UNQ674/PRO1308	Homo sapiens (Human)	263	cell differentiation [GO:0030154]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0090101]; ossification [GO:0001503]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of BMP signaling pathway [GO:0030510]; regulation of transcription by RNA polymerase II [GO:0006357]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activin binding [GO:0048185]; fibronectin binding [GO:0001968]; cell differentiation [GO:0030154]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0090101]; ossification [GO:0001503]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of BMP signaling pathway [GO:0030510]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0001503; GO:0001968; GO:0002244; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005788; GO:0006357; GO:0022409; GO:0030154; GO:0030510; GO:0030514; GO:0032926; GO:0045671; GO:0045944; GO:0048185; GO:0090101
LOC105326367	protein dead ringer homolog	10	0.372405342308778	2.89459666029737	0.5	0.744810684617557	0.318510039115924	1.64399873403095e-62	8.79716874569834e-57	protein dead ringer homolog	Q4H3P5	1	2.88e-82	T23D8.8.1	5.53e-70	retn-PC	5.03e-74	XP_011669570.1	1.97e-79	reviewed	DRI_CIOIN	Protein dead ringer homolog	Ci-DRIL1/2	Ciona intestinalis (Transparent sea squirt) (Ascidia intestinalis)	571	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]; DNA binding [GO:0003677]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0003677; GO:0005634; GO:0006357
LOC105327296	allene oxide synthase-lipoxygenase protein	2	0.205133604528815	2.83983449509626	0.653138871274572	0.31407348965237	0.161459919964286	2.6161806292973e-164	1.39993918418202e-158	allene oxide synthase-lipoxygenase protein	O16025	1	1.52e-108	C13C4.7.2	3.02e-4	CG30048-PD	9.88e-5	XP_030849258.1	0	reviewed	AOSL_PLEHO	Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)]		Plexaura homomalla (Black sea rod)	1066	arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; oxylipin biosynthetic process [GO:0031408]	cytoplasm [GO:0005737]; membrane [GO:0016020]; allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; oxylipin biosynthetic process [GO:0031408]	GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0047677
LOC105347275	double homeobox protein B	14	0.304300591966912	10.5360045406207	0.826086956521739	0.368363874486262	0.246538940148577	6.21409981398434e-13	3.32521452326153e-7	double homeobox protein B	Q93356	2	8.65e-9	C37E2.5a.3	7.62e-10	oc-PE	3.61e-7	XP_003727685.2	4.7e-8	reviewed	HM37_CAEEL	Homeobox protein ceh-37	ceh-37 C37E2.5	Caenorhabditis elegans	278	neuron fate specification [GO:0048665]; olfactory behavior [GO:0042048]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere organization [GO:0032200]	chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; telomeric DNA binding [GO:0042162]; neuron fate specification [GO:0048665]; olfactory behavior [GO:0042048]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere organization [GO:0032200]	GO:0000723; GO:0000781; GO:0000978; GO:0000981; GO:0003691; GO:0005634; GO:0006355; GO:0006357; GO:0008301; GO:0016233; GO:0032200; GO:0042048; GO:0042162; GO:0048665
LOC105347275	double homeobox protein B	6	0.30545415968554	8.74278807891604	0.956873315363881	0.319221107727705	0.531628216862503	2.21098063286071e-165	1.18311342448883e-159	double homeobox protein B	Q93356	2	8.65e-9	C37E2.5a.3	7.62e-10	oc-PE	3.61e-7	XP_003727685.2	4.7e-8	reviewed	HM37_CAEEL	Homeobox protein ceh-37	ceh-37 C37E2.5	Caenorhabditis elegans	278	neuron fate specification [GO:0048665]; olfactory behavior [GO:0042048]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere organization [GO:0032200]	chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded telomeric DNA binding [GO:0003691]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; telomeric DNA binding [GO:0042162]; neuron fate specification [GO:0048665]; olfactory behavior [GO:0042048]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere organization [GO:0032200]	GO:0000723; GO:0000781; GO:0000978; GO:0000981; GO:0003691; GO:0005634; GO:0006355; GO:0006357; GO:0008301; GO:0016233; GO:0032200; GO:0042048; GO:0042162; GO:0048665
LOC105340413	isthmin-1	4	0.404642839908255	7.59920533166396	0.645865834633385	0.62651222314297506	0.32911778823225	5.60421361418669e-187	2.99885953866021e-181	isthmin-1	Q5EGE1	1	1.24e-61	C02B4.1.1	4.81e-4	AdamTS-A-PE	0.033	XP_011682695.2	1.24e-48	reviewed	ISM1_DANRE	Isthmin-1	ism1	Danio rerio (Zebrafish) (Brachydanio rerio)	461	angiogenesis [GO:0001525]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of angiogenesis [GO:0016525]	extracellular region [GO:0005576]; angiogenesis [GO:0001525]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of angiogenesis [GO:0016525]	GO:0001525; GO:0005576; GO:0016525; GO:0030218; GO:0035162; GO:0071425
LOC105348209	uncharacterized LOC105348209	12	0.664764435647407	26.7944825020791	0.96875	0.686208449700549	0.792823859526535	9.59578312199078e-49	5.13478031484224e-43	uncharacterized LOC105348209	Q9JLT0	1	3.51e-37	F20G4.3.1	1.28e-33	uif-PG	1.75e-6	XP_030834372.1	0	reviewed	MYH10_RAT	Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB)	Myh10	Rattus norvegicus (Rat)	1976	actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; adult heart development [GO:0007512]; aorta development [GO:0035904]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cardiac myofibril assembly [GO:0055003]; cardiac septum development [GO:0003279]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cerebellar Purkinje cell layer development [GO:0021680]; coronary vasculature development [GO:0060976]; exocytosis [GO:0006887]; fourth ventricle development [GO:0021592]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral ventricle development [GO:0021670]; mitotic cytokinesis [GO:0000281]; myofibril assembly [GO:0030239]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nuclear migration [GO:0007097]; plasma membrane repair [GO:0001778]; positive regulation of protein secretion [GO:0050714]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; retina development in camera-type eye [GO:0060041]; substrate-dependent cell migration, cell extension [GO:0006930]; third ventricle development [GO:0021678]; ventricular cardiac muscle cell development [GO:0055015]	actomyosin [GO:0042641]; axon [GO:0030424]; brush border [GO:0005903]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; polysome [GO:0005844]; postsynaptic actin cytoskeleton [GO:0098871]; spindle [GO:0005819]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; adult heart development [GO:0007512]; aorta development [GO:0035904]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cardiac myofibril assembly [GO:0055003]; cardiac septum development [GO:0003279]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cerebellar Purkinje cell layer development [GO:0021680]; coronary vasculature development [GO:0060976]; exocytosis [GO:0006887]; fourth ventricle development [GO:0021592]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral ventricle development [GO:0021670]; mitotic cytokinesis [GO:0000281]; myofibril assembly [GO:0030239]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nuclear migration [GO:0007097]; plasma membrane repair [GO:0001778]; positive regulation of protein secretion [GO:0050714]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; retina development in camera-type eye [GO:0060041]; substrate-dependent cell migration, cell extension [GO:0006930]; third ventricle development [GO:0021678]; ventricular cardiac muscle cell development [GO:0055015]	GO:0000146; GO:0000281; GO:0001701; GO:0001725; GO:0001764; GO:0001778; GO:0003279; GO:0005516; GO:0005524; GO:0005737; GO:0005819; GO:0005829; GO:0005844; GO:0005903; GO:0005938; GO:0006887; GO:0006930; GO:0007097; GO:0007155; GO:0007409; GO:0007411; GO:0007420; GO:0007507; GO:0007512; GO:0008283; GO:0008360; GO:0009898; GO:0016459; GO:0016460; GO:0021592; GO:0021670; GO:0021678; GO:0021680; GO:0030027; GO:0030036; GO:0030048; GO:0030239; GO:0030424; GO:0030426; GO:0030496; GO:0031032; GO:0031175; GO:0031594; GO:0032154; GO:0032982; GO:0035613; GO:0035904; GO:0042641; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043531; GO:0048027; GO:0050714; GO:0050885; GO:0051015; GO:0051017; GO:0055003; GO:0055015; GO:0060041; GO:0060976; GO:0070650; GO:0097513; GO:0098871; GO:0098974; GO:0098978; GO:1905274
LOC105328000	calmodulin-A	11	0.573537572988273	8.2437049906752	0.872340425531915	0.657469900742654	0.56884477864662	1.44721688398991e-46	7.74417332358071e-41	calmodulin-A	P41041	1	1.72e-70	T21H3.3a.1	2.4e-69	Cam-PD	1.59e-60	XP_030854314.1	3.87e-70	reviewed	CALM_PNECA	Calmodulin (CaM)		Pneumocystis carinii	151	calcium-mediated signaling [GO:0019722]	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]	GO:0005509; GO:0019722
LOC105328003	calmodulin	11	0.539677880304963	11.9685168790263	0.936170212765957	0.576474099416666	0.623439617729616	6.85041380111861e-51	3.66571122828897e-45	calmodulin	P04352	2	4.3e-27	T21H3.3a.1	8.22e-27	Cam-PD	1.97e-24	XP_011675927.1	2.57e-27	reviewed	CALM_CHLRE	Calmodulin (CaM)		Chlamydomonas reinhardtii (Chlamydomonas smithii)	163	calcium-mediated signaling [GO:0019722]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]	GO:0005509; GO:0005737; GO:0005856; GO:0019722; GO:0031514
LOC105328005	calmodulin-A	14	0.337117978983669	5.05720568499848	0.782608695652174	0.430761862034689	0.290996153734719	5.34158834081194e-15	2.8583266538752e-9	calmodulin-A	P02594	2	1.23e-68	T21H3.3a.1	5.43e-69	Cam-PD	1.3e-68	XP_030854314.1	2.92e-70	reviewed	CALM_ELEEL	Calmodulin (CaM)	calm	Electrophorus electricus (Electric eel) (Gymnotus electricus)	149		calcium ion binding [GO:0005509]	GO:0005509
LOC105328005	calmodulin-A	6	0.385985429614837	4.7050316079626	0.948787061994609	0.406819870417911	0.695974658361199	3.08440039271921e-217	1.65048732534719e-211	calmodulin-A	P02594	2	1.23e-68	T21H3.3a.1	5.43e-69	Cam-PD	1.3e-68	XP_030854314.1	2.92e-70	reviewed	CALM_ELEEL	Calmodulin (CaM)	calm	Electrophorus electricus (Electric eel) (Gymnotus electricus)	149		calcium ion binding [GO:0005509]	GO:0005509
LOC105328008	calmodulin-A	7	0.575675247129266	4.04088224357593	0.648648648648649	0.887499339324286	0.460366797464223	7.00082125399537e-143	3.74619545958296e-137	calmodulin-A	Q95NR9	3	1.1e-83	T21H3.3a.1	1.45e-83	Cam-PD	9.14e-84	XP_001177619.1	7.29e-84	reviewed	CALM_METSE	Calmodulin (CaM)		Metridium senile (Brown sea anemone) (Frilled sea anemone)	149	calcium-mediated signaling [GO:0019722]	calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]	GO:0005509; GO:0019722
LOC105338027	forkhead box protein B1	2	0.255426177698487	11.1079707542643	0.509194673430564	0.501627748730404	0.133618755535572	7.44860597501044e-136	3.98580864607589e-130	forkhead box protein B1	Q64732	2	8.02e-53	F38A6.1b.1	9.33e-48	fkh-PD	4.64e-47	XP_003727565.2	6.06e-80	reviewed	FOXB1_MOUSE	Forkhead box protein B1 (Transcription factor FKH-5)	Foxb1 Fkh5 Foxb1a Foxb1b Mf3	Mus musculus (Mouse)	325	anatomical structure morphogenesis [GO:0009653]; axon target recognition [GO:0007412]; cell differentiation [GO:0030154]; cell migration in diencephalon [GO:0061381]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; floor plate development [GO:0033504]; hypothalamus cell migration [GO:0021855]; inferior colliculus development [GO:0061379]; lactation [GO:0007595]; mammary gland lobule development [GO:0061377]; mammillary body development [GO:0021767]; mammillothalamic axonal tract development [GO:0061374]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of transcription by RNA polymerase II [GO:0006357]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; telencephalon cell migration [GO:0022029]; thalamus development [GO:0021794]; urogenital system development [GO:0001655]; visual learning [GO:0008542]	nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; axon target recognition [GO:0007412]; cell differentiation [GO:0030154]; cell migration in diencephalon [GO:0061381]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; floor plate development [GO:0033504]; hypothalamus cell migration [GO:0021855]; inferior colliculus development [GO:0061379]; lactation [GO:0007595]; mammary gland lobule development [GO:0061377]; mammillary body development [GO:0021767]; mammillothalamic axonal tract development [GO:0061374]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of transcription by RNA polymerase II [GO:0006357]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; telencephalon cell migration [GO:0022029]; thalamus development [GO:0021794]; urogenital system development [GO:0001655]; visual learning [GO:0008542]	GO:0000978; GO:0000981; GO:0001655; GO:0001756; GO:0005634; GO:0006357; GO:0007412; GO:0007595; GO:0008542; GO:0009653; GO:0021510; GO:0021767; GO:0021794; GO:0021855; GO:0022029; GO:0030154; GO:0030901; GO:0033504; GO:0043524; GO:0043565; GO:0061030; GO:0061374; GO:0061377; GO:0061379; GO:0061381; GO:1990837
LOC105324613	chitin synthase chs-2	1	0.507459807149093	5.67461706186467	0.771493642057316	0.657762785699526	0.371546677455954	0	0	chitin synthase chs-2	G5EBQ8	1	0	F48A11.1b.1	0	kkv-PD	0	XP_030836433.1	0.63	reviewed	CHS2_CAEEL	Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)	chs-2 F48A11.1	Caenorhabditis elegans	1668	cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063]	cell periphery [GO:0071944]; cell septum [GO:0030428]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063]	GO:0004100; GO:0005886; GO:0006031; GO:0006038; GO:0016021; GO:0030428; GO:0061063; GO:0071944
LOC105335795	uncharacterized LOC105335795	4	0.182007194215606	14.622981585534	0.994539781591264	0.183006449399534	0.394136906013702	1.57240662540561e-224	8.41407364507546e-219	uncharacterized LOC105335795		NA	NA	C49H3.1.1	1.7	escl-PC	0.29	XP_030851350.1	5.4	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105329519	dynein light chain 1, axonemal	11	0.51371138487478	11.795622107494	0.936170212765957	0.548737161116242	0.564220513021556	3.36299102515189e-46	1.79956340148698e-40	dynein light chain 1, axonemal	Q05A62	2	8.76e-99	K10D2.8.1	1.62e-10	CG8800-PA	5.57e-65	XP_030855209.1	2.04e-88	reviewed	DNAL1_MOUSE	Dynein axonemal light chain 1	Dnal1 Dnalc1	Mus musculus (Mouse)	190	outer dynein arm assembly [GO:0036158]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; outer dynein arm assembly [GO:0036158]	GO:0005737; GO:0005874; GO:0036157; GO:0036158; GO:0043014; GO:0045504
LOC105336795	paired mesoderm homeobox protein 2	7	0.622036225685509	9.98331296244279	0.902702702702703	0.689082046418078	0.689205562991093	9.25914589777243e-215	4.95464304306521e-209	paired mesoderm homeobox protein 2	O97039	1	1.58e-25	F58E6.10a.1	3e-49	CG32532-PC	1.83e-69	XP_785238.2	1.47e-23	reviewed	RX_DUGJA	Retinal homeobox protein Rax (DjRax)	RAX	Dugesia japonica (Planarian)	268		nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]	GO:0000981; GO:0003677; GO:0005634
LOC105330091	dimethylaniline monooxygenase [N-oxide-forming] 5	14	0.198939732443429	7.67445373484568	0.695652173913044	0.28597586538743	0.107243097579358	2.0955399616979e-6	1	dimethylaniline monooxygenase [N-oxide-forming] 5	P49109	2	9.61e-156	F53F4.5a.1	5.12e-136	Fmo-2-PA	2.31e-49	XP_786100.3	8.08e-148	reviewed	FMO5_CAVPO	Flavin-containing monooxygenase 5 (FMO 5) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (NADPH oxidase) (EC 1.6.3.1)	FMO5	Cavia porcellus (Guinea pig)	533	lipid metabolic process [GO:0006629]; NADPH oxidation [GO:0070995]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; aldehyde oxidase activity [GO:0004031]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]; lipid metabolic process [GO:0006629]; NADPH oxidation [GO:0070995]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805]	GO:0004031; GO:0004497; GO:0004499; GO:0005789; GO:0005829; GO:0006629; GO:0006805; GO:0016021; GO:0050660; GO:0050661; GO:0070995; GO:0090181; GO:0106294
LOC105318132	keratin, type II cytoskeletal 2 epidermal-like	13	0.39908055832936	6.57440126645919	0.96551724137931	0.413333435412551	0.330591366612889	8.10021015137844e-20	4.33448725368382e-14	keratin, type II cytoskeletal 2 epidermal-like	P40477	1	0.003	T07D4.4a.1	2.6		NA	XP_792448.4	1	reviewed	NU159_YEAST	Nucleoporin NUP159 (Nuclear pore protein NUP159)	NUP159 NUP158 RAT7 YIL115C	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1460	ncRNA export from nucleus [GO:0097064]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore localization [GO:0051664]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein export from nucleus [GO:0006611]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; selective autophagy [GO:0061912]	nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleus [GO:0005634]; adenyl-nucleotide exchange factor activity [GO:0000774]; structural constituent of nuclear pore [GO:0017056]; transcription corepressor activity [GO:0003714]; ncRNA export from nucleus [GO:0097064]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore localization [GO:0051664]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein export from nucleus [GO:0006611]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; selective autophagy [GO:0061912]	GO:0000055; GO:0000056; GO:0000774; GO:0003714; GO:0005634; GO:0005635; GO:0005643; GO:0006607; GO:0006611; GO:0006913; GO:0016973; GO:0017056; GO:0031965; GO:0044613; GO:0044614; GO:0051664; GO:0061912; GO:0097064
LOC105330266	uncharacterized LOC105330266	1	0.434485701492955	35.0058084106816	0.993736951983299	0.437224056754466	0.792624334764211	0	0	uncharacterized LOC105330266	P55000	2	0.048	K04A8.9.1	0.34	CG7781-PB	2.64e-5	XP_030844860.1	0.012	reviewed	SLUR1_HUMAN	Secreted Ly-6/uPAR-related protein 1 (SLURP-1) (ARS component B) (ARS(component B)-81/S) (Anti-neoplastic urinary protein) (ANUP)	SLURP1 ARS	Homo sapiens (Human)	103	cell activation [GO:0001775]; cell adhesion [GO:0007155]; locomotory behavior [GO:0007626]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; neuromuscular process controlling posture [GO:0050884]; urokinase plasminogen activator signaling pathway [GO:0038195]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; acetylcholine receptor activator activity [GO:0030549]; cytokine activity [GO:0005125]; cell activation [GO:0001775]; cell adhesion [GO:0007155]; locomotory behavior [GO:0007626]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; neuromuscular process controlling posture [GO:0050884]; urokinase plasminogen activator signaling pathway [GO:0038195]	GO:0001775; GO:0005125; GO:0005576; GO:0005615; GO:0007155; GO:0007626; GO:0008285; GO:0010839; GO:0030336; GO:0030549; GO:0038195; GO:0050884; GO:0070062
LOC105334607	structural maintenance of chromosomes protein 5	8	0.443777916038539	7.17415792991176	0.880503144654088	0.504004918929483	0.514385688115922	1.49769288544266e-146	8.01427444543452e-141	structural maintenance of chromosomes protein 5	Q8CG46	1	0	C27A2.1.1	5.12e-101	SMC5-PF	5.25e-77	XP_030832464.1	0	reviewed	SMC5_MOUSE	Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (mSMC5) (Protein expressed in male leptotene and zygotene spermatocytes 453) (MLZ-453)	Smc5 Kiaa0594 Smc5l1	Mus musculus (Mouse)	1101	cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]	cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]	GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0003697; GO:0005524; GO:0005634; GO:0005737; GO:0006974; GO:0007059; GO:0016605; GO:0016607; GO:0016887; GO:0018393; GO:0019827; GO:0030054; GO:0030261; GO:0030915; GO:0034184; GO:0035061; GO:0035861; GO:0044772; GO:0051301; GO:0051984; GO:0071459; GO:0090398
LOC105341338	uncharacterized LOC105341338	3	0.338951063181816	15.0311508605855	0.98895790200138	0.342735583077775	0.560737124008509	0	0	uncharacterized LOC105341338	Q9I8X3	1	0.1	F28H7.11.1	1.3		NA	XP_030844854.1	7.4	reviewed	FGFR3_DANRE	Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1)	fgfr3	Danio rerio (Zebrafish) (Brachydanio rerio)	800	apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; regulation of hematopoietic stem cell differentiation [GO:1902036]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; regulation of hematopoietic stem cell differentiation [GO:1902036]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	GO:0004714; GO:0005007; GO:0005524; GO:0005887; GO:0006915; GO:0007169; GO:0008284; GO:0017134; GO:0033674; GO:0043235; GO:0043410; GO:1902036
LOC105342811	galectin-4	3	0.337032945879304	2.29284206612683	0.750862663906142	0.448860972958742	0.3652196692501	1.52743271301112e-218	8.17341464193952e-213	galectin-4	O54891	1	7.99e-37	ZK892.1b.1	2.67e-33	galectin-PB	7.38e-14	XP_030855227.1	4.73e-38	reviewed	LEG6_MOUSE	Galectin-6 (Gal-6)	Lgals6	Mus musculus (Mouse)	301	antibacterial peptide biosynthetic process [GO:0002780]; defense response to bacterium [GO:0042742]	carbohydrate binding [GO:0030246]; antibacterial peptide biosynthetic process [GO:0002780]; defense response to bacterium [GO:0042742]	GO:0002780; GO:0030246; GO:0042742
LOC105346311	usherin-like	7	0.380419725226987	1.56826633790833	0.572972972972973	0.663940086481062	0.350774064307987	6.86321553482273e-109	3.67256153840792e-103	usherin-like	O75445	3	0	K08C7.3a.1	8.37e-95	LanA-PA	1.7e-81	XP_030854301.1	0	reviewed	USH2A_HUMAN	Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein)	USH2A	Homo sapiens (Human)	5202	animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601]	apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601]	GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0009887; GO:0009888; GO:0016021; GO:0016324; GO:0016477; GO:0017022; GO:0032391; GO:0032421; GO:0034446; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050896; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696
LOC105345931	homeobox protein prospero	4	0.480187212259048	6.76122401059254	0.668486739469579	0.718319727089964	0.387439600249941	1.20368609483622e-220	6.44102058835618e-215	homeobox protein prospero	P29617	3	5.33e-80	K12H4.1.1	3.04e-68	pros-PL	2.86e-80	XP_030854159.1	1.33e-76	reviewed	PROS_DROME	Homeobox protein prospero	pros CG17228	Drosophila melanogaster (Fruit fly)	1703	asymmetric neuroblast division [GO:0055059]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; axonogenesis involved in innervation [GO:0060385]; brain development [GO:0007420]; cell dedifferentiation [GO:0043697]; cell fate commitment [GO:0045165]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; G1 to G0 transition [GO:0070314]; ganglion mother cell fate determination [GO:0007402]; glial cell differentiation [GO:0010001]; male courtship behavior [GO:0008049]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast differentiation [GO:0014016]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; R7 cell fate commitment [GO:0007465]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron differentiation [GO:0045664]; regulation of protein localization to nucleus [GO:1900180]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of taste [GO:0050909]; synapse assembly [GO:0007416]	apical cortex [GO:0045179]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; asymmetric neuroblast division [GO:0055059]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; axonogenesis involved in innervation [GO:0060385]; brain development [GO:0007420]; cell dedifferentiation [GO:0043697]; cell fate commitment [GO:0045165]; central nervous system development [GO:0007417]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; G1 to G0 transition [GO:0070314]; ganglion mother cell fate determination [GO:0007402]; glial cell differentiation [GO:0010001]; male courtship behavior [GO:0008049]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast differentiation [GO:0014016]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; R7 cell fate commitment [GO:0007465]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gene expression [GO:0010468]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron differentiation [GO:0045664]; regulation of protein localization to nucleus [GO:1900180]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of taste [GO:0050909]; synapse assembly [GO:0007416]	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0002052; GO:0003677; GO:0003700; GO:0005634; GO:0005886; GO:0005938; GO:0006357; GO:0007399; GO:0007402; GO:0007405; GO:0007406; GO:0007409; GO:0007411; GO:0007416; GO:0007417; GO:0007420; GO:0007422; GO:0007465; GO:0008049; GO:0008104; GO:0008285; GO:0010001; GO:0010468; GO:0010628; GO:0010629; GO:0014016; GO:0043565; GO:0043697; GO:0045165; GO:0045179; GO:0045180; GO:0045664; GO:0045676; GO:0045944; GO:0048813; GO:0050771; GO:0050909; GO:0051090; GO:0055059; GO:0055060; GO:0060385; GO:0061564; GO:0070314; GO:0070983; GO:1900180; GO:1902692
LOC105317802	calmodulin-like protein 12	11	0.510793091608775	9.01987934084269	0.851063829787234	0.600181882640311	0.52405638905378	5.08781772140596e-43	2.7225319652661e-37	calmodulin-like protein 12	P27164	2	9.09e-45	T21H3.3a.1	1.63e-43	Cam-PD	1.59e-43	XP_011675926.1	1.07e-44	reviewed	CALM3_PETHY	Calmodulin-related protein	CAM53	Petunia hybrida (Petunia)	184		calcium ion binding [GO:0005509]	GO:0005509
LOC105345100	uncharacterized LOC105345100	14	0.263058818035493	4.75887388816465	0.652173913043478	0.403356854321089	0.196659388543214	1.31191121162242e-10	7.02014184628848e-5	uncharacterized LOC105345100	Q8IID4	1	0.91	K11C4.5k.1	1.3	CG13577-PB	1.4	XP_030833117.1	1.66e-11	reviewed	DYHC2_PLAF7	Dynein heavy chain-like protein 2	PF11_0240 PF3D7_1122900	Plasmodium falciparum (isolate 3D7)	5251	microtubule-based movement [GO:0007018]	axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; microtubule-based movement [GO:0007018]	GO:0003774; GO:0003777; GO:0005524; GO:0005874; GO:0005875; GO:0005930; GO:0007018; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959
LOC105321187	sodium channel protein 1 brain	12	0.672887430724654	15.6216673854474	1	0.672887430724654	0.929857827914474	6.47877479001699e-57	3.46684422033641e-51	sodium channel protein 1 brain	P15390	1	0	C54D2.5a.3	7.08e-134	NaCP60E-PJ	0	XP_030833315.1	0	reviewed	SCN4A_RAT	Sodium channel protein type 4 subunit alpha (Mu-1) (SkM1) (Sodium channel protein skeletal muscle subunit alpha) (Sodium channel protein type IV subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.4)	Scn4a	Rattus norvegicus (Rat)	1840	cation transport [GO:0006812]; choline transport [GO:0015871]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction by action potential [GO:0100001]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; cation transport [GO:0006812]; choline transport [GO:0015871]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction by action potential [GO:0100001]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	GO:0001518; GO:0005244; GO:0005248; GO:0005887; GO:0006812; GO:0006813; GO:0006814; GO:0015871; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0086010; GO:0100001
LOC105333922	forkhead box protein L2	4	0.240534003655447	5.36015261163741	0.284711388455538	0.844834500510365	0.132830012880288	1.30319897750829e-75	6.97352198456506e-70	forkhead box protein L2	Q12951	3	2.25e-31	C25A1.2.2	1.41e-39	fd102C-PA	3.8e-36	XP_003725384.1	8.84e-47	reviewed	FOXI1_HUMAN	Forkhead box protein I1 (Forkhead-related protein FKHL10) (Forkhead-related transcription factor 6) (FREAC-6) (Hepatocyte nuclear factor 3 forkhead homolog 3) (HFH-3) (HNF-3/fork-head homolog 3)	FOXI1 FKHL10 FREAC6	Homo sapiens (Human)	378	anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; embryo development ending in birth or egg hatching [GO:0009792]; inner ear morphogenesis [GO:0042472]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; embryo development ending in birth or egg hatching [GO:0009792]; inner ear morphogenesis [GO:0042472]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005730; GO:0006357; GO:0008301; GO:0009653; GO:0009792; GO:0030154; GO:0042472; GO:0043231; GO:0043565; GO:0045944; GO:1990837
LOC105333915	zinc finger protein basonuclin-2	10	0.272607737307497	7.84814224409473	0.670588235294118	0.406520310019951	0.255195605957028	2.26707521330864e-50	1.21313008324316e-44	zinc finger protein basonuclin-2	Q6ZN30	1	2.66e-73	F55C5.11.1	1.09e-17	disco-r-PD	1.96e-26	XP_001180755.2	6.42e-7	reviewed	BNC2_HUMAN	Zinc finger protein basonuclin-2	BNC2	Homo sapiens (Human)	1099	endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; rDNA binding [GO:0000182]; endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586]	GO:0000182; GO:0000785; GO:0003416; GO:0005634; GO:0005654; GO:0006355; GO:0043586; GO:0046872; GO:0060021; GO:0060485
LOC117689456	uncharacterized LOC117689456_ncRNA	6	0.61905084464145	12.4690990851436	0.975741239892183	0.634441611497176	0.847076687086814	1.68874671317896e-265	9.03661876195765e-260	uncharacterized LOC117689456_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105341333	homeobox protein six1	5	0.471464334421263	7.98949566629248	0.754297269969666	0.625037837456608	0.439824275187321	2.93323012671239e-224	1.56959490664482e-218	homeobox protein six1	Q6NZ04	1	1.05e-130	C10G8.7.1	4.37e-80	so-PA	1.08e-116	NP_001268684.1	6.92e-135	reviewed	SIX1B_DANRE	Homeobox protein six1b (Homeobox protein six1a) (Sine oculis homeobox homolog 1a) (Sine oculis homeobox homolog 1b)	six1b six1 six1a	Danio rerio (Zebrafish) (Brachydanio rerio)	284	adenohypophysis development [GO:0021984]; apoptotic process [GO:0006915]; extraocular skeletal muscle development [GO:0002074]; inner ear development [GO:0048839]; negative regulation of transcription, DNA-templated [GO:0045892]; peripheral nervous system neuron development [GO:0048935]; pharyngeal muscle development [GO:0043282]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle fiber development [GO:0048741]; striated muscle cell differentiation [GO:0051146]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adenohypophysis development [GO:0021984]; apoptotic process [GO:0006915]; extraocular skeletal muscle development [GO:0002074]; inner ear development [GO:0048839]; negative regulation of transcription, DNA-templated [GO:0045892]; peripheral nervous system neuron development [GO:0048935]; pharyngeal muscle development [GO:0043282]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle fiber development [GO:0048741]; striated muscle cell differentiation [GO:0051146]	GO:0000978; GO:0000981; GO:0002074; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0014857; GO:0021984; GO:0043282; GO:0045892; GO:0048741; GO:0048839; GO:0048935; GO:0051146
LOC105340122	uncharacterized LOC105340122	8	0.329899972040978	1.45931046099289	0.440251572327044	0.749344222207363	0.270149127233279	3.05644508842637e-77	1.63552821837766e-71	uncharacterized LOC105340122	P34756	3	0.011	W06H8.8i.1	1.6	CG34126-PD	2	XP_030848927.1	0.054	reviewed	FAB1_YEAST	1-phosphatidylinositol 3-phosphate 5-kinase FAB1 (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (Formation of aploid and binucleate cells protein 1) (Styryl dye vacuolar localization protein 7) (Type III PIP kinase) (PIPkin-III)	FAB1 SVL7 YFR019W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	2278	1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; regulation of phosphatidylinositol biosynthetic process [GO:0010511]	endosome membrane [GO:0010008]; fungal-type vacuole membrane [GO:0000329]; mitochondrion [GO:0005739]; PAS complex [GO:0070772]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; regulation of phosphatidylinositol biosynthetic process [GO:0010511]	GO:0000285; GO:0000329; GO:0005524; GO:0005739; GO:0010008; GO:0010511; GO:0016310; GO:0032266; GO:0046854; GO:0046872; GO:0070772; GO:1903100
LOC105338883	radial spoke head protein 4 homolog A	11	0.52494340898081	32.7377963243452	1	0.52494340898081	0.7156697498861	3.33171087523993e-58	1.78282514302789e-52	radial spoke head protein 4 homolog A	Q8BYM7	2	4.26e-178	D2085.5c.1	0.45	Rsph4a-PA	3.01e-18	NP_999761.1	0	reviewed	RSH4A_MOUSE	Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3)	Rsph4a Rshl3	Mus musculus (Mouse)	716	axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177]	axoneme [GO:0005930]; cilium [GO:0005929]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177]	GO:0001534; GO:0001535; GO:0003341; GO:0005654; GO:0005730; GO:0005929; GO:0005930; GO:0035082; GO:0060294; GO:0062177; GO:0120221
LOC105328118	retinal homeobox protein Rax	10	0.292990930585046	5.52538006158891	0.717647058823529	0.408266050815229	0.3149149290908	8.05229334721372e-62	4.30884658844084e-56	retinal homeobox protein Rax	O42115	1	6.76e-32	F26C11.2.1	4.32e-26	hbn-PA	6.98e-38	XP_781057.3	1.91e-34	reviewed	ARX_DANRE	Aristaless-related homeobox protein (ARX)	arx	Danio rerio (Zebrafish) (Brachydanio rerio)	453	enteric nervous system development [GO:0048484]; neuron development [GO:0048666]; pancreatic A cell development [GO:0003322]; regulation of transcription by RNA polymerase II [GO:0006357]; subthalamus development [GO:0021539]; telencephalon development [GO:0021537]; thalamus development [GO:0021794]	nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; enteric nervous system development [GO:0048484]; neuron development [GO:0048666]; pancreatic A cell development [GO:0003322]; regulation of transcription by RNA polymerase II [GO:0006357]; subthalamus development [GO:0021539]; telencephalon development [GO:0021537]; thalamus development [GO:0021794]	GO:0000977; GO:0000981; GO:0003322; GO:0005634; GO:0006357; GO:0021537; GO:0021539; GO:0021794; GO:0048484; GO:0048666
LOC105328118	retinal homeobox protein Rax	4	0.239789247889033	4.89244624722817	0.645865834633385	0.371267893470701	0.215444187285313	3.93518450993635e-122	2.10574871274302e-116	retinal homeobox protein Rax	O42115	1	6.76e-32	F26C11.2.1	4.32e-26	hbn-PA	6.98e-38	XP_781057.3	1.91e-34	reviewed	ARX_DANRE	Aristaless-related homeobox protein (ARX)	arx	Danio rerio (Zebrafish) (Brachydanio rerio)	453	enteric nervous system development [GO:0048484]; neuron development [GO:0048666]; pancreatic A cell development [GO:0003322]; regulation of transcription by RNA polymerase II [GO:0006357]; subthalamus development [GO:0021539]; telencephalon development [GO:0021537]; thalamus development [GO:0021794]	nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; enteric nervous system development [GO:0048484]; neuron development [GO:0048666]; pancreatic A cell development [GO:0003322]; regulation of transcription by RNA polymerase II [GO:0006357]; subthalamus development [GO:0021539]; telencephalon development [GO:0021537]; thalamus development [GO:0021794]	GO:0000977; GO:0000981; GO:0003322; GO:0005634; GO:0006357; GO:0021537; GO:0021539; GO:0021794; GO:0048484; GO:0048666
LOC105318644	uncharacterized LOC105318644_ncRNA	13	0.377523724993052	17.5846508826409	0.758620689655172	0.497644910218114	0.290232159968059	1.38504830153377e-17	7.41150426537134e-12	uncharacterized LOC105318644_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC117689486	uncharacterized LOC117689486	12	0.696245383700245	31.925259282515	1	0.696245383700245	0.941558285357589	1.29816981481682e-57	6.94661053267e-52	uncharacterized LOC117689486	Q9V410	1	9.96e-5	F53E4.1a.2	4.17e-5	Megf8-PC	3.62e-6	XP_030834386.1	6.29e-7	reviewed	LZTR1_DROME	Leucine-zipper-like transcriptional regulator 1 homolog	Lztr1 night owl nowl CG3711	Drosophila melanogaster (Fruit fly)	975	gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of glycogen metabolic process [GO:0070875]; protein ubiquitination [GO:0016567]; sleep [GO:0030431]; triglyceride homeostasis [GO:0070328]	Golgi apparatus [GO:0005794]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of glycogen metabolic process [GO:0070875]; protein ubiquitination [GO:0016567]; sleep [GO:0030431]; triglyceride homeostasis [GO:0070328]	GO:0005794; GO:0007214; GO:0016567; GO:0030431; GO:0046580; GO:0070328; GO:0070875
LOC105340345	uncharacterized LOC105340345	14	0.197152396233149	7.01895065876764	0.739130434782609	0.266735594903672	0.121354165996932	4.49618409336289e-7	0.240594407783123	uncharacterized LOC105340345	B9M1X7	1	0.38	Y37E11AM.1b.1	1.8	Mbs-PU	2	XP_011671251.1	1.02e-11	reviewed	TAL_GEODF	Probable transaldolase (EC 2.2.1.2)	tal Geob_0911	Geotalea daltonii (strain DSM 22248 / JCM 15807 / FRC-32) (Geobacter daltonii)	214	carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]	cytoplasm [GO:0005737]; aldehyde-lyase activity [GO:0016832]; transaldolase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]	GO:0004801; GO:0005737; GO:0005975; GO:0006098; GO:0016832
LOC105328490	girdin	13	0.386708223072997	5.10357376296851	0.827586206896552	0.467272436213205	0.314047226791374	6.66140113562244e-19	3.56456903888065e-13	girdin	P42567	1	0.012	F56A4.5.1	0.078		NA	XP_030851488.1	0.021	reviewed	EPS15_MOUSE	Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p)	Eps15	Mus musculus (Mouse)	897	clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of protein localization [GO:0032880]; viral entry into host cell [GO:0046718]	aggresome [GO:0016235]; AP-2 adaptor complex [GO:0030122]; ciliary membrane [GO:0060170]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; SH3 domain binding [GO:0017124]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of protein localization [GO:0032880]; viral entry into host cell [GO:0046718]	GO:0005509; GO:0005829; GO:0005886; GO:0005905; GO:0006895; GO:0006897; GO:0015031; GO:0016197; GO:0016235; GO:0017124; GO:0019065; GO:0030122; GO:0030132; GO:0030136; GO:0031593; GO:0031901; GO:0032880; GO:0042802; GO:0043231; GO:0046718; GO:0048268; GO:0060170
LOC105337859	cell division control protein 42	9	0.743044059049418	5.33776591695381	0.938628158844765	0.791627709064188	0.785870437556868	2.59005119473476e-207	1.38595711471213e-201	cell division control protein 42	Q9H4E5	1	5.26e-50	R07G3.1.1	1.14e-45	Mtl-PC	1.14e-47	XP_030842342.1	3.49e-45	reviewed	RHOJ_HUMAN	Rho-related GTP-binding protein RhoJ (Ras-like protein family member 7B) (Tc10-like GTP-binding protein)	RHOJ ARHJ RASL7B RHOI TCL	Homo sapiens (Human)	214	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670]; retina vasculature morphogenesis in camera-type eye [GO:0061299]	extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670]; retina vasculature morphogenesis in camera-type eye [GO:0061299]	GO:0001525; GO:0003924; GO:0005525; GO:0005886; GO:0006897; GO:0007163; GO:0008360; GO:0010594; GO:0030036; GO:0032488; GO:0061299; GO:0070062; GO:0090050; GO:1903670
LOC105339545	arginase, hepatic	3	0.456546550887585	26.057604427147	0.989648033126294	0.461322142424066	0.626516494826979	0	0	arginase, hepatic	P49900	1	3.54e-119	T21F4.1.1	4.21e-28	arg-PA	8.95e-73	XP_791131.3	1.14e-105	reviewed	ARGI_LITCT	Arginase, hepatic (EC 3.5.3.1)		Lithobates catesbeianus (American bullfrog) (Rana catesbeiana)	323	arginine metabolic process [GO:0006525]; urea cycle [GO:0000050]	arginase activity [GO:0004053]; metal ion binding [GO:0046872]; arginine metabolic process [GO:0006525]; urea cycle [GO:0000050]	GO:0000050; GO:0004053; GO:0006525; GO:0046872
LOC105320196	multiple coagulation factor deficiency protein 2 homolog	1	0.462164564425424	28.4004331570183	0.994496109318656	0.464722345411747	0.806278441625624	0	0	multiple coagulation factor deficiency protein 2 homolog	Q8K5B3	1	4.95e-17	F55A11.1.1	4.98e-19	CG17271-PA	6.16e-19	XP_001194225.2	1.76e-36	reviewed	MCFD2_RAT	Multiple coagulation factor deficiency protein 2 homolog (Neural stem cell-derived neuronal survival protein)	Mcfd2 Sdnsf	Rattus norvegicus (Rat)	145	brain development [GO:0007420]; carboxylic acid metabolic process [GO:0019752]; negative regulation of cell death [GO:0060548]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; brain development [GO:0007420]; carboxylic acid metabolic process [GO:0019752]; negative regulation of cell death [GO:0060548]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	GO:0005509; GO:0005576; GO:0005783; GO:0005793; GO:0005794; GO:0007420; GO:0015031; GO:0016192; GO:0019752; GO:0060548
LOC105343814	FAM10 family protein At4g22670	1	0.476970178233906	7.06750870778523	0.798064148794838	0.597658946281676	0.366298785360393	0	0	FAM10 family protein At4g22670	Q84PB3	2	0.21	Y47D7A.16a.1	2.1		NA	XP_030850582.1	1.7	reviewed	IF4G1_ORYSJ	Eukaryotic translation initiation factor isoform 4G-1 (eIF(iso)-4G-1) (eIF(iso)4G-1) (Eukaryotic initiation factor iso-4F subunit p82) (eIF-(iso)4F p82 subunit)	Os04g0499300 LOC_Os04g42140 OSJNBa0029H02.9	Oryza sativa subsp. japonica (Rice)	793		eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]	GO:0003729; GO:0003743; GO:0016281
LOC105319105	mis18-binding protein 1	8	0.356156130011653	7.08175225352119	0.89937106918239	0.396005766936033	0.437848355616098	1.03479314662664e-124	5.53726091105087e-119	mis18-binding protein 1	Q80WQ8	1	2.42e-17	K06A5.4.1	5.2e-5	CG1620-PC	2.3	XP_030854759.1	1.58e-18	reviewed	M18BP_MOUSE	Mis18-binding protein 1 (Kinetochore-associated protein KNL-2 homolog)	Mis18bp1 Kiaa1903 Knl2 M18bp1	Mus musculus (Mouse)	998	cell cycle [GO:0007049]; cell division [GO:0051301]	chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; cell division [GO:0051301]	GO:0000775; GO:0003677; GO:0005634; GO:0007049; GO:0051301
LOC105339284	golgin subfamily A member 6-like protein 22	12	0.693483699813477	15.4006787659331	0.96875	0.715854141742944	0.819687101396518	2.40562404318462e-50	1.28726867050043e-44	golgin subfamily A member 6-like protein 22	Q9UPV0	3	1.3	T22A3.8.1	6.36e-4		NA	XP_030842151.1	8.67e-46	reviewed	CE164_HUMAN	Centrosomal protein of 164 kDa (Cep164)	CEP164 KIAA1052 NPHP15	Homo sapiens (Human)	1460	cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]	GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0007049; GO:0051301; GO:0060271; GO:0097539
LOC105344501	tumor necrosis factor	12	0.77950652477657	22.9927548489739	0.96875	0.804651896543557	0.831191260452339	4.96068606500024e-51	2.65450279887015e-45	tumor necrosis factor	O14788	1	6.05e-14	Y71A12B.12b.1	0.061	ND-42-PC	3	XP_030837604.1	0.08	reviewed	TNF11_HUMAN	Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]	TNFSF11 OPGL RANKL TRANCE	Homo sapiens (Human)	317	bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]; cytokine-mediated signaling pathway [GO:0019221]; ERK1 and ERK2 cascade [GO:0070371]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; JNK cascade [GO:0007254]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; monocyte chemotaxis [GO:0002548]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; paracrine signaling [GO:0038001]; positive regulation of bone resorption [GO:0045780]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast development [GO:2001206]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; regulation of actin binding [GO:1904616]; TNFSF11-mediated signaling pathway [GO:0071847]; tooth eruption [GO:0044691]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]; cytokine-mediated signaling pathway [GO:0019221]; ERK1 and ERK2 cascade [GO:0070371]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; JNK cascade [GO:0007254]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; monocyte chemotaxis [GO:0002548]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; paracrine signaling [GO:0038001]; positive regulation of bone resorption [GO:0045780]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast development [GO:2001206]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; regulation of actin binding [GO:1904616]; TNFSF11-mediated signaling pathway [GO:0071847]; tooth eruption [GO:0044691]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	GO:0000122; GO:0001503; GO:0002158; GO:0002548; GO:0005125; GO:0005164; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006955; GO:0007249; GO:0007254; GO:0010628; GO:0019221; GO:0019722; GO:0030316; GO:0032813; GO:0033209; GO:0033598; GO:0034112; GO:0036035; GO:0038001; GO:0042802; GO:0043123; GO:0043406; GO:0043491; GO:0044691; GO:0045453; GO:0045672; GO:0045780; GO:0045944; GO:0046330; GO:0050870; GO:0051091; GO:0051092; GO:0051466; GO:0051897; GO:0055074; GO:0060749; GO:0070371; GO:0071812; GO:0071847; GO:0071848; GO:1902533; GO:1904616; GO:1990830; GO:2001206
LOC105339352	zinc finger protein ZIC 4	10	0.349666789878171	4.12316695131303	0.670588235294118	0.521432932274465	0.348904566218936	2.3907554876403e-68	1.27931238748022e-62	zinc finger protein ZIC 4	A0JC51	1	6.14e-136	C47C12.3a.2	6.55e-57	opa-PA	4.53e-100	XP_030837642.1	7.88e-129	reviewed	ZIC4_XENLA	Zinc finger protein ZIC 4 (XlZic4) (Zinc finger protein of the cerebellum 4)	zic4	Xenopus laevis (African clawed frog)	530	nervous system development [GO:0007399]; neural crest formation [GO:0014029]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; neural crest formation [GO:0014029]	GO:0003677; GO:0005634; GO:0007399; GO:0014029; GO:0046872
LOC105339354	zinc finger protein ZIC 4	10	0.479451388510418	13.1681329197266	0.888235294117647	0.539779708919014	0.538971012421516	5.15765940843629e-105	2.75990481072953e-99	zinc finger protein ZIC 4	O73689	1	8.07e-121	C47C12.3b.1	6.32e-54	opa-PA	3.99e-95	XP_030837642.1	1e-114	reviewed	ZIC1_XENLA	Zinc finger protein ZIC 1 (XZic1) (XlZic1) (ODD-paired-like) (Xopl) (ZIC-related protein 1) (ZIC-r1) (Zinc finger protein of the cerebellum 1)	zic1 opl	Xenopus laevis (African clawed frog)	443	dorsal/ventral neural tube patterning [GO:0021904]; neural crest cell differentiation [GO:0014033]; neural crest cell fate commitment [GO:0014034]; neural crest formation [GO:0014029]; neural plate development [GO:0001840]; neurogenesis [GO:0022008]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; dorsal/ventral neural tube patterning [GO:0021904]; neural crest cell differentiation [GO:0014033]; neural crest cell fate commitment [GO:0014034]; neural crest formation [GO:0014029]; neural plate development [GO:0001840]; neurogenesis [GO:0022008]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055]	GO:0001840; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0014029; GO:0014033; GO:0014034; GO:0016055; GO:0021904; GO:0022008; GO:0030177; GO:0042307; GO:0045893; GO:0045944; GO:0046872
LOC105348069	transcription factor Sox-2	4	0.205330330123874	3.43432760231433	0.585803432137286	0.350510630118251	0.145813757939853	6.84789012923046e-83	3.66436079127225e-77	transcription factor Sox-2	P48430	1	4.49e-79	K08A8.2a.3	2.43e-52	Sox21a-PA	1.08e-46	NP_999639.1	2.59e-59	reviewed	SOX2_CHICK	Transcription factor SOX-2 (cSox2) (delta EF2a)	SOX2	Gallus gallus (Chicken)	315	anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; forebrain development [GO:0030900]; inner ear development [GO:0048839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ precursor cell fate determination [GO:0016360]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; forebrain development [GO:0030900]; inner ear development [GO:0048839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ precursor cell fate determination [GO:0016360]	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006355; GO:0009653; GO:0016360; GO:0030154; GO:0030900; GO:0043565; GO:0045165; GO:0045665; GO:0045893; GO:0045944; GO:0048839
LOC105320997	myosin regulatory light chain A, smooth adductor muscle	5	0.799275393252236	71.3935036782245	0.918099089989889	0.870576391989495	0.728741040978995	0	0	myosin regulatory light chain A, smooth adductor muscle	P04113	1	1.63e-80	C56G7.1.1	5.93e-55	sqh-PE	3.15e-53	XP_783666.1	3.41e-59	reviewed	MLRA_MIZYE	Myosin regulatory light chain A, smooth adductor muscle		Mizuhopecten yessoensis (Japanese scallop) (Patinopecten yessoensis)	161		myosin complex [GO:0016459]; calcium ion binding [GO:0005509]	GO:0005509; GO:0016459
LOC105334836	cytochrome P450 26A1	2	0.203301883462193	3.36162466600633	0.562206721623335	0.361614110331466	0.122222037009076	2.91511699524013e-124	1.55990242508895e-118	cytochrome P450 26A1	O43174	2	2.95e-125	Y80D3A.5.1	4.41e-27	Cyp4d20-PA	1.74e-22	XP_001199776.1	1.24e-102	reviewed	CP26A_HUMAN	Cytochrome P450 26A1 (EC 1.14.13.-) (Cytochrome P450 retinoic acid-inactivating 1) (Cytochrome P450RAI) (hP450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome)	CYP26A1 CYP26 P450RAI1	Homo sapiens (Human)	497	kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; all-trans retinoic acid 4-hydrolase activity [GO:0062182]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]	GO:0001822; GO:0001972; GO:0004497; GO:0005506; GO:0005789; GO:0006766; GO:0006805; GO:0008401; GO:0016125; GO:0016491; GO:0016709; GO:0019825; GO:0020037; GO:0032526; GO:0033189; GO:0034653; GO:0042573; GO:0048387; GO:0062182; GO:0062183
LOC105317061	myosin essential light chain, striated adductor muscle	5	0.864366603579794	328.296490109686	0.992922143579373	0.87052807631407	0.911417275689251	0	0	myosin essential light chain, striated adductor muscle	P07291	2	1.17e-80	F09F7.2a.2	3.96e-43	Mlc-c-PA	6.51e-32	XP_785794.2	1.07e-30	reviewed	MLE_ARGIR	Myosin essential light chain, striated adductor muscle (E-LC) (Sulfhydryl light chain) (SHLC)		Argopecten irradians (Bay scallop) (Aequipecten irradians)	157		myosin complex [GO:0016459]; calcium ion binding [GO:0005509]	GO:0005509; GO:0016459
LOC117689752	uncharacterized LOC117689752	1	0.513331702587073	65.0204787179667	0.740937559309167	0.692813714377892	0.171149520169948	8.02652281051024e-157	4.29505656808651e-151	uncharacterized LOC117689752	Q2M2H8	3	0.49	T12A7.2a.2	0.009	Myo10A-PF	8.2	XP_787095.2	0.03	reviewed	MGAL_HUMAN	Probable maltase-glucoamylase 2 (Maltase-glucoamylase (alpha-glucosidase) pseudogene) [Includes: Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)]	MGAM2	Homo sapiens (Human)	2515	carbohydrate metabolic process [GO:0005975]	integral component of membrane [GO:0016021]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]	GO:0004339; GO:0004553; GO:0004558; GO:0005975; GO:0016021; GO:0030246
LOC117689753	uncharacterized LOC117689753	1	0.495103139633228	37.6935341659932	0.708293793888783	0.699008157215294	0.214495021805298	5.5716599344083e-197	2.98143980418136e-191	uncharacterized LOC117689753	Q8Y2E3	2	0.55	T12A7.2a.2	0.01	Myo10A-PF	7	XP_030829176.1	0.018	reviewed	PTH_RALSO	Peptidyl-tRNA hydrolase (PTH) (EC 3.1.1.29)	pth RSc0393 RS03361	Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum)	200	translation [GO:0006412]	cytoplasm [GO:0005737]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation [GO:0006412]	GO:0004045; GO:0005737; GO:0006412
LOC105344530	uncharacterized LOC105344530	9	0.66436409848928	29.0173396648534	0.916967509025271	0.72452305228949	0.680918637338243	2.7234054122586e-179	1.45731602334287e-173	uncharacterized LOC105344530	P37482	1	0.14	F15G9.4a.1	2.5	CG15594-PB	0.53	XP_030837559.1	2.1	reviewed	YYCB_BACSU	Uncharacterized transporter YycB	yycB BSU40480	Bacillus subtilis (strain 168)	402		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0016021; GO:0022857
LOC105344238	uncharacterized LOC105344238_ncRNA	13	0.399081097522482	18.5680529426204	0.689655172413793	0.578667591407599	0.275576362499292	8.97364728353561e-17	4.80187045059818e-11	uncharacterized LOC105344238_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105346676	mitotic apparatus protein p62	8	0.438787586715226	8.98833064946693	0.874213836477987	0.501922491278568	0.478078719418902	3.5434977676320904e-136	1.89615400344207e-130	mitotic apparatus protein p62	P91753	1	1.66e-18	C06G4.1.1	1.3	Nph-PB	3.68e-9	XP_030841325.1	3.72e-19	reviewed	MP62_LYTPI	Mitotic apparatus protein p62		Lytechinus pictus (Painted sea urchin)	411	cell cycle [GO:0007049]; cell division [GO:0051301]	nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; cell cycle [GO:0007049]; cell division [GO:0051301]	GO:0003676; GO:0005634; GO:0007049; GO:0051301
LOC105335285	beta-1,4-galactosyltransferase galt-1	3	0.316062943620055	0.564136121289005	0.51207729468599	0.617217257824069	0.272199625072672	2.70849053375763e-162	1.44933495253798e-156	beta-1,4-galactosyltransferase galt-1	O16374	4	1.8e-29	M03F8.4.1	1.59e-30	CG12910-PC	1.37e-21	XP_011680506.2	0.049	reviewed	GALT1_CAEEL	Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)	galt-1 M03F8.4	Caenorhabditis elegans	425	N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125]	GO:0003831; GO:0006491; GO:0016021; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872
LOC105325626	methyltransferase-like protein 27	7	0.499627798446485	11.1220246704807	0.548648648648649	0.910651652340884	0.367868614774739	3.56590806508587e-114	1.90814593289197e-108	methyltransferase-like protein 27	Q8N6F8	2	1.39e-27	R08E5.3.1	0.003	CG1441-PB	0.26	XP_030846743.1	6.4e-29	reviewed	MET27_HUMAN	Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein)	METTL27 WBSCR27	Homo sapiens (Human)	245	organic substance metabolic process [GO:0071704]	methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; organic substance metabolic process [GO:0071704]	GO:0008168; GO:0008757; GO:0071704
LOC105343313	protein transport protein Sec24-like CEF	1	0.397397612535257	3.15666402677704	0.753843234010249	0.527162140092716	0.348313596286581	1.1125369292536e-308	1.11253692965017e-308	protein transport protein Sec24-like CEF	P40989	2	0.015	T03F1.9.2	3		NA	XP_030828493.1	0.24	reviewed	FKS2_YEAST	1,3-beta-glucan synthase component GSC2 (EC 2.4.1.34) (1,3-beta-D-glucan-UDP glucosyltransferase) (FK506 sensitivity protein 2) (Glucan synthase of cerevisiae protein 2)	GSC2 FKS2 GLS2 YGR032W	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	1895	(1->3)-beta-D-glucan biosynthetic process [GO:0006075]; ascospore wall assembly [GO:0030476]; fungal-type cell wall polysaccharide biosynthetic process [GO:0051278]; regulation of cell shape [GO:0008360]	1,3-beta-D-glucan synthase complex [GO:0000148]; cell periphery [GO:0071944]; cellular bud neck [GO:0005935]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; prospore membrane [GO:0005628]; 1,3-beta-D-glucan synthase activity [GO:0003843]; glucosyltransferase activity [GO:0046527]; (1->3)-beta-D-glucan biosynthetic process [GO:0006075]; ascospore wall assembly [GO:0030476]; fungal-type cell wall polysaccharide biosynthetic process [GO:0051278]; regulation of cell shape [GO:0008360]	GO:0000148; GO:0003843; GO:0005628; GO:0005886; GO:0005935; GO:0006075; GO:0008360; GO:0016021; GO:0030476; GO:0046527; GO:0051278; GO:0071944
LOC105328983	uncharacterized LOC105328983	2	0.161921492843882	8.63883479975008	0.854533925174382	0.189485154507867	0.0711993926481363	9.7706482005156906e-73	5.22835201728155e-67	uncharacterized LOC105328983	Q9ULX7	1	7.39e-49	K05G3.3.1	7.71e-33	CAH2-PA	4.75e-33	XP_030829642.1	6.9e-46	reviewed	CAH14_HUMAN	Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV)	CA14 UNQ690/PRO1335	Homo sapiens (Human)	337	one-carbon metabolic process [GO:0006730]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]	GO:0004089; GO:0005886; GO:0006730; GO:0008270; GO:0016021; GO:0016836
LOC105349033	GATA zinc finger domain-containing protein 14	8	0.350501663027937	1.58430213405757	0.443396226415094	0.79049311236088	0.259870652356307	2.39128915838402e-74	1.27959795896456e-68	GATA zinc finger domain-containing protein 14	Q9H1Q7	1	1.64e-93	D2030.8.2	2.01e-33		NA	XP_030841298.1	1.76e-90	reviewed	PED1A_HUMAN	PC-esterase domain-containing protein 1A (Protein FAM113A) (Sarcoma antigen NY-SAR-23)	PCED1A C20orf81 FAM113A	Homo sapiens (Human)	454		transferase activity [GO:0016740]	GO:0016740
LOC117689669	prisilkin-39-like	1	0.440804654945789	37.0930890209308	0.627823116340862	0.702115999670302	0.148859904389315	2.5444667062607e-136	1.36156449025375e-130	prisilkin-39-like	I1S4T3	3	0.017	F54D8.6.1	5.31e-5	Ilp3-PA	9.8	XP_798354.3	0.025	reviewed	ABAA_GIBZE	Conidiophore development regulator abaA	abaA FGRAMPH1_01T02219 FGRRES_15794/FGRRES_11850 FGSG_11851/FGSG_11850	Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) (Wheat head blight fungus) (Fusarium graminearum)	858	conidium formation [GO:0048315]; sporulation resulting in formation of a cellular spore [GO:0030435]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; conidium formation [GO:0048315]; sporulation resulting in formation of a cellular spore [GO:0030435]	GO:0003700; GO:0005634; GO:0030435; GO:0048315
LOC105342064	shematrin-like protein 2	1	0.434898749795291	39.9666691749137	0.654773201746062	0.66419753990475	0.157835629321354	1.45250970585168e-144	7.77249563678882e-139	shematrin-like protein 2	I1S4T3	3	0.023	F54D8.6.1	6.09e-5		NA	XP_798354.3	0.028	reviewed	ABAA_GIBZE	Conidiophore development regulator abaA	abaA FGRAMPH1_01T02219 FGRRES_15794/FGRRES_11850 FGSG_11851/FGSG_11850	Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) (Wheat head blight fungus) (Fusarium graminearum)	858	conidium formation [GO:0048315]; sporulation resulting in formation of a cellular spore [GO:0030435]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; conidium formation [GO:0048315]; sporulation resulting in formation of a cellular spore [GO:0030435]	GO:0003700; GO:0005634; GO:0030435; GO:0048315
LOC105347548	homeobox protein Nkx-2.5	9	0.729726839821735	7.91039604843062	0.996389891696751	0.732370777647176	0.877116425671849	7.84702088778686e-232	4.19900365322185e-226	homeobox protein Nkx-2.5	A6NCS4	1	2.64e-50	K03A11.3.1	4.78e-30	scro-PF	5.15e-37	XP_783123.1	1.5e-38	reviewed	NKX26_HUMAN	Homeobox protein Nkx-2.6 (Homeobox protein NK-2 homolog F)	NKX2-6 NKX2F	Homo sapiens (Human)	301	atrial cardiac muscle cell development [GO:0055014]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; embryonic heart tube development [GO:0035050]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; hypothalamus development [GO:0021854]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell apoptotic process [GO:1904036]; pericardium development [GO:0060039]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; tongue development [GO:0043586]; ventricular cardiac muscle cell development [GO:0055015]	chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; atrial cardiac muscle cell development [GO:0055014]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; embryonic heart tube development [GO:0035050]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; hypothalamus development [GO:0021854]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell apoptotic process [GO:1904036]; pericardium development [GO:0060039]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; tongue development [GO:0043586]; ventricular cardiac muscle cell development [GO:0055015]	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008284; GO:0021854; GO:0030154; GO:0030855; GO:0035050; GO:0043066; GO:0043586; GO:0045944; GO:0048565; GO:0050673; GO:0050679; GO:0055014; GO:0055015; GO:0060037; GO:0060039; GO:1904019; GO:1904036
LOC105322816	carbohydrate sulfotransferase 13	13	0.460669118133956	5.51710186268275	0.96551724137931	0.477121586638741	0.444154212372235	4.30170942362042e-26	2.30187912625468e-20	carbohydrate sulfotransferase 13	Q7T3S3	1	2.9e-35	C18B2.1.1	0.062	CG31743-PB	9.54e-29	XP_011672230.2	2.5e-32	reviewed	CHSTB_DANRE	Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1)	chst11	Danio rerio (Zebrafish) (Brachydanio rerio)	352	carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166]	GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756
LOC117690118	uncharacterized LOC117690118	13	0.372572831848858	3.72699407809672	0.896551724137931	0.415562004754496	0.31471095399344	6.12135475434256e-19	3.27558589988674e-13	uncharacterized LOC117690118	Q9NAN2	2	1.1	T26E3.3a.2	0.096	Hsc70-1-PD	1.4		NA	reviewed	PAR6_CAEEL	Partitioning defective protein 6	par-6 T26E3.3	Caenorhabditis elegans	309	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; gastrulation [GO:0007369]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; polarity specification of anterior/posterior axis [GO:0009949]; regulation of cellular localization [GO:0060341]; single fertilization [GO:0007338]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; P granule [GO:0043186]; protein kinase C binding [GO:0005080]; small GTPase binding [GO:0031267]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; gastrulation [GO:0007369]; gonad development [GO:0008406]; gonadal mesoderm development [GO:0007506]; polarity specification of anterior/posterior axis [GO:0009949]; regulation of cellular localization [GO:0060341]; single fertilization [GO:0007338]	GO:0005080; GO:0005634; GO:0005737; GO:0005923; GO:0005938; GO:0007098; GO:0007155; GO:0007163; GO:0007338; GO:0007369; GO:0007506; GO:0008406; GO:0009949; GO:0016021; GO:0016324; GO:0030154; GO:0031267; GO:0040001; GO:0043186; GO:0051301; GO:0060341
LOC105338658	uncharacterized LOC105338658	4	0.182520368089838	3.40233173873221	0.260530421216849	0.700572191290936	0.104021003444549	1.69212258358775e-59	9.05468331458474e-54	uncharacterized LOC105338658		NA	NA	Y48B6A.8.1	1.7	CG9503-PA	2.2	XP_030828648.1	0.007	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105337598	uncharacterized LOC105337598	7	0.4696851934243	2.07133549096491	0.540540540540541	0.868917607834955	0.368096503102617	3.03166062722412e-114	1.62226585491265e-108	uncharacterized LOC105337598	E9Q9W7	2	6.62e-48	C25F6.2a.1	6.22e-10	dysc-PJ	4.54e-17	XP_030842018.1	9.95e-34	reviewed	PDZD7_MOUSE	PDZ domain-containing protein 7	Pdzd7	Mus musculus (Mouse)	1021	auditory receptor cell development [GO:0060117]; auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; sensory perception of sound [GO:0007605]	cilium [GO:0005929]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; USH2 complex [GO:1990696]; identical protein binding [GO:0042802]; auditory receptor cell development [GO:0060117]; auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; sensory perception of sound [GO:0007605]	GO:0002141; GO:0002142; GO:0005634; GO:0005654; GO:0005886; GO:0005929; GO:0007605; GO:0032420; GO:0032426; GO:0042802; GO:0045184; GO:0050910; GO:0051649; GO:0060088; GO:0060113; GO:0060117; GO:1990696
LOC105339321	T-box-containing protein TBX6L	4	0.375703145856619	2.95273789779231	0.585803432137286	0.641346781608769	0.300032271841358	2.73418816796906e-170	1.46308596218559e-164	T-box-containing protein TBX6L	D3ZJK7	1	2.36e-52	F21H11.3.2	7.97e-49	Doc2-PA	9.22e-49	XP_011680189.2	4.19e-49	reviewed	TBX6_RAT	T-box transcription factor TBX6 (T-box protein 6)	Tbx6	Rattus norvegicus (Rat)	436	cardiac chamber development [GO:0003205]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; heart looping [GO:0001947]; mesoderm formation [GO:0001707]; mesodermal cell fate specification [GO:0007501]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction involved in regulation of gene expression [GO:0023019]; somite rostral/caudal axis specification [GO:0032525]	chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; cardiac chamber development [GO:0003205]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; heart looping [GO:0001947]; mesoderm formation [GO:0001707]; mesodermal cell fate specification [GO:0007501]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction involved in regulation of gene expression [GO:0023019]; somite rostral/caudal axis specification [GO:0032525]	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001707; GO:0001708; GO:0001947; GO:0003205; GO:0005634; GO:0006357; GO:0007417; GO:0007501; GO:0008284; GO:0010977; GO:0014043; GO:0023019; GO:0032525; GO:0043433; GO:0045944; GO:0061629; GO:1990837
LOC105335804	tctex1 domain-containing protein 1-A-like	11	0.556594383249401	17.6339725697137	0.957446808510638	0.581331911393819	0.640092963437086	3.2803274571085e-52	1.75532946491841e-46	tctex1 domain-containing protein 1-A-like	Q3B8D7	1	5.2e-27	D1009.5.1	4.17e-8	CG14763-PD	6.5e-9	XP_793740.1	9.17e-34	reviewed	DYL5A_XENLA	Dynein light chain Tctex-type 5-A (Tctex1 domain-containing protein 1-A)	Dynlt5-a tctex1d1-a	Xenopus laevis (African clawed frog)	177			
LOC109617263	uncharacterized LOC109617263_ncRNA	13	0.449997466320398	33.1198741838967	0.96551724137931	0.466068804403269	0.415350559351429	1.67664541477729e-24	8.97186374610647e-19	uncharacterized LOC109617263_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105334650	parkin coregulated gene protein homolog	11	0.519273081734221	28.1897740140143	1	0.519273081734221	0.742445164053998	2.49945588038829e-60	1.33747883724282e-54	parkin coregulated gene protein homolog	Q9DAK2	1	4.01e-136	E04F6.2.1	1.29e-22	CG15120-PA	1.62e-82	XP_791188.1	8.33e-132	reviewed	PACRG_MOUSE	Parkin coregulated gene protein homolog (Hypertension-related protein 1-like protein) (PARK2 coregulated gene protein)	Pacrg	Mus musculus (Mouse)	241	cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; protein localization [GO:0008104]; spermatid development [GO:0007286]	axonemal microtubule [GO:0005879]; cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; manchette [GO:0002177]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]; cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; protein localization [GO:0008104]; spermatid development [GO:0007286]	GO:0001664; GO:0002177; GO:0003779; GO:0005739; GO:0005829; GO:0005879; GO:0005929; GO:0007286; GO:0008104; GO:0030544; GO:0031072; GO:0031625; GO:0031982; GO:0034620; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051087; GO:0051879; GO:0060548; GO:0097225
LOC105339630	histone-binding protein RBBP4	14	0.228668580735077	9.40012476046126	0.91304347826087	0.250446540805085	0.183654325845104	5.31692178798251e-10	2.84512738412375e-4	histone-binding protein RBBP4	Q24572	1	0	K07A1.12.1	0	Caf1-55-PB	0	XP_030851281.1	0	reviewed	CAF1_DROME	Chromatin assembly factor 1 p55 subunit (CAF-1 p55 subunit) (CAF-1) (Nucleosome-remodeling factor 55 kDa subunit) (NURF-55)	Caf1-55 Caf1 CG4236	Drosophila melanogaster (Fruit fly)	430	chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; eggshell chorion gene amplification [GO:0007307]; facultative heterochromatin assembly [GO:0140718]; heterochromatin assembly [GO:0031507]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome organization [GO:0034728]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]	CAF-1 complex [GO:0033186]; ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; Myb complex [GO:0031523]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; polytene chromosome [GO:0005700]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; transcription cis-regulatory region binding [GO:0000976]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; eggshell chorion gene amplification [GO:0007307]; facultative heterochromatin assembly [GO:0140718]; heterochromatin assembly [GO:0031507]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome organization [GO:0034728]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]	GO:0000122; GO:0000976; GO:0005634; GO:0005667; GO:0005700; GO:0006334; GO:0006338; GO:0006355; GO:0007307; GO:0007346; GO:0007379; GO:0016573; GO:0016575; GO:0016581; GO:0016589; GO:0031497; GO:0031507; GO:0031523; GO:0033186; GO:0034728; GO:0035097; GO:0035098; GO:0042393; GO:0042803; GO:0042826; GO:0045892; GO:0045893; GO:0070822; GO:0140718
LOC105347694	uncharacterized LOC105347694	13	0.394418584536246	2.93941043644368	0.931034482758621	0.423634775983376	0.378959748621507	1.7173194173181e-22	9.18951358762255e-17	uncharacterized LOC105347694	Q8TIW9	1	1.64e-4	ZC404.1.1	0.3		NA	XP_030833192.1	0.086	reviewed	Y4021_METAC	Putative ABC transporter ATP-binding protein MA_4021 (EC 7.-.-.-)	MA_4021	Methanosarcina acetivorans (strain ATCC 35395 / DSM 2834 / JCM 12185 / C2A)	276	transmembrane transport [GO:0055085]	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; transmembrane transport [GO:0055085]	GO:0005524; GO:0005886; GO:0055085
LOC105324198	glutamate receptor ionotropic, kainate 2	5	0.622407276526983	6.3661783909535	0.895854398382204	0.694763878651452	0.658368858754367	0	0	glutamate receptor ionotropic, kainate 2	Q13002	1	0	K10D3.1.1	5.41e-149	KaiR1D-PA	0	XP_030850956.1	0	reviewed	GRIK2_HUMAN	Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)	GRIK2 GLUR6	Homo sapiens (Human)	908	behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of synaptic transmission [GO:0050806]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]	anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of synaptic transmission [GO:0050806]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]	GO:0001662; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015276; GO:0015277; GO:0019228; GO:0032983; GO:0035249; GO:0038023; GO:0042734; GO:0043025; GO:0043524; GO:0045211; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0070161; GO:0098686; GO:0098978; GO:0099171; GO:0099507; GO:0120169; GO:1904315
LOC105332320	glutamate receptor ionotropic, kainate 2-like	12	0.713709615989264	5.84406999980687	0.90625	0.787541645229533	0.726804490117883	8.21762388890745e-45	4.39731628394549e-39	glutamate receptor ionotropic, kainate 2-like	Q91755	2	0	K10D3.1.1	2.37e-135	KaiR1D-PA	0	XP_030850956.1	1.04e-176	reviewed	GRIK2_XENLA	Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6)	grik2 glur6	Xenopus laevis (African clawed frog)	913	detection of cold stimulus involved in thermoception [GO:0120169]	anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; ionotropic glutamate receptor activity [GO:0004970]; detection of cold stimulus involved in thermoception [GO:0120169]	GO:0004970; GO:0005234; GO:0016021; GO:0045211; GO:0070161; GO:0120169
LOC105330685	synaptotagmin-12	7	0.387760237785324	2.2478532901816	0.489189189189189	0.792659049616408	0.298148333668105	1.16044256714839e-92	6.20962101221641e-87	synaptotagmin-12	Q8IV01	1	9.49e-76	F31E8.2a.1	1.86e-56	Syt12-PA	6.07e-71	XP_030844175.1	2.42e-108	reviewed	SYT12_HUMAN	Synaptotagmin-12 (Synaptotagmin XII) (SytXII)	SYT12	Homo sapiens (Human)	421	calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; long-term synaptic potentiation [GO:0060291]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neurotransmitter secretion [GO:0046928]; spontaneous exocytosis of neurotransmitter [GO:0048792]; vesicle-mediated transport [GO:0016192]	anchoring junction [GO:0070161]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; long-term synaptic potentiation [GO:0060291]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neurotransmitter secretion [GO:0046928]; spontaneous exocytosis of neurotransmitter [GO:0048792]; vesicle-mediated transport [GO:0016192]	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030672; GO:0046928; GO:0048792; GO:0060291; GO:0070161; GO:0070382; GO:0071277; GO:0098686
LOC105337048	uncharacterized LOC105337048	12	0.805556800508472	12.015693126368	1	0.805556800508472	0.942525101090703	1.136679752606e-57	6.08246429057494e-52	uncharacterized LOC105337048	C0HL13	1	6.18e-5	F29D11.1.1	1.44e-4	trol-PAV	4.31e-6	XP_030844687.1	1.71e-8	reviewed	LRP2_PIG	Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)	LRP2	Sus scrofa (Pig)	4652	coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124]; coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]	GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016021; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167
LOC105332808	sestrin-1	10	0.26466765000641	6.38632247239179	0.805882352941176	0.328419711686787	0.26862431115482	6.06516389909441e-53	3.24551772371661e-47	sestrin-1	P58003	1	2.29e-153	Y74C9A.5.1	2.86e-48	Sesn-PD	4.07e-71	XP_030851090.1	2.05e-152	reviewed	SESN1_XENLA	Sestrin-1 (EC 1.11.1.-) (XPA26) (p53-regulated protein PA26)	sesn1 pa26	Xenopus laevis (African clawed frog)	481	negative regulation of TORC1 signaling [GO:1904262]; regulation of response to reactive oxygen species [GO:1901031]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; leucine binding [GO:0070728]; oxidoreductase activity [GO:0016491]; negative regulation of TORC1 signaling [GO:1904262]; regulation of response to reactive oxygen species [GO:1901031]	GO:0005634; GO:0005737; GO:0016491; GO:0070728; GO:1901031; GO:1904262
LOC105348692	four-jointed box protein 1	4	0.364226870511444	4.31121584643313	0.822932917316693	0.442596064450873	0.427600613031701	5.4280171071937e-244	2.90457537819621e-238	four-jointed box protein 1	P54360	2	6.8e-89	Y54G2A.17c.2	0.076	fj-PA	7.36e-89	XP_011662184.2	1.22e-82	reviewed	FOJO_DROME	Extracellular serine/threonine protein kinase four-jointed (EC 2.7.11.1) [Cleaved into: Protein four-jointed, secreted isoform]	fj CG10917	Drosophila melanogaster (Fruit fly)	583	cell-cell signaling [GO:0007267]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; imaginal disc growth [GO:0007446]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived wing vein specification [GO:0007474]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]; regulation of establishment of planar polarity [GO:0090175]; regulation of protein binding [GO:0043393]; regulation of tube length, open tracheal system [GO:0035159]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Wnt-protein binding [GO:0017147]; cell-cell signaling [GO:0007267]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; imaginal disc growth [GO:0007446]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived wing vein specification [GO:0007474]; Notch signaling pathway [GO:0007219]; protein phosphorylation [GO:0006468]; regulation of establishment of planar polarity [GO:0090175]; regulation of protein binding [GO:0043393]; regulation of tube length, open tracheal system [GO:0035159]; Wnt signaling pathway [GO:0016055]	GO:0000139; GO:0001736; GO:0001737; GO:0004672; GO:0004674; GO:0005615; GO:0005737; GO:0005886; GO:0006468; GO:0007219; GO:0007267; GO:0007446; GO:0007474; GO:0016021; GO:0016055; GO:0016348; GO:0017147; GO:0035159; GO:0042067; GO:0043393; GO:0090175; GO:0106310
LOC105324157	mucin-17	13	0.392477511455327	1.09364513492652	0.827586206896552	0.474243659675186	0.318920803746149	3.58070230215542e-19	1.91606244750178e-13	mucin-17	Q3TNW5	1	4	F12F6.1.1	0.52		NA	XP_030829998.1	6.99e-10	reviewed	MUCL3_MOUSE	Mucin-like protein 3 (Diffuse panbronchiolitis critical region protein 1 homolog)	Mucl3 Dpcr1 Gm630	Mus musculus (Mouse)	500		cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	GO:0005737; GO:0005886; GO:0016021
LOC105347667	dnaJ homolog subfamily B member 13	11	0.521051107212506	15.635932600838	1	0.521051107212506	0.66922889027147	1.60755596403091e-54	8.60216056800654e-49	dnaJ homolog subfamily B member 13	Q80Y75	1	3.33e-146	F54D5.8.2	2.57e-96	CG5001-PC	5.12e-99	XP_798465.1	1.07e-166	reviewed	DJB13_MOUSE	DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein)	Dnajb13 Tsarg Tsarg3 Tsarg6	Mus musculus (Mouse)	316	axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514]; sperm connecting piece [GO:0097224]; sperm flagellum [GO:0036126]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085]	GO:0005737; GO:0005829; GO:0005930; GO:0031514; GO:0036126; GO:0051082; GO:0051085; GO:0051087; GO:0097224; GO:1904158
LOC105336078	dimethylaniline monooxygenase [N-oxide-forming] 2	3	0.471797199174043	3.26455140461386	0.696342305037957	0.677536314770256	0.389686620635365	1.82068062784291e-233	9.74260769403765e-228	dimethylaniline monooxygenase [N-oxide-forming] 2	Q8K2I3	3	2.39e-155	H24K24.5a.1	1.88e-129	Fmo-2-PA	1.57e-42	XP_786100.3	1.01e-150	reviewed	FMO2_MOUSE	Dimethylaniline monooxygenase [N-oxide-forming] 2 (EC 1.14.13.-) (Dimethylaniline oxidase 2) (Pulmonary flavin-containing monooxygenase 2) (FMO 2)	Fmo2	Mus musculus (Mouse)	535	energy homeostasis [GO:0097009]; NADP metabolic process [GO:0006739]; NADPH oxidation [GO:0070995]; negative regulation of fatty acid oxidation [GO:0046322]; organic acid metabolic process [GO:0006082]; oxygen metabolic process [GO:0072592]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; energy homeostasis [GO:0097009]; NADP metabolic process [GO:0006739]; NADPH oxidation [GO:0070995]; negative regulation of fatty acid oxidation [GO:0046322]; organic acid metabolic process [GO:0006082]; oxygen metabolic process [GO:0072592]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805]	GO:0004497; GO:0004499; GO:0005789; GO:0006082; GO:0006739; GO:0006805; GO:0009404; GO:0016020; GO:0016021; GO:0046322; GO:0050660; GO:0050661; GO:0070995; GO:0072592; GO:0097009
LOC105344573	outer dense fiber protein 3	11	0.535202479673973	17.2403768685219	0.957446808510638	0.558989256548372	0.617746270504798	1.93578930015236e-50	1.03585634082593e-44	outer dense fiber protein 3	Q8AVY1	1	7.3e-84	C40A11.7.1	0.17	CG8086-PK	1.74e-31	XP_802079.1	2.38e-82	reviewed	ODF3A_XENLA	Outer dense fiber protein 3 (Outer dense fiber of sperm tails protein 3)	odf3	Xenopus laevis (African clawed frog)	256		cytoplasm [GO:0005737]	GO:0005737
LOC117691246	uncharacterized LOC117691246_ncRNA	7	0.450655103732694	18.3701519483914	0.945945945945946	0.476406823945991	0.474377712305188	3.0186849669245e-147	1.61532247528103e-141	uncharacterized LOC117691246_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105345330	inner centromere protein	8	0.291999610729707	17.4064482260415	0.962264150943396	0.303450575856362	0.406126489466134	1.08080326926941e-115	5.78346475812216e-110	inner centromere protein	P53352	1	7.23e-44	Y39G10AR.13b.1	8.47e-15	Incenp-PC	1	XP_030844392.1	1.81e-61	reviewed	INCE_CHICK	Inner centromere protein	INCENP	Gallus gallus (Chicken)	877	chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; meiotic spindle midzone assembly [GO:0051257]; metaphase plate congression [GO:0051310]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of mitotic cytokinesis [GO:1902412]	chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; meiotic spindle midzone [GO:1990385]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; protein serine/threonine kinase activator activity [GO:0043539]; chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; meiotic spindle midzone assembly [GO:0051257]; metaphase plate congression [GO:0051310]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of mitotic cytokinesis [GO:1902412]	GO:0000070; GO:0000281; GO:0000775; GO:0000776; GO:0005634; GO:0005721; GO:0005737; GO:0005819; GO:0005874; GO:0007059; GO:0016572; GO:0030496; GO:0032133; GO:0032991; GO:0043539; GO:0051257; GO:0051310; GO:0071902; GO:1902412; GO:1990385
LOC105326826	uncharacterized LOC105326826	7	0.563529195917544	6.27028759808666	0.637837837837838	0.883499163091064	0.456040878230178	1.55612967266289e-141	8.32697436879293e-136	uncharacterized LOC105326826	Q8N7M0	2	3.47e-18	D1009.5.1	1.17e-7	CG5359-PC	3.38e-6	XP_784517.1	9.76e-22	reviewed	DYLT5_HUMAN	Dynein light chain Tctex-type 5 (Tctex1 domain-containing protein 1)	DYNLT5 TCTEX1D1	Homo sapiens (Human)	179	microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein intermediate chain binding [GO:0045505]; microtubule-based movement [GO:0007018]	GO:0005737; GO:0005868; GO:0007018; GO:0045505
LOC105326827	metabotropic glutamate receptor 5	6	0.393926167513839	0.651492281943641	0.463611859838275	0.849689582253689	0.319570832960882	2.07749255752842e-99	1.11168288747392e-93	metabotropic glutamate receptor 5	P41594	2	0	F45H11.4a.1	0	mGluR-PB	0	XP_030851338.1	0	reviewed	GRM5_HUMAN	Metabotropic glutamate receptor 5 (mGluR5)	GRM5 GPRC1E MGLUR5	Homo sapiens (Human)	1212	calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of locomotion [GO:0040013]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein tyrosine kinase activity [GO:0061098]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]	astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of locomotion [GO:0040013]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein tyrosine kinase activity [GO:0061098]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]	GO:0001640; GO:0001932; GO:0002029; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0006355; GO:0006417; GO:0006448; GO:0006468; GO:0007205; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007612; GO:0007626; GO:0008066; GO:0030296; GO:0031687; GO:0035584; GO:0040013; GO:0042802; GO:0043197; GO:0043198; GO:0043410; GO:0048170; GO:0050808; GO:0050890; GO:0051966; GO:0061098; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099055; GO:0099170; GO:0099530; GO:0099553; GO:0099583; GO:1902938; GO:1904646; GO:1990782
LOC105334847	myophilin	10	0.284466923026289	12.4331737735369	0.941176470588235	0.302246105715432	0.3914378401084	1.57908472919694e-76	8.44980871271117e-71	myophilin	Q24799	1	4.91e-40	F43G9.9.3	1.72e-53	Chd64-PB	1.41e-60	XP_797586.3	2.05e-39	reviewed	MYPH_ECHGR	Myophilin		Echinococcus granulosus (Hydatid tapeworm)	190			
LOC117691704	uncharacterized LOC117691704	9	0.695805284500958	6.60848184408387	0.978339350180505	0.71121056755264	0.849289627132077	2.44101484098289e-224	1.30620656952867e-218	uncharacterized LOC117691704	P86728	1	1.32e-5	R10H10.2.1	0.51	CG10527-PA	2.64e-14	XP_030842141.1	7.14e-11	reviewed	UP5_HALAI	Uncharacterized protein 5		Haliotis asinina (Donkey's ear abalone) (Ass's ear abalone)	173		extracellular region [GO:0005576]	GO:0005576
LOC105320766	uncharacterized LOC105320766_ncRNA	7	0.621446607986427	13.6742610704396	0.813513513513514	0.763904468288964	0.566214513330925	5.66426949478843e-176	3.03099592081725e-170	uncharacterized LOC105320766_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105324965	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1-A	14	0.231521827024875	6.2244583189764	0.869565217391304	0.266250101078606	0.179566245388175	8.25822232734591e-10	4.41904083314141e-4	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1-A	Q6DFM1	1	0	R07E5.3.1	1.59e-129	Snr1-PA	1.46e-176	XP_030847928.1	0	reviewed	SNF5_XENTR	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	smarcb1	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	378	chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]	brahma complex [GO:0035060]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0000228; GO:0003677; GO:0003712; GO:0003713; GO:0005634; GO:0006338; GO:0006357; GO:0016514; GO:0035060; GO:0071564; GO:0071565
LOC105332313	X-box-binding protein 1	10	0.26586722433665	30.9456723961815	0.988235294117647	0.269032310340658	0.491897420114641	6.62293340468481e-96	3.54398464831408e-90	X-box-binding protein 1	Q3SZZ2	1	1.54e-35	R74.3c.1	6.77e-18	Xbp1-PD	2.06e-14	XP_790957.3	4.15e-24	reviewed	XBP1_BOVIN	X-box-binding protein 1 (XBP-1) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form]	XBP1	Bos taurus (Bovine)	261	adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; endothelial cell proliferation [GO:0001935]; fatty acid homeostasis [GO:0055089]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; protein destabilization [GO:0031648]; regulation of autophagy [GO:0010506]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; sterol homeostasis [GO:0055092]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; endothelial cell proliferation [GO:0001935]; fatty acid homeostasis [GO:0055089]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; protein destabilization [GO:0031648]; regulation of autophagy [GO:0010506]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; sterol homeostasis [GO:0055092]; ubiquitin-dependent protein catabolic process [GO:0006511]	GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001525; GO:0001889; GO:0001935; GO:0002639; GO:0003700; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006511; GO:0006915; GO:0006990; GO:0007517; GO:0010506; GO:0016021; GO:0030154; GO:0031490; GO:0031648; GO:0034976; GO:0035356; GO:0042149; GO:0042632; GO:0043066; GO:0045348; GO:0045579; GO:0045582; GO:0045600; GO:0045944; GO:0046982; GO:0055089; GO:0055092; GO:0060612; GO:0071222; GO:0071230; GO:0071353; GO:0071375; GO:0071498; GO:0071499; GO:1900100; GO:1903489; GO:1990418; GO:2000347
LOC105344977	uncharacterized LOC105344977_misc_RNA	4	0.18704148399584	4.57015349936984	0.826053042121685	0.226427934355682	0.153502265257356	3.30797598199258e-87	1.77012441177209e-81	uncharacterized LOC105344977_misc_RNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105346613	cytochrome P450 27C1	4	0.187857523502674	2.31012819379126	0.358034321372855	0.524691383726422	0.138878840011078	5.30981526811986e-79	2.84132462849308e-73	cytochrome P450 27C1	A8WGA0	2	5.67e-108	ZK177.5.2	2.45e-68	Cyp49a1-PE	3.65e-73	XP_030831852.1	7.62e-123	reviewed	C27C1_DANRE	Cytochrome P450 27C1 (EC 1.14.19.53) (All-trans retinol 3,4-desaturase)	cyp27c1	Danio rerio (Zebrafish) (Brachydanio rerio)	540	lipid metabolic process [GO:0006629]	membrane [GO:0016020]; mitochondrion [GO:0005739]; all-trans retinal 3,4-desaturase activity [GO:0061897]; all-trans retinoic acid 3,4-desaturase activity [GO:0061898]; all-trans retinol 3,4-desaturase activity [GO:0061896]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; retinoic acid binding [GO:0001972]; lipid metabolic process [GO:0006629]	GO:0001972; GO:0004497; GO:0005506; GO:0005739; GO:0006629; GO:0016020; GO:0020037; GO:0061896; GO:0061897; GO:0061898; GO:1904768
LOC105345003	uncharacterized LOC105345003	6	0.308492333391822	2.90973377093471	0.889487870619946	0.346820168752624	0.452074736053635	1.63991344318246e-140	8.77530802754477e-135	uncharacterized LOC105345003	Q1WV73	1	0.17	F11H8.3.1	1	Art2-PB	1.3	XP_003727918.1	2.51e-7	reviewed	RSMA_LIGS1	Ribosomal RNA small subunit methyltransferase A (EC 2.1.1.182) (16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase) (16S rRNA dimethyladenosine transferase) (16S rRNA dimethylase) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase)	rsmA ksgA LSL_0229	Ligilactobacillus salivarius (strain UCC118) (Lactobacillus salivarius)	296		cytoplasm [GO:0005737]; 16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase activity [GO:0052908]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0052908
LOC105319984	low-density lipoprotein receptor-related protein 12	1	0.427522622562358	14.4175206016941	0.589865249572974	0.724780147452081	0.227445489822224	4.69391808490426e-209	2.51175311857695e-203	low-density lipoprotein receptor-related protein 12	Q5R662	2	3.23e-12	Y105E8A.7b.1	1.74e-9	CG6024-PF	1.36e-8	XP_030840750.1	3.3e-21	reviewed	LRP12_PONAB	Low-density lipoprotein receptor-related protein 12 (LRP-12)	LRP12	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	859	endocytosis [GO:0006897]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; endocytosis [GO:0006897]	GO:0005905; GO:0006897; GO:0016021
LOC105338896	stromelysin-3	9	0.759260932257375	5.0632585994436	0.884476534296029	0.858429707082827	0.737947274096663	1.70718489543808e-194	9.13528295028079e-189	stromelysin-3	Q9JHI0	1	5.57e-61	C31B8.8.1	7.33e-36	Mmp1-PL	2.96e-62	XP_030835862.1	7.08e-71	reviewed	MMP19_MOUSE	Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI)	Mmp19 Rasi	Mus musculus (Mouse)	527	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]	anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725]	GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0009725; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0031225; GO:0051591
LOC105349129	neuropilin and tolloid-like protein 1	5	0.558392114397162	4.7211312858823	0.717896865520728	0.777816621322244	0.45766079530677	1.56551161258946e-233	8.37717787989522e-228	neuropilin and tolloid-like protein 1	Q8R4I7	2	3.56e-48	K03E5.1.1	7.44e-37	Neto-PB	1.18e-40	XP_030831452.1	3.67e-35	reviewed	NETO1_MOUSE	Neuropilin and tolloid-like protein 1 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1)	Neto1 Btcl1	Mus musculus (Mouse)	533	memory [GO:0007613]; positive regulation of excitatory postsynaptic potential [GO:2000463]; receptor localization to synapse [GO:0097120]; regulation of kainate selective glutamate receptor activity [GO:2000312]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; visual learning [GO:0008542]	anchoring junction [GO:0070161]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synapse [GO:0045202]; ionotropic glutamate receptor binding [GO:0035255]; memory [GO:0007613]; positive regulation of excitatory postsynaptic potential [GO:2000463]; receptor localization to synapse [GO:0097120]; regulation of kainate selective glutamate receptor activity [GO:2000312]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; visual learning [GO:0008542]	GO:0007613; GO:0008542; GO:0014069; GO:0035255; GO:0045202; GO:0048169; GO:0060076; GO:0070161; GO:0097120; GO:0098839; GO:0098978; GO:0099061; GO:2000312; GO:2000463
LOC105332773	zinc finger homeobox protein 4	2	0.160944916933343	4.8706430631223	0.846797717184528	0.190063002848497	0.133203072576603	1.97450642141034e-135	1.05657418214805e-129	zinc finger homeobox protein 4	Q61329	1	0	ZC123.3d.1	2.46e-81	zfh2-PA	6.79e-57	XP_030831789.1	0	reviewed	ZFHX3_MOUSE	Zinc finger homeobox protein 3 (AT motif-binding factor 1) (AT-binding transcription factor 1) (Alpha-fetoprotein enhancer-binding protein) (Zinc finger homeodomain protein 3) (ZFH-3)	Zfhx3 Atbf1	Mus musculus (Mouse)	3726	brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to transforming growth factor beta [GO:0071559]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to transforming growth factor beta [GO:0071559]	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005739; GO:0006357; GO:0007420; GO:0007517; GO:0008270; GO:0016604; GO:0019899; GO:0032922; GO:0045662; GO:0045663; GO:0045664; GO:0045785; GO:0045893; GO:0045944; GO:0071559; GO:1904059
LOC105344715	acetylcholine receptor subunit alpha-like 1	3	0.315905447883042	1.31620555784858	0.665286404416839	0.474841280064862	0.35518032413204	1.95801021029612e-212	1.04774692761114e-206	acetylcholine receptor subunit alpha-like 1	P09478	2	7.8e-70	D2092.3.1	1.65e-68	nAChRalpha1-PC	1.31e-62	XP_782644.4	6.22e-70	reviewed	ACH1_DROME	Acetylcholine receptor subunit alpha-like 1 (Nicotinic acetylcholine receptor alpha 1)	nAChRalpha1 Acr96Aa AcrB als nAcRalpha-96Aa CG5610	Drosophila melanogaster (Fruit fly)	567	cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]	acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]	GO:0004888; GO:0005231; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0070161; GO:0098655; GO:1904315
LOC109618378	uncharacterized LOC109618378	7	0.46598793390895	2.11643758808561	0.497297297297297	0.937040954056041	0.347899781136864	5.30164884675499e-108	2.83695471108937e-102	uncharacterized LOC109618378	A7TRZ7	1	0.39	C52E12.1.1	0.11	CG6686-PB	9.2	XP_030836334.1	0.51	reviewed	PRM1_VANPO	Plasma membrane fusion protein PRM1	PRM1 Kpol_388p9	Vanderwaltozyma polyspora (strain ATCC 22028 / DSM 70294 / BCRC 21397 / CBS 2163 / NBRC 10782 / NRRL Y-8283 / UCD 57-17) (Kluyveromyces polysporus)	659		integral component of membrane [GO:0016021]; mating projection tip [GO:0043332]; plasma membrane [GO:0005886]	GO:0005886; GO:0016021; GO:0043332
LOC105328642	basement membrane-specific heparan sulfate proteoglycan core protein	6	0.546226164670921	12.5559708743659	0.983827493261456	0.555205224912087	0.714933863641604	2.91613070058053e-223	1.56044486692625e-217	basement membrane-specific heparan sulfate proteoglycan core protein	P98160	4	0	ZC101.2i.1	1.09e-136	trol-PAK	0	XP_030842937.1	0	reviewed	PGBM_HUMAN	Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]	HSPG2	Homo sapiens (Human)	4391	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]	GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016525; GO:0030021; GO:0030154; GO:0043202; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072359; GO:0098797; GO:1905907
LOC105318652	protein IWS1 homolog	14	0.280563384403333	4.81579427299528	0.652173913043478	0.430197189418443	0.226743096204013	5.18640459816987e-12	2.77528659171748e-6	protein IWS1 homolog	Q18DN4	1	0.33	F46B6.7.2	5.9	Osi18-PA	1.2	XP_030847822.1	7.48e-17	reviewed	HMU_HALWD	Halomucin	hmu HQ_1081A	Haloquadratum walsbyi (strain DSM 16790 / HBSQ001)	9159	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	GO:0005509; GO:0005576; GO:0007156; GO:0016020; GO:0030246
LOC105318662	WD repeat and SOCS box-containing protein 1	14	0.198625216671032	4.44893229220077	0.608695652173913	0.326312855959553	0.101832558051113	3.78784704465916e-6	1	WD repeat and SOCS box-containing protein 1	Q9Y6I7	1	3.06e-122	T03F6.5.1	1.83e-16	wds-PB	8.44e-15	XP_003727659.1	1.21e-95	reviewed	WSB1_HUMAN	WD repeat and SOCS box-containing protein 1 (WSB-1) (SOCS box-containing WD protein SWiP-1)	WSB1 SWIP1	Homo sapiens (Human)	421	intracellular signal transduction [GO:0035556]; protein aggregate center assembly [GO:0140454]; protein K27-linked ubiquitination [GO:0044314]; protein polyubiquitination [GO:0000209]	cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; intracellular signal transduction [GO:0035556]; protein aggregate center assembly [GO:0140454]; protein K27-linked ubiquitination [GO:0044314]; protein polyubiquitination [GO:0000209]	GO:0000209; GO:0005829; GO:0035556; GO:0044314; GO:0061630; GO:0140454
LOC105318672	solute carrier family 43 member 3	13	0.37722254218551	45.7411970360042	0.96551724137931	0.390694775834993	0.369087888613198	6.0307255558542e-22	3.22708949074203e-16	solute carrier family 43 member 3	Q8NBI5	2	1.86e-52	F02D8.5.1	3.4	AP-1gamma-PB	1	XP_030848095.1	1.75e-40	reviewed	S43A3_HUMAN	Equilibrative nucleobase transporter 1 (Protein FOAP-13) (Solute carrier family 43 member 3)	SLC43A3 ENBT1 PSEC0252	Homo sapiens (Human)	491	hypoxanthine transport [GO:0035344]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; adenine transmembrane transporter activity [GO:0015207]; fatty acid transmembrane transporter activity [GO:0015245]; guanine transmembrane transporter activity [GO:0015208]; xenobiotic transmembrane transporter activity [GO:0042910]; hypoxanthine transport [GO:0035344]	GO:0015207; GO:0015208; GO:0015245; GO:0016021; GO:0016323; GO:0035344; GO:0042910
LOC105318673	hypothetical protein	1	0.442096078173131	34.3823257989151	0.634465743025242	0.696800549175659	0.183493084485759	3.22152377492985e-168	1.72386314415516e-162	hypothetical protein	A1RL84	1	0.57	T05G5.8a.2	0.2	CG15252-PC	4.7	XP_030854102.1	1.4	reviewed	FABV_SHESW	Enoyl-[acyl-carrier-protein] reductase [NADH] (ENR) (EC 1.3.1.9)	fabV Sputw3181_2606	Shewanella sp. (strain W3-18-1)	401	fatty acid biosynthetic process [GO:0006633]	enoyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0004318]; enoyl-[acyl-carrier-protein] reductase activity [GO:0016631]; NAD binding [GO:0051287]; fatty acid biosynthetic process [GO:0006633]	GO:0004318; GO:0006633; GO:0016631; GO:0051287
LOC105340661	putative phosphatidylglycerol/phosphatidylinositol transfer protein 2	3	0.544931589055155	3.91169128011246	0.805383022774327	0.676611715973367	0.529667895638248	1.11253692925684e-308	1.11253866450175e-308	putative phosphatidylglycerol/phosphatidylinositol transfer protein 2	Q54SW1	2	4.89e-8	T20F10.2b.1	0.62		NA	XP_030831835.1	9.27e-16	reviewed	Y2179_DICDI	Putative phosphatidylglycerol/phosphatidylinositol transfer protein DDB_G0282179	DDB_G0282179	Dictyostelium discoideum (Slime mold)	145	sterol transport [GO:0015918]	sterol binding [GO:0032934]; sterol transport [GO:0015918]	GO:0015918; GO:0032934
LOC105325414	uncharacterized LOC105325414	12	0.682018550309631	26.2722767077997	0.96875	0.704019148706716	0.784961899989059	2.82177114645458e-48	1.50995231463702e-42	uncharacterized LOC105325414	Q80YA8	3	8.29e-10	Y64G10A.7d.1	3.3e-4	Ser-PB	8.18e-7	XP_030854391.1	6.27e-10	reviewed	CRUM2_MOUSE	Protein crumbs homolog 2 (crumbs2) (Crumbs-like protein 2)	Crb2	Mus musculus (Mouse)	1282	circulatory system development [GO:0072359]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ingression involved in gastrulation with mouth forming second [GO:0055111]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm formation [GO:0001707]; negative regulation of endopeptidase activity [GO:0010951]; notochord formation [GO:0014028]; photoreceptor cell maintenance [GO:0045494]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; regulation of gastrulation [GO:0010470]; retina homeostasis [GO:0001895]; retinal cone cell development [GO:0046549]; somitogenesis [GO:0001756]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]; circulatory system development [GO:0072359]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ingression involved in gastrulation with mouth forming second [GO:0055111]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm formation [GO:0001707]; negative regulation of endopeptidase activity [GO:0010951]; notochord formation [GO:0014028]; photoreceptor cell maintenance [GO:0045494]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; regulation of gastrulation [GO:0010470]; retina homeostasis [GO:0001895]; retinal cone cell development [GO:0046549]; somitogenesis [GO:0001756]	GO:0001707; GO:0001756; GO:0001895; GO:0005509; GO:0005737; GO:0005886; GO:0007157; GO:0010470; GO:0010718; GO:0010951; GO:0014028; GO:0016021; GO:0016324; GO:0016327; GO:0019828; GO:0030010; GO:0030054; GO:0030513; GO:0032991; GO:0035003; GO:0044877; GO:0045177; GO:0045197; GO:0045199; GO:0045494; GO:0046549; GO:0055111; GO:0072359
LOC105321850	uncharacterized LOC105321850	10	0.33599379172682	8.03152971992659	0.805882352941176	0.416926602872697	0.359402262938983	2.2953790795797e-70	1.22827570851573e-64	uncharacterized LOC105321850	Q7TQH7	2	2.7e-4	K03E5.1.1	3.91e-4	LpR2-PC	1.15e-4	XP_030840750.1	8.99e-6	reviewed	LRP10_MOUSE	Low-density lipoprotein receptor-related protein 10 (LRP-10)	Lrp10 Lrp9	Mus musculus (Mouse)	713	inner ear development [GO:0048839]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle receptor activity [GO:0005041]; inner ear development [GO:0048839]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]	GO:0005041; GO:0005886; GO:0005905; GO:0006629; GO:0006869; GO:0016021; GO:0048839
LOC105322328	echinoderm microtubule-associated protein-like 2	7	0.399828900044862	1.598770587352	0.508108108108108	0.786897303279781	0.307345337985902	1.7093701929189e-95	9.14697665192449e-90	echinoderm microtubule-associated protein-like 2	Q9VUI3	3	1.35e-146	F38A6.2b.2	2.5e-47	DCX-EMAP-PC	1.23e-143	XP_030842589.1	4.67e-162	reviewed	EMAL_DROME	Echinoderm microtubule-associated protein-like CG42247	DCX-EMAP CG42247	Drosophila melanogaster (Fruit fly)	1076	adult locomotory behavior [GO:0008344]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; microtubule cytoskeleton organization [GO:0000226]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; sensory dendrite [GO:0071683]; microtubule binding [GO:0008017]; adult locomotory behavior [GO:0008344]; intracellular signal transduction [GO:0035556]; melanotic encapsulation of foreign target [GO:0035011]; microtubule cytoskeleton organization [GO:0000226]; sensory perception of sound [GO:0007605]	GO:0000226; GO:0005737; GO:0005874; GO:0007605; GO:0008017; GO:0008344; GO:0035011; GO:0035556; GO:0071683
LOC105344011	tripartite motif-containing protein 45	5	0.392416892869053	1.67952662140657	0.469160768452983	0.836423075533391	0.259411962033431	1.2727936682797e-131	6.81082074245816e-126	tripartite motif-containing protein 45	F7H9X2	1	4.97e-31	F26F4.7.1	1.36e-14	mei-P26-PD	2.62e-17	XP_787393.2	1.42e-45	reviewed	TRIM2_CALJA	Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)	TRIM2	Callithrix jacchus (White-tufted-ear marmoset)	744	regulation of neuron apoptotic process [GO:0043523]	cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]	GO:0004842; GO:0005737; GO:0008270; GO:0043523
LOC105319384	G protein-activated inward rectifier potassium channel 2	13	0.39018961401141	23.2086480014558	0.96551724137931	0.40412495736896	0.354823878279196	3.70455103914094e-21	1.98233489745263e-15	G protein-activated inward rectifier potassium channel 2	P48545	3	1.38e-84	M02A10.2b.1	2.13e-88	Irk1-PD	4.21e-78	XP_011660845.2	8.32e-83	reviewed	KCNJ5_MOUSE	G protein-activated inward rectifier potassium channel 4 (GIRK-4) (Cardiac inward rectifier) (CIR) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5)	Kcnj5 Girk4	Mus musculus (Mouse)	419	membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]	external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]	GO:0005242; GO:0005886; GO:0008076; GO:0009897; GO:0015467; GO:0030315; GO:0034765; GO:0086089; GO:0086091; GO:0098914; GO:1990573
LOC105343715	sal-like protein 1	2	0.179183971643333	4.07027783624804	0.727203551046291	0.246401398048078	0.137505867855222	8.14516421667715e-140	4.35854253365768e-134	sal-like protein 1	Q9BXA9	2	1.44e-94	F15C11.1.1	2.07e-32	salr-PC	1.73e-46	XP_030832052.1	3.23e-108	reviewed	SALL3_HUMAN	Sal-like protein 3 (Zinc finger protein 796) (Zinc finger protein SALL3) (hSALL3)	SALL3 ZNF796	Homo sapiens (Human)	1300	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872
LOC117692972	sal-like protein 1	2	0.180022232510124	3.6305033795128	0.698414711477489	0.257758362691543	0.138687846122115	5.07765929740081e-141	2.71709611131355e-135	sal-like protein 1	Q9ER74	1	2.3e-8	T03F6.2.1	4.1	CG42458-PA	0.35	XP_030832052.1	1.96e-4	reviewed	SALL1_MOUSE	Sal-like protein 1 (Zinc finger protein Spalt-3) (Sal-3) (mSal-3)	Sall1 Sal3	Mus musculus (Mouse)	1322	branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; forelimb morphogenesis [GO:0035136]; GABAergic neuron differentiation [GO:0097154]; heart development [GO:0007507]; hindlimb morphogenesis [GO:0035137]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis [GO:0072309]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of ectoderm development [GO:2000384]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mesoderm development [GO:2000381]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; olfactory bulb development [GO:0021772]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase II [GO:0006366]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]	chromocenter [GO:0010369]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; forelimb morphogenesis [GO:0035136]; GABAergic neuron differentiation [GO:0097154]; heart development [GO:0007507]; hindlimb morphogenesis [GO:0035137]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis [GO:0072309]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of ectoderm development [GO:2000384]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mesoderm development [GO:2000381]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; olfactory bulb development [GO:0021772]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase II [GO:0006366]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]	GO:0000122; GO:0000792; GO:0000978; GO:0000981; GO:0000987; GO:0001657; GO:0001658; GO:0001822; GO:0001843; GO:0003281; GO:0003337; GO:0003340; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0006366; GO:0007224; GO:0007507; GO:0008013; GO:0010369; GO:0016581; GO:0021553; GO:0021772; GO:0021889; GO:0021915; GO:0030177; GO:0030182; GO:0031129; GO:0035136; GO:0035137; GO:0042733; GO:0044877; GO:0045666; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048566; GO:0060173; GO:0061034; GO:0061629; GO:0072073; GO:0072092; GO:0072309; GO:0090190; GO:0097154; GO:2000177; GO:2000381; GO:2000384
LOC105324812	uncharacterized LOC105324812_ncRNA	6	0.33287296554658	7.68169222444985	0.921832884097035	0.361099035724506	0.48363531132311	2.32237270922102e-150	1.24272021568584e-144	uncharacterized LOC105324812_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105338345	uncharacterized LOC105338345	5	0.552228818528655	19.1831164489347	0.868554095045501	0.635802446478276	0.502865238318438	3.9767107517396e-257	2.12796973694188e-251	uncharacterized LOC105338345	P41110	1	2.2		NA	RpL31-PB	1	XP_789104.5	0.3	reviewed	IF4G1_RABIT	Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220)	EIF4G1 EIF4G	Oryctolagus cuniculus (Rabbit)	1402	positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]	cytoplasmic stress granule [GO:0010494]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]	GO:0003729; GO:0003743; GO:0010494; GO:0036493
LOC105323138	Friend leukemia integration 1 transcription factor	9	0.775866794245426	3.04646623099367	0.963898916967509	0.804925475677839	0.869718933214484	7.7259443820594e-230	4.13421464639504e-224	Friend leukemia integration 1 transcription factor	Q90837	1	1.48e-100	C42D8.4a.1	8.21e-59	Ets65A-PB	6.64e-70	XP_030834089.1	5.43e-64	reviewed	ERG_CHICK	Transcriptional regulator Erg	ERG	Gallus gallus (Chicken)	478	cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565
LOC117692375	G protein-coupled receptor 161-like	6	0.331497299384829	1.27827001925314	0.609164420485175	0.544183619786601	0.41031094360179	1.63128185047739e-127	8.72911968445253e-122	G protein-coupled receptor 161-like	Q2YDN1	1	2.43e-35	C02D4.2g.1	2.79e-19	Octalpha2R-PC	7.07e-13	XP_782439.4	3.56e-37	reviewed	GP161_BOVIN	G protein-coupled receptor 161	GPR161	Bos taurus (Bovine)	528	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]	GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0016021; GO:0055037; GO:0060170; GO:1901621
LOC105343134	cytochrome b5 domain-containing protein 1	11	0.508571772704545	9.54611041865898	0.914893617021277	0.555880774816596	0.579029558922159	2.25913086696868e-47	1.20887899996188e-41	cytochrome b5 domain-containing protein 1	Q567I9	1	5.36e-108	F58B4.2.1	3.19e-6	CG15429-PA	2.44e-28	XP_798302.2	4.82e-131	reviewed	CB5D1_DANRE	Cytochrome b5 domain-containing protein 1	cyb5d1 zgc:112008	Danio rerio (Zebrafish) (Brachydanio rerio)	214		metal ion binding [GO:0046872]	GO:0046872
LOC105320410	histone H3	8	0.325286350857678	15.6162547491637	0.861635220125786	0.377522115228984	0.27563860334237	8.69352712059708e-79	4.65197591044847e-73	histone H3	P02299	4	8.12e-96	F22B3.2.1	2.62e-94	His3:CG33866-PA	1.05e-96	XP_030843368.1	5.75e-96	reviewed	H3_DROME	Histone H3	His3; His3:CG31613 CG31613; His3:CG33803 CG33803; His3:CG33806 CG33806; His3:CG33809 CG33809; His3:CG33812 CG33812; His3:CG33815 CG33815; His3:CG33818 CG33818; His3:CG33821 CG33821; His3:CG33824 CG33824; His3:CG33827 CG33827; His3:CG33830 CG33830; His3:CG33833 CG33833; His3:CG33836 CG33836; His3:CG33839 CG33839; His3:CG33842 CG33842; His3:CG33845 CG33845; His3:CG33848 CG33848; His3:CG33851 CG33851; His3:CG33854 CG33854; His3:CG33857 CG33857; His3:CG33860 CG33860; His3:CG33863 CG33863; His3:CG33866 CG33866	Drosophila melanogaster (Fruit fly)	136	nucleosome assembly [GO:0006334]	chromatin [GO:0000785]; nucleosome [GO:0000786]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; RCAF complex [GO:0035059]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; nucleosome assembly [GO:0006334]	GO:0000785; GO:0000786; GO:0005634; GO:0005700; GO:0006334; GO:0030527; GO:0031492; GO:0035059; GO:0046982
LOC105320409	histone H2B	8	0.303563550648106	60.8826871949768	0.952830188679245	0.318591449195042	0.259741460615251	2.60009245352245e-74	1.39133027261949e-68	histone H2B	P35069	2	3.8e-68	H02I12.6.1	2e-62	His2B:CG33910-PA	1.78e-60	XP_781938.1	2.62e-67	reviewed	H2B3_TIGCA	Histone H2B.3		Tigriopus californicus (Marine copepod)	123		nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; structural constituent of chromatin [GO:0030527]	GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0044877; GO:0046982
LOC105320407	histone H1-delta-like	8	0.324138904061946	45.8553837650549	0.915094339622642	0.354213647737796	0.298554156366931	3.0192411001744e-85	1.61562006663212e-79	histone H1-delta-like	P15870	1	6.27e-25	Y73B6BL.9a.1	8.27e-26	His1:CG33864-PA	2.87e-11	XP_030840668.1	9.15e-26	reviewed	H1D_STRPU	Histone H1-delta		Strongylocentrotus purpuratus (Purple sea urchin)	185	chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; structural constituent of chromatin [GO:0030527]; chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]	GO:0000786; GO:0003690; GO:0005634; GO:0006334; GO:0030261; GO:0030527; GO:0031492; GO:0045910
LOC105324863	neutral cholesterol ester hydrolase 1	3	0.389656618109217	9.27125146751701	0.779848171152519	0.499657026230314	0.436072678436439	6.55236696722436e-262	3.50622398309749e-256	neutral cholesterol ester hydrolase 1	B2GV54	1	5.88e-64	Y43F8A.3a.1	2.47e-50	Hsl-PC	2.41e-6	XP_011672621.1	1.28e-61	reviewed	NCEH1_RAT	Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Acetylalkylglycerol acetylhydrolase) (2-acetyl MAGE hydrolase) (EC 3.1.1.71) (Arylacetamide deacetylase-like 1)	Nceh1 Aadacl1	Rattus norvegicus (Rat)	408	ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; protein dephosphorylation [GO:0006470]; SMAD protein signal transduction [GO:0060395]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; acetylalkylglycerol acetylhydrolase activity [GO:0047378]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; protein dephosphorylation [GO:0006470]; SMAD protein signal transduction [GO:0060395]; xenobiotic metabolic process [GO:0006805]	GO:0005783; GO:0005886; GO:0006470; GO:0006805; GO:0016020; GO:0016021; GO:0016042; GO:0017171; GO:0042301; GO:0046485; GO:0047378; GO:0060395
LOC105330146	alkaline phosphatase	3	0.407718158685263	2.37008175510923	0.859213250517598	0.474524989505981	0.55886649975541	0	0	alkaline phosphatase	P08289	2	2.36e-150	F08C6.1a.2	2.3	phu-PA	1.09e-118	XP_030842571.1	7.64e-148	reviewed	PPBT_RAT	Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1)	Alpl	Rattus norvegicus (Rat)	524	biomineralization [GO:0110148]; bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; futile creatine cycle [GO:0140651]; multicellular organism aging [GO:0010259]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]	anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; adenosine-diphosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462]; biomineralization [GO:0110148]; bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; futile creatine cycle [GO:0140651]; multicellular organism aging [GO:0010259]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]	GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005615; GO:0005758; GO:0005886; GO:0010259; GO:0016311; GO:0016462; GO:0016887; GO:0019725; GO:0030282; GO:0031012; GO:0031225; GO:0031966; GO:0032496; GO:0033280; GO:0033883; GO:0034516; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0051384; GO:0052732; GO:0055062; GO:0055074; GO:0065010; GO:0071407; GO:0071529; GO:0110148; GO:0120162; GO:0140651; GO:1904383
LOC105338114	coactosin-like protein	10	0.268522685564571	8.4843499578567	0.817647058823529	0.328409039899116	0.337441187334218	3.80974109721779e-66	2.03862293905002e-60	coactosin-like protein	B0BNA5	1	6.33e-37	K08E3.4.1	0.004	CG6891-PC	2.22e-44	XP_030848899.1	2.74e-5	reviewed	COTL1_RAT	Coactosin-like protein	Cotl1 Clp	Rattus norvegicus (Rat)	142	defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833]	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833]	GO:0003779; GO:0005634; GO:0005829; GO:0005886; GO:0019899; GO:0030833; GO:0030864; GO:0050832; GO:0051015
LOC105333120	putative defense protein 3	13	0.393316095811941	6.69063997352969	0.931034482758621	0.42245062142764	0.361011777921322	1.68543375228716e-21	9.0188908431888e-16	putative defense protein 3	Q0Q028	1	1.02e-12	F23B12.4c.2	0.004	l(2)34Fc-PB	2.61e-11	XP_030836407.1	1.06e-14	reviewed	DFP3_ANTMY	Putative defense protein 3 (DFP-3)		Antheraea mylitta (Tasar silkworm)	163	defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]	extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]	GO:0005576; GO:0042742; GO:0042832; GO:0045087
LOC105334469	leucine-rich repeat-containing protein 15	3	0.48702566498086	4.1826437188046	0.835058661145618	0.583223296328319	0.553613052763864	0	0	leucine-rich repeat-containing protein 15	Q8R5M3	1	2.13e-44	T21D12.9c.2	3.39e-28	atk-PC	5.51e-31	XP_030828123.1	1.96e-28	reviewed	LRC15_RAT	Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by amyloid-beta) (rLib)	Lrrc15 Lib	Rattus norvegicus (Rat)	578	negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]	GO:0001968; GO:0005518; GO:0009986; GO:0016021; GO:0030335; GO:0043236; GO:0046813; GO:1903077
LOC105333268	zinc metalloproteinase nas-14	9	0.64357137224767	34.6590224597472	0.981949458483754	0.655401728355164	0.790797136590441	1.23935875222023e-208	6.63190783183062e-203	zinc metalloproteinase nas-14	Q20191	5	3.7700000000000003e-51	F39D8.4.1	3.32e-52	CG5715-PA	1.92e-40	NP_001354909.1	7.59e-55	reviewed	"NAS13_CAEEL"	Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)	nas-13 F39D8.4	Caenorhabditis elegans	450	proteolysis [GO:0006508]	extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]	GO:0004222; GO:0005576; GO:0006508; GO:0008270
LOC105341623	uncharacterized LOC105341623	5	0.428961145048655	1.51358743187164	0.483316481294237	0.887536762454225	0.290359228875275	2.29010626824084e-147	1.22545418498582e-141	uncharacterized LOC105341623	Q2YB00	1	0.16	C33H5.2.1	0.94	CG5004-PF	1.9	XP_030842367.1	5.4	reviewed	EFG_NITMU	Elongation factor G (EF-G)	fusA Nmul_A0764	Nitrosospira multiformis (strain ATCC 25196 / NCIMB 11849 / C 71)	696		cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005737
LOC105340061	somatomedin-B and thrombospondin type-1 domain-containing protein	4	0.286407010768233	9.74720586293429	0.915756630265211	0.312754504092738	0.314166733604358	2.16441190218834e-178	1.1581941241562e-172	somatomedin-B and thrombospondin type-1 domain-containing protein	Q8IVN8	2	4.73e-35	R17.3c.1	2.06e-25	CG42339-PB	1.12e-29	XP_030848395.1	3.32e-26	reviewed	SBSPO_HUMAN	Somatomedin-B and thrombospondin type-1 domain-containing protein (RPE-spondin)	SBSPON C8orf84 RPESP	Homo sapiens (Human)	264		collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	GO:0005576; GO:0062023
LOC105344310	LIM/homeobox protein Lhx5	2	0.176129675653589	1.91807220710734	0.392517438173748	0.448718091285476	0.0882378313922996	7.06835225625381e-90	3.78233183913947e-84	LIM/homeobox protein Lhx5	P61375	1	2.64e-132	ZC247.3.1	3.34e-42	Lim1-PA	2.72e-99	XP_030847226.1	2.27e-73	reviewed	LHX5_MOUSE	LIM/homeobox protein Lhx5 (LIM homeobox protein 5)	Lhx5	Mus musculus (Mouse)	402	cell proliferation in forebrain [GO:0021846]; cell-cell signaling [GO:0007267]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; cerebellum development [GO:0021549]; forebrain neuron differentiation [GO:0021879]; hippocampus development [GO:0021766]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]	nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell proliferation in forebrain [GO:0021846]; cell-cell signaling [GO:0007267]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; cerebellum development [GO:0021549]; forebrain neuron differentiation [GO:0021879]; hippocampus development [GO:0021766]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007267; GO:0021527; GO:0021549; GO:0021702; GO:0021766; GO:0021846; GO:0021879; GO:0021937; GO:0030182; GO:0042127; GO:0045893; GO:0046872; GO:1990837
LOC105330417	uncharacterized LOC105330417	5	0.483377364772219	3.67198982230837	0.567239635995956	0.852157243778474	0.353660148934514	9.31002300342514e-180	4.98186778931682e-174	uncharacterized LOC105330417	Q5ZIZ2	1	2.06e-17	T22A3.4b.1	1.04e-4	Smyd5-PA	1.95e-12	XP_030841506.1	7.27e-23	reviewed	SMYD5_CHICK	Histone-lysine N-trimethyltransferase SMYD5 (EC 2.1.1.372) (SET and MYND domain-containing protein 5) ([histone H4]-lysine20 N-trimethyltransferase SMYD5)	SMYD5 RCJMB04_22j23	Gallus gallus (Chicken)	420	histone H4-K20 trimethylation [GO:0034773]; negative regulation of gene expression, epigenetic [GO:0045814]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell division [GO:2000035]	histone methyltransferase activity (H4-K20 specific) [GO:0042799]; metal ion binding [GO:0046872]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of gene expression, epigenetic [GO:0045814]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell division [GO:2000035]	GO:0034773; GO:0042799; GO:0045814; GO:0046872; GO:2000035; GO:2000736
LOC105330418	uncharacterized LOC105330418	5	0.470077000159061	2.88334051629997	0.568250758341759	0.827235147966746	0.344812168987154	3.24815162116881e-175	1.7381119177004e-169	uncharacterized LOC105330418	Q6GMV2	2	1.55e-15	F52H3.5.1	0.004	Stip1-PA	3.83e-6	XP_030841813.1	8.16e-16	reviewed	SMYD5_HUMAN	Histone-lysine N-trimethyltransferase SMYD5 (EC 2.1.1.372) (Protein NN8-4AG) (Retinoic acid-induced protein 15) (SET and MYND domain-containing protein 5) ([histone H4]-lysine20 N-trimethyltransferase SMYD5)	SMYD5 RAI15	Homo sapiens (Human)	418	histone H4-K20 trimethylation [GO:0034773]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transposition [GO:0010529]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell division [GO:2000035]	histone methyltransferase activity (H4-K20 specific) [GO:0042799]; metal ion binding [GO:0046872]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transposition [GO:0010529]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell division [GO:2000035]	GO:0010529; GO:0034773; GO:0042799; GO:0045814; GO:0046872; GO:2000035; GO:2000736
LOC105331830	uncharacterized LOC105331830	2	0.192611449063128	3.24803887890487	0.715282181357007	0.269280368060774	0.202259641764109	2.31369826875519e-206	1.23807845319705e-200	uncharacterized LOC105331830	E1BBQ2	2	5.25e-13	R03H10.11.1	0.066	CG31195-PB	2.21e-70	XP_030831956.1	6.24e-25	reviewed	GP158_BOVIN	Probable G-protein coupled receptor 158	GPR158	Bos taurus (Bovine)	1216		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021
LOC105345796	hypothetical protein	5	0.578254744152589	3.39336577660455	0.687563195146613	0.841020502892516	0.458701731374614	4.49628960727002e-234	2.40600053916705e-228	hypothetical protein	Q8N554	4	2.27e-16	Y47D3A.6a.1	7.78e-11	Cf2-PA	1.94e-14	XP_030848619.1	1.82e-13	reviewed	ZN276_HUMAN	Zinc finger protein 276 (Zfp-276) (Zinc finger protein 477)	ZNF276 CENP-Z ZFP276 ZNF477	Homo sapiens (Human)	614	regulation of transcription by RNA polymerase II [GO:0006357]	chromosome [GO:0005694]; kinetochore [GO:0000776]; nucleus [GO:0005634]; chromatin insulator sequence binding [GO:0043035]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0000776; GO:0005634; GO:0005694; GO:0006357; GO:0008270; GO:0043035; GO:1990837
LOC105340282	protein OVEREXPRESSOR OF CATIONIC PEROXIDASE 3	2	0.220657655274676	39.0429433449809	0.703741280913126	0.313549398421484	0.145981105142291	1.82494760341471e-148	9.76544062168037e-143	protein OVEREXPRESSOR OF CATIONIC PEROXIDASE 3	Q24DE2	2	1.7	W03D2.1c.1	0.21		NA	XP_030839292.1	0.025	reviewed	CF251_TETTS	Cilia- and flagella-associated protein 251	CFAP251 FAP251 TTHERM_01262850	Tetrahymena thermophila (strain SB210)	996	cilium movement [GO:0003341]; cilium organization [GO:0044782]	motile cilium [GO:0031514]; cilium movement [GO:0003341]; cilium organization [GO:0044782]	GO:0003341; GO:0031514; GO:0044782
LOC105335618	uncharacterized LOC105335618	8	0.662904227022006	4.50961070757163	0.767295597484277	0.863948951610648	0.603212467813956	4.85362502101566e-172	2.59721357774565e-166	uncharacterized LOC105335618	O22184	2	0.19	CD4.2.1	0.088	Fem-1-PA	3	XP_011663284.2	8.17e-83	reviewed	TPS05_ARATH	Putative terpenoid synthase 5 (AtTPS05) (EC 4.2.3.-)	TPS05 At2g23230 T20D16.14	Arabidopsis thaliana (Mouse-ear cress)	596	diterpenoid biosynthetic process [GO:0016102]; sesquiterpene biosynthetic process [GO:0051762]	cytoplasm [GO:0005737]; cyclase activity [GO:0009975]; magnesium ion binding [GO:0000287]; terpene synthase activity [GO:0010333]; diterpenoid biosynthetic process [GO:0016102]; sesquiterpene biosynthetic process [GO:0051762]	GO:0000287; GO:0005737; GO:0009975; GO:0010333; GO:0016102; GO:0051762
LOC105334421	PCNA-associated factor	8	0.352047105188176	6.48017197308403	0.877358490566038	0.401257990859641	0.41515674987886	2.93944952058683e-118	1.57292295406218e-112	PCNA-associated factor	Q5HZL4	1	2.76e-25	ZK673.11c.1	3.1		NA	XP_030843179.1	1.53e-17	reviewed	PAF15_XENLA	PCNA-associated factor (PCNA-associated factor of 15 kDa) (PAF15) (p15PAF) (PCNA-clamp-associated factor)	pclaf paf	Xenopus laevis (African clawed frog)	123	cellular response to DNA damage stimulus [GO:0006974]; centrosome cycle [GO:0007098]; DNA replication [GO:0006260]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; centrosome cycle [GO:0007098]; DNA replication [GO:0006260]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	GO:0003682; GO:0005634; GO:0006260; GO:0006974; GO:0007098; GO:0009411; GO:0019985; GO:0048471; GO:0051726
LOC117681156	uncharacterized LOC117681156	10	0.296161097250957	13.4441335713967	0.782352941176471	0.378551778441073	0.222875918245627	3.4916344686049e-44	1.86840153722623e-38	uncharacterized LOC117681156	A0A067XMP0	2	0.33	F15H10.8.1	0.24	Gbs-76A-PD	1.7	XP_793469.2	1.6	reviewed	PTAE_PESFW	Oxidoreductase ptaE (EC 1.-.-.-) (Dihydrogeodin oxidase) (DHGO) (Pestheic acid biosynthesis cluster protein E)	ptaE PFICI_10828	Pestalotiopsis fici (strain W106-1 / CGMCC3.15140)	610		copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]	GO:0005507; GO:0016491
LOC105345408	quinone reductase-like	4	0.529802706575941	19.9701415967746	0.952418096723869	0.556271146462208	0.613446541302955	0	0	quinone reductase-like	Q93T20	1	6.3e-16	W06D12.2.1	0.24	Gdn1-PA	5.4	XP_030830078.1	3.02e-51	reviewed	CHRR_PSEPU	Quinone reductase (EC 1.6.5.2) (Chromate reductase) (CHRR) (EC 1.6.-.-) (NAD(P)H dehydrogenase (quinone))	chrR	Pseudomonas putida (Arthrobacter siderocapsulatus)	186		"NADH dehydrogenase (quinone) activity [GO:0050136]; NADPH dehydrogenase (quinone) activity [GO:0008753]"	GO:0008753; GO:0050136
LOC105321684	hyccin	4	0.352396216243347	5.94634453524407	0.643525741029641	0.547602362695723	0.271243044849469	7.75109233398868e-154	4.14767151665601e-148	hyccin	Q6P9N1	3	4.14e-71	D1069.3b.1	3.69e-27	Hyccin-PA	5.16e-46	XP_030830379.1	4.67e-50	reviewed	HYCCI_MOUSE	Hyccin (Down-regulated by CTNNB1 protein A) (Protein FAM126A)	Fam126a Drctnnb1a	Mus musculus (Mouse)	521	myelination [GO:0042552]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; myelination [GO:0042552]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]	GO:0005737; GO:0005829; GO:0005886; GO:0042552; GO:0043005; GO:0046854; GO:0072659
LOC105329712	thymosin beta	10	0.39942506326089	21.1329547118866	0.941176470588235	0.424389129714696	0.483378020953778	2.9345047784886e-94	1.57027698300748e-88	thymosin beta	O17389	2	1.56e-13	F08F1.8.1	1.38e-14	cib-PE	1.27e-23	XP_030834105.1	0.007	reviewed	TYB_CAEEL	Thymosin beta (Tetrathymosin beta)	tth-1 F08F1.8	Caenorhabditis elegans	151	actin filament organization [GO:0007015]	anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]	GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0070161
LOC105348737	POU domain, class 4, transcription factor 3	7	0.601601137467046	30.0885054733268	0.689189189189189	0.87291145436395	0.490379225868955	3.08123029876739e-152	1.64879098271282e-146	POU domain, class 4, transcription factor 3	P24350	3	2.97e-102	C30A5.7a.1	2.3e-79	acj6-PH	2.02e-94	XP_786727.2	5.08e-98	reviewed	IPOU_DROME	Inhibitory POU protein (I-POU) (Abnormal chemosensory jump 6 protein)	acj6 Ipou CG9151	Drosophila melanogaster (Fruit fly)	396	axon guidance [GO:0007411]; chemosensory jump behavior [GO:0007636]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; synaptic target recognition [GO:0008039]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; axon guidance [GO:0007411]; chemosensory jump behavior [GO:0007636]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; synaptic target recognition [GO:0008039]	GO:0000978; GO:0000981; GO:0003700; GO:0003714; GO:0005634; GO:0006357; GO:0007411; GO:0007636; GO:0008039; GO:0045944; GO:0048813; GO:0050911; GO:0070983
LOC105338903	sodium- and chloride-dependent glycine transporter 1	6	0.36670433468632	0.790699126773849	0.493261455525606	0.743427913489754	0.301182169341339	9.79838016893583e-94	5.24319161543891e-88	sodium- and chloride-dependent glycine transporter 1	A7Y2W8	1	1.4e-176	T23G5.5.1	2.02e-128	DAT-PA	1.03e-136	XP_003729242.1	3.65e-165	reviewed	SC6A9_XENLA	Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9)	slc6a9 glyt1	Xenopus laevis (African clawed frog)	633	neurotransmitter transport [GO:0006836]; regulation of synaptic transmission, glycinergic [GO:0060092]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; neurotransmitter transport [GO:0006836]; regulation of synaptic transmission, glycinergic [GO:0060092]	GO:0005886; GO:0005887; GO:0006836; GO:0015375; GO:0060092
LOC105338906	complement C1q-like protein 4	4	0.296069663052848	1.4388418345752	0.379095163806552	0.780990345748459	0.193167992107936	1.53809333371131e-109	8.2304604761559e-104	complement C1q-like protein 4	Q86Z23	1	6.53e-18		NA	CG2681-PA	0.58	XP_003724148.1	6.33e-10	reviewed	C1QL4_HUMAN	Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11)	C1QL4 CTRP11	Homo sapiens (Human)	238	ERK1 and ERK2 cascade [GO:0070371]; fibroblast proliferation [GO:0048144]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast proliferation [GO:0048144]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]	GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048144; GO:0048147; GO:0070371; GO:0070373
LOC105338907	myosin heavy chain, striated muscle	5	0.686629393576189	84.1006272046177	0.776541961577351	0.884214153967254	0.538828648956465	5.36907376605623e-276	2.87303432480682e-270	myosin heavy chain, striated muscle	P24733	1	0	F11C3.3.3	0	Mhc-PU	0	XP_003727482.1	0	reviewed	MYS_ARGIR	Myosin heavy chain, striated muscle		Argopecten irradians (Bay scallop) (Aequipecten irradians)	1938		myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]	GO:0003774; GO:0005516; GO:0005524; GO:0016459; GO:0030016; GO:0032982; GO:0051015
LOC105319736	peptidyl-prolyl cis-trans isomerase FKBP2	1	0.570235175825538	42.8313099560887	0.920288479787436	0.619626550097908	0.481222557345097	0	0	peptidyl-prolyl cis-trans isomerase FKBP2	Q9Y680	2	2.95e-42	F36H1.1a.3	5.36e-27	Fkbp14-PF	1.08e-55	XP_030855230.1	3.33e-31	reviewed	FKBP7_HUMAN	Peptidyl-prolyl cis-trans isomerase FKBP7 (PPIase FKBP7) (EC 5.2.1.8) (23 kDa FK506-binding protein) (23 kDa FKBP) (FKBP-23) (FK506-binding protein 7) (FKBP-7) (Rotamase)	FKBP7 FKBP23 UNQ670/PRO1304	Homo sapiens (Human)	222	peptidyl-proline modification [GO:0018208]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; peptidyl-proline modification [GO:0018208]	GO:0003755; GO:0005509; GO:0005528; GO:0005783; GO:0005788; GO:0018208
LOC105320302	prolyl 4-hydroxylase subunit alpha-1	1	0.454143874786499	8.28799170600529	0.691402543177074	0.656844379975313	0.270514472132396	1.81227029722098e-249	9.69760334205325e-244	prolyl 4-hydroxylase subunit alpha-1	P16924	1	9.43e-60	F35G2.4.1	1.46e-46	PH4alphaEFB-PA	2.35e-47	XP_030835071.1	8.28e-49	reviewed	P4HA1_CHICK	Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)	P4HA1 P4HA	Gallus gallus (Chicken)	516	peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]	GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0018401; GO:0031418
LOC117681265	uncharacterized LOC117681265_ncRNA	8	0.334701310430656	3.51334389122245	0.72327044025157206	0.462760942247603	0.343658714143534	5.48785113795388e-98	2.93659304672823e-92	uncharacterized LOC117681265_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105325311	sodium- and chloride-dependent taurine transporter	3	0.423157413000092	8.10697496296789	0.880607315389924	0.480529068524399	0.605650320367959	0	0	sodium- and chloride-dependent taurine transporter	P31647	1	0	T03F7.1.1	8.2e-170	Gat-PA	2.59e-166	XP_030854516.1	0	reviewed	S6A11_RAT	Sodium- and chloride-dependent GABA transporter 3 (GAT-3) (Solute carrier family 6 member 11)	Slc6a11 Gabt3 Gat-3 Gat-b	Rattus norvegicus (Rat)	627	brain development [GO:0007420]; monocarboxylic acid transport [GO:0015718]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; neurotransmitter binding [GO:0042165]; taurine:sodium symporter activity [GO:0005369]; brain development [GO:0007420]; monocarboxylic acid transport [GO:0015718]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725]	GO:0001504; GO:0005332; GO:0005369; GO:0005737; GO:0005886; GO:0005887; GO:0006836; GO:0007420; GO:0008028; GO:0009410; GO:0015718; GO:0016020; GO:0035725; GO:0042165; GO:0042995; GO:0043005; GO:0045202; GO:0098810; GO:0098982; GO:0099055; GO:0099056
LOC105327950	putative T-box protein 7	4	0.21095777629301	2.71229856471744	0.300312012480499	0.70246199794192	0.125548645974462	1.5578281470242e-71	8.33606304097825e-66	putative T-box protein 7	P56158	1	8.06e-43	T27A1.6.1	1.84e-39	byn-PC	1.12e-39	XP_030850404.1	4.16e-39	reviewed	TBXT_HALRO	T-box transcription factor T (AS-T) (Brachyury protein homolog) (Protein T)	TBXT T	Halocynthia roretzi (Sea squirt) (Cynthia roretzi)	471	positive regulation of transcription, DNA-templated [GO:0045893]	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; positive regulation of transcription, DNA-templated [GO:0045893]	GO:0003677; GO:0003700; GO:0005634; GO:0045893
LOC105338011	tetraspanin-9	1	0.465244514010458	7.67766272090664	0.684949705826533	0.679238942732364	0.298957916693235	2.22676988642379e-276	1.19156238038446e-270	tetraspanin-9	B5X3I6	1	6.26e-10	B0563.2.2	2.73e-9	Tsp66E-PC	1.29e-8	XP_030829377.1	5.96e-15	reviewed	TSN9_SALSA	Tetraspanin-9 (Tspan-9)	tspan9	Salmo salar (Atlantic salmon)	239		integral component of membrane [GO:0016021]	GO:0016021
LOC105338464	ADAM 17-like protease	12	0.697420169975337	8.36260506073534	0.9375	0.743914847973693	0.762446708931308	6.19257719745638e-47	3.31369759897649e-41	ADAM 17-like protease	Q9VAC5	2	3.55e-148	ZK154.7.1	7.18e-62	Tace-PA	2.02e-149	XP_011683752.1	1.03e-119	reviewed	ADA17_DROME	ADAM 17-like protease (EC 3.4.24.-)	Tace CG7908	Drosophila melanogaster (Fruit fly)	732	membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of cell death [GO:0010942]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of cell death [GO:0010942]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0007220; GO:0010942; GO:0016021; GO:0033209; GO:0040015; GO:0046872; GO:1903427
LOC105347812	innexin unc-9	7	0.455764286538349	3.26888065279056	0.543243243243243	0.838969084672583	0.361765118657871	2.75203309015819e-112	1.47263492280837e-106	innexin unc-9	Q03412	1	1.06e-101	R07D5.1g.1	2.82e-104	shakB-PA	6.85e-20	XP_011665548.2	1.3	reviewed	UNC7_CAEEL	Innexin unc-7 (Uncoordinated protein 7)	unc-7 unc-12 unc-124 R07D5.1	Caenorhabditis elegans	522	cellular response to dopamine [GO:1903351]; gap junction assembly [GO:0016264]; ion transmembrane transport [GO:0034220]; locomotion [GO:0040011]; oviposition [GO:0018991]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of male mating behavior [GO:1902435]; regulation of neuronal signal transduction [GO:1902847]; regulation of pharyngeal pumping [GO:0043051]; response to anesthetic [GO:0072347]; spicule insertion [GO:0034609]	cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; cellular response to dopamine [GO:1903351]; gap junction assembly [GO:0016264]; ion transmembrane transport [GO:0034220]; locomotion [GO:0040011]; oviposition [GO:0018991]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of male mating behavior [GO:1902435]; regulation of neuronal signal transduction [GO:1902847]; regulation of pharyngeal pumping [GO:0043051]; response to anesthetic [GO:0072347]; spicule insertion [GO:0034609]	GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0016264; GO:0018991; GO:0032589; GO:0034220; GO:0034609; GO:0040011; GO:0043051; GO:0055077; GO:0072347; GO:0090325; GO:1902435; GO:1902847; GO:1903351
LOC105340983	cholesterol 7-desaturase	12	0.712255522072654	25.1623615610081	1	0.712255522072654	0.847660911105382	5.17326831887518e-52	2.76825726357666e-46	cholesterol 7-desaturase	F7J184	1	1.48e-163	C12D8.5.1	2.55e-108	nvd-PA	2.32e-101	XP_011675548.2	1.33e-132	reviewed	NVD_XENLA	Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Xl)	nvd XELAEV_18041408mg	Xenopus laevis (African clawed frog)	454	cholesterol metabolic process [GO:0008203]	integral component of membrane [GO:0016021]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]	GO:0008203; GO:0016021; GO:0016491; GO:0046872; GO:0051537
LOC105322258	hypothetical protein	11	0.577229729357089	10.9793227864837	0.957446808510638	0.602884383995182	0.667894793130586	2.05090862590835e-54	1.09745761299256e-48	hypothetical protein	A3BT52	2	0.54	Y116A8A.4.1	6.9		NA	XP_030847118.1	0.5	reviewed	RH29_ORYSJ	DEAD-box ATP-dependent RNA helicase 29 (RNAH) (EC 3.6.4.13)	Os08g0416100 LOC_Os08g32090 OsJ_026224 OsJ_27320 P0433E10.15	Oryza sativa subsp. japonica (Rice)	851	rRNA processing [GO:0006364]	nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	GO:0003724; GO:0003729; GO:0005524; GO:0005730; GO:0006364; GO:0016887
LOC105330734	acyl-CoA 6-desaturase	12	0.745865604874723	33.73458210614	1	0.745865604874723	0.893087848140773	1.01154130398499e-54	5.41283844092802e-49	acyl-CoA 6-desaturase	A4FV48	1	2.9e-168	W08D2.4a.1	2.16e-39	CG3566-PB	1.02e-10	XP_030835157.1	2.1e-158	reviewed	FADS2_BOVIN	Acyl-CoA 6-desaturase (EC 1.14.19.3) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase) (Fatty acid desaturase 2)	FADS2	Bos taurus (Bovine)	444	lipid metabolic process [GO:0006629]; unsaturated fatty acid biosynthetic process [GO:0006636]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; linoleoyl-CoA desaturase activity [GO:0016213]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; lipid metabolic process [GO:0006629]; unsaturated fatty acid biosynthetic process [GO:0006636]	GO:0005789; GO:0006629; GO:0006636; GO:0016021; GO:0016213; GO:0016717
LOC105330727	cilia- and flagella-associated protein 157	11	0.509531514649972	13.8631483893394	0.978723404255319	0.52060828670758	0.676266224266696	4.44780783215865e-55	2.38005755345075e-49	cilia- and flagella-associated protein 157	Q0VFN8	1	2.26e-119	K08C7.3c.1	1.07e-4	CG17122-PA	1.32e-29	XP_030853485.1	0	reviewed	CF157_XENTR	Cilia- and flagella-associated protein 157	cfap157	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	519	sperm axoneme assembly [GO:0007288]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule binding [GO:0008017]; sperm axoneme assembly [GO:0007288]	GO:0005737; GO:0007288; GO:0008017; GO:0036064
LOC105344257	cytosolic phospholipase A2	7	0.457160373178836	6.90546762669997	0.678378378378378	0.673901745323384	0.384887421606151	1.92666753259359e-119	1.03097521003109e-113	cytosolic phospholipase A2	P47712	2	0	K10F12.3a.1	0.011	Smurf-PB	1.6	XP_030833351.1	0.024	reviewed	PA24A_HUMAN	Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]	PLA2G4A CPLA2 PLA2G4	Homo sapiens (Human)	749	arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; establishment of localization in cell [GO:0051649]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475]; icosanoid metabolic process [GO:0006690]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; platelet activating factor biosynthetic process [GO:0006663]; positive regulation of macrophage activation [GO:0043032]; positive regulation of platelet activation [GO:0010572]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T-helper 1 type immune response [GO:0002827]; prostaglandin biosynthetic process [GO:0001516]; regulation of cell population proliferation [GO:0042127]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; ceramide 1-phosphate binding [GO:1902387]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phospholipase A2 activity [GO:0004623]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; establishment of localization in cell [GO:0051649]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475]; icosanoid metabolic process [GO:0006690]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; platelet activating factor biosynthetic process [GO:0006663]; positive regulation of macrophage activation [GO:0043032]; positive regulation of platelet activation [GO:0010572]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T-helper 1 type immune response [GO:0002827]; prostaglandin biosynthetic process [GO:0001516]; regulation of cell population proliferation [GO:0042127]	GO:0000139; GO:0001516; GO:0002827; GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005737; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006071; GO:0006640; GO:0006663; GO:0006690; GO:0008374; GO:0010314; GO:0010572; GO:0019369; GO:0019370; GO:0032266; GO:0032308; GO:0034478; GO:0034638; GO:0036151; GO:0042127; GO:0043032; GO:0043231; GO:0046475; GO:0047498; GO:0047499; GO:0050482; GO:0051649; GO:0070273; GO:0071236; GO:0102545; GO:1902387
LOC105343929	glycine receptor subunit alpha-3	12	0.703562764783884	10.7825479328737	0.875	0.804071731181582	0.675278304499219	9.60814393273191e-42	5.14139468355631e-36	glycine receptor subunit alpha-3	P24524	1	1.12e-105	B0207.12a.2	1.39e-95	GluClalpha-PH	3.15e-85	XP_030836733.1	1.38e-78	reviewed	GLRA3_RAT	Glycine receptor subunit alpha-3	Glra3	Rattus norvegicus (Rat)	464	cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]	anchoring junction [GO:0070161]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]	GO:0004888; GO:0005231; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030425; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:0070161; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0098982; GO:0099060; GO:1902476; GO:1904315; GO:2000300
LOC105324492	teneurin-m	6	0.276597570310975	4.82472038237583	0.921832884097035	0.300051750249625	0.386943892516081	2.93444550899243e-120	1.57024526742592e-114	teneurin-m	O61307	2	0	R13F6.4e.1	0	Ten-m-PB	0	XP_030836269.1	0	reviewed	TENM_DROME	Teneurin-m (Tenm) (Odd Oz protein) (Tenascin-like protein)	Ten-m odz CG5723	Drosophila melanogaster (Fruit fly)	2731	cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]	anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499]	GO:0001745; GO:0001941; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007274; GO:0008039; GO:0008045; GO:0016200; GO:0022416; GO:0031005; GO:0031012; GO:0031122; GO:0031594; GO:0034110; GO:0034116; GO:0040017; GO:0042051; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0045211; GO:0045467; GO:0046982; GO:0048058; GO:0048499; GO:0048790; GO:0050808; GO:0051124; GO:0070161; GO:0097090; GO:0099190; GO:0099559; GO:2000331
LOC105339511	abnormal spindle-like microcephaly-associated protein homolog	8	0.293977843301999	8.74437199870151	0.877358490566038	0.335071520322708	0.303785080784563	1.00965444763186e-86	5.40274172163389e-81	abnormal spindle-like microcephaly-associated protein homolog	Q8IZT6	2	0	C45G3.1.1	2.15e-27	asp-PA	5.13e-79	XP_787918.4	0	reviewed	ASPM_HUMAN	Abnormal spindle-like microcephaly-associated protein (Abnormal spindle protein homolog) (Asp homolog)	ASPM MCPH5	Homo sapiens (Human)	3477	asymmetric cell division [GO:0008356]; cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; meiotic spindle assembly [GO:0090306]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]; spindle organization [GO:0007051]	apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; asymmetric cell division [GO:0008356]; cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; meiotic spindle assembly [GO:0090306]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]; spindle organization [GO:0007051]	GO:0001764; GO:0002052; GO:0005516; GO:0005634; GO:0005737; GO:0005813; GO:0007051; GO:0007283; GO:0008356; GO:0008584; GO:0016324; GO:0021873; GO:0021987; GO:0030496; GO:0036449; GO:0045665; GO:0045769; GO:0048477; GO:0048589; GO:0051445; GO:0051653; GO:0051661; GO:0072687; GO:0090263; GO:0090306; GO:0097150; GO:0097431
LOC105339464	leucine-rich repeat transmembrane neuronal protein 3	3	0.536332880707969	5.3438384816172	0.859903381642512	0.623712956778368	0.590866381774387	0	0	leucine-rich repeat transmembrane neuronal protein 3	Q7L985	1	3.54e-23	K03A1.2b.1	8.62e-17	kek2-PA	2.55e-15	XP_030830715.1	5.25e-19	reviewed	LIGO2_HUMAN	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 3) (Leucine-rich repeat neuronal protein 6C)	LINGO2 LERN3 LRRN6C UNQ9234/PRO31993	Homo sapiens (Human)	606		extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	GO:0005615; GO:0016021; GO:0031012
LOC105321897	uncharacterized LOC105321897	11	0.557053143306248	17.0418134249683	0.893617021276596	0.623368993699849	0.567670097406466	1.7929060169246e-46	9.59398352904486e-41	uncharacterized LOC105321897	Q12WL4	1	0.11	W02F12.5.1	0.2	obe-PA	3.1	XP_030832100.1	2.5	reviewed	VATE_METBU	V-type ATP synthase subunit E (V-ATPase subunit E)	atpE Mbur_1240	Methanococcoides burtonii (strain DSM 6242 / NBRC 107633 / OCM 468 / ACE-M)	183	proton motive force-driven plasma membrane ATP synthesis [GO:0042777]	proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton motive force-driven plasma membrane ATP synthesis [GO:0042777]	GO:0005524; GO:0033178; GO:0042777; GO:0046933; GO:0046961
LOC105317956	cilia- and flagella-associated protein 77	11	0.542925200835209	13.2846301119002	0.978723404255319	0.554727922592496	0.684075107444201	1.06876846637727e-55	5.71906556506206e-50	cilia- and flagella-associated protein 77	A2BFC9	1	2.58e-46	C09D1.1j.1	0.34	LanB1-PB	7.2	XP_780064.2	6.9e-72	reviewed	CFA77_DANRE	Cilia- and flagella-associated protein 77	cfap77 si:ch211-215c18.4	Danio rerio (Zebrafish) (Brachydanio rerio)	240		cilium [GO:0005929]	GO:0005929
LOC105327400	uncharacterized LOC105327400_ncRNA	12	0.674946912756637	25.6277575582578	1	0.674946912756637	0.830344135167847	5.57231636399157e-51	2.9817910649028e-45	uncharacterized LOC105327400_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105342649	uncharacterized LOC105342649	13	0.383178767883139	13.9805942397595	1	0.383178767883139	0.365460478876062	9.56839037335494e-22	5.12012223590522e-16	uncharacterized LOC105342649	Q6INA9	1	0.48	R11E3.7a.2	1.6		NA	XP_030850379.1	0.1	reviewed	SETB1_XENLA	Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.366) (SET domain bifurcated 1)	setdb1	Xenopus laevis (African clawed frog)	1269	chromatin organization [GO:0006325]; histone lysine methylation [GO:0034968]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265]	chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone lysine methylation [GO:0034968]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265]	GO:0003677; GO:0005634; GO:0005694; GO:0006325; GO:0007265; GO:0008270; GO:0018024; GO:0034968; GO:0090309; GO:1990841
LOC105341304	fibrocystin-L-like	12	0.741585278479294	22.1395076755049	0.96875	0.765507384236691	0.846973288694411	5.68536261268227e-52	3.04228301694718e-46	fibrocystin-L-like	Q86WI1	2	0	C39E9.2.1	2.44e-22	CG8483-PA	7.15e-13	XP_030842165.1	0	reviewed	PKHL1_HUMAN	Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1)	PKHD1L1	Homo sapiens (Human)	4243	immune response [GO:0006955]; sensory perception of sound [GO:0007605]	cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; stereocilium coat [GO:0120234]; stereocilium tip [GO:0032426]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]; sensory perception of sound [GO:0007605]	GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016021; GO:0032426; GO:0038023; GO:0120234
LOC105346085	tumor necrosis factor receptor superfamily member 16	7	0.503512169993772	5.0416202641877	0.651351351351351	0.773026982977991	0.44952654841785	1.65769054830268e-139	8.87043473921148e-134	tumor necrosis factor receptor superfamily member 16	Q9Z0W1	2	1.49e-36	B0350.2d.1	0.99	Ank-PE	0.007	XP_030830229.1	7.13e-47	reviewed	TNR16_MOUSE	Tumor necrosis factor receptor superfamily member 16 (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (CD antigen CD271)	Ngfr Tnfrsf16	Mus musculus (Mouse)	427	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular glucose homeostasis [GO:0001678]; cellular response to amyloid-beta [GO:1904646]; cellular response to oxidative stress [GO:0034599]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast proliferation [GO:0048144]; glucose homeostasis [GO:0042593]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; intracellular protein transport [GO:0006886]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myelination [GO:0031643]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of cell death [GO:0010941]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; skin development [GO:0043588]	cell surface [GO:0009986]; cell-cell junction [GO:0005911]; clathrin-coated endocytic vesicle [GO:0045334]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuronal cell body membrane [GO:0032809]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; amyloid-beta binding [GO:0001540]; calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; identical protein binding [GO:0042802]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; neurotrophin TRKA receptor binding [GO:0005168]; preprotein binding [GO:0070678]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular glucose homeostasis [GO:0001678]; cellular response to amyloid-beta [GO:1904646]; cellular response to oxidative stress [GO:0034599]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast proliferation [GO:0048144]; glucose homeostasis [GO:0042593]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; intracellular protein transport [GO:0006886]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myelination [GO:0031643]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of cell death [GO:0010941]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; skin development [GO:0043588]	GO:0001540; GO:0001678; GO:0001942; GO:0005035; GO:0005168; GO:0005516; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005791; GO:0005794; GO:0005886; GO:0005911; GO:0006886; GO:0006919; GO:0007165; GO:0007266; GO:0007411; GO:0007417; GO:0007623; GO:0008543; GO:0009611; GO:0009897; GO:0009986; GO:0010468; GO:0010941; GO:0010976; GO:0010977; GO:0014069; GO:0015026; GO:0016021; GO:0016048; GO:0016525; GO:0019233; GO:0021675; GO:0030135; GO:0030336; GO:0030426; GO:0031069; GO:0031267; GO:0031625; GO:0031643; GO:0032224; GO:0032590; GO:0032809; GO:0032922; GO:0034599; GO:0035025; GO:0035907; GO:0040037; GO:0042475; GO:0042488; GO:0042593; GO:0042802; GO:0043065; GO:0043066; GO:0043121; GO:0043197; GO:0043204; GO:0043410; GO:0043524; GO:0043588; GO:0044877; GO:0045121; GO:0045334; GO:0045666; GO:0048144; GO:0048146; GO:0048406; GO:0051402; GO:0051799; GO:0051897; GO:0051902; GO:0051968; GO:0061000; GO:0070678; GO:1900182; GO:1901216; GO:1902895; GO:1903588; GO:1904646; GO:2000179; GO:2000377; GO:2000463; GO:2001235
LOC105331131	protocadherin-11 X-linked	7	0.499574074745098	3.52717681041338	0.786486486486487	0.635197277167307	0.515697671262898	3.79637509864842e-160	2.03147068628756e-154	protocadherin-11 X-linked	Q6KEQ9	1	1.11e-111	F15B9.7a.1	1.37e-55	ds-PB	2.12e-79	XP_787157.2	1.29e-86	reviewed	PC11X_PIG	Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome) (PCDH-X)	PCDH11X PCDH11 PCDHX	Sus scrofa (Pig)	1117	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	GO:0005509; GO:0005887; GO:0007155; GO:0007156
LOC105320921	sodium-coupled monocarboxylate transporter 1	3	0.372800275348131	1.24733044407387	0.666666666666667	0.559200413022197	0.380934734546762	4.02473925733478e-228	2.1536701745139e-222	sodium-coupled monocarboxylate transporter 1	Q8N695	2	1.87e-138	ZK822.5a.2	3.92e-71	CG32669-PA	2.01e-104	XP_030838764.1	1.56e-153	reviewed	SC5A8_HUMAN	Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8)	SLC5A8 AIT SMCT SMCT1	Homo sapiens (Human)	610	apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; propanoate transport [GO:0015730]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; organic acid:sodium symporter activity [GO:0005343]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; symporter activity [GO:0015293]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; propanoate transport [GO:0015730]; sodium ion transport [GO:0006814]	GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006915; GO:0008028; GO:0015129; GO:0015293; GO:0015552; GO:0015730; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161
LOC105330613	zinc finger protein 239	10	0.248513369386673	5.03427571993399	0.7	0.355019099123818	0.267566481934357	9.67245784836629e-53	5.17580957432359e-47	zinc finger protein 239	P24399	2	2.39e-42	Y38H8A.5.1	3.9e-34	Clamp-PA	5.06e-36	XP_030849328.1	1.68e-40	reviewed	ZN239_MOUSE	Zinc finger protein 239 (Zfp-239) (Zinc finger protein MOK-2)	Znf239 Mok-2 Mok2 Zfp239	Mus musculus (Mouse)	201	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872
LOC105345077	uncharacterized LOC105345077	3	0.32829157437461	1.96284527725906	0.782608695652174	0.419483678367557	0.378243969770771	1.76401419434988e-226	9.43938107510178e-221	uncharacterized LOC105345077	Q3U0J8	2	1.22e-68	C31E10.8.1	2.08e-141	CG12241-PA	2.34e-40	XP_030853737.1	1.07e-173	reviewed	TBD2B_MOUSE	TBC1 domain family member 2B	Tbc1d2b Kiaa1055	Mus musculus (Mouse)	965	activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]	cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]	GO:0005096; GO:0005769; GO:0005829; GO:0006897; GO:0090630
LOC105333574	temptin	1	0.412632193915011	10.0127189098694	0.969823495919529	0.425471434391036	0.682849044298191	0	0	temptin	Q7Z0T3	1	1.11e-15	F35G12.3a.2	0.025	da-PC	0.025	XP_030850948.1	6.3	reviewed	TEMPT_APLCA	Temptin		Aplysia californica (California sea hare)	125		extracellular region [GO:0005576]; pheromone activity [GO:0005186]	GO:0005186; GO:0005576
LOC105343428	leucine-rich repeat-containing protein 74B	2	0.156408649988167	3.46608096013512	0.669245402663285	0.233708964403391	0.121301423641784	2.51024128051115e-123	1.34325019113176e-117	leucine-rich repeat-containing protein 74B	Q0VAA2	2	1.56e-44	F28C1.3c.1	4.98e-8	LRR-PG	3.05e-4	XP_030848176.1	2.95e-70	reviewed	LR74A_HUMAN	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)	LRRC74A C14orf166B LRRC74	Homo sapiens (Human)	488			
LOC105320897	FK506-binding protein 2	1	0.39769304890666	20.6084502767797	0.994496109318656	0.399894021887251	0.736240866819369	0	0	FK506-binding protein 2	Q5R941	1	1.05e-50	F36H1.1a.3	2.58e-39	Fkbp14-PF	6.36e-79	XP_030855230.1	2.12e-43	reviewed	FKB14_PONAB	Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (FK506-binding protein 14) (FKBP-14) (Rotamase)	FKBP14	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	211		endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005509; GO:0005788
LOC117681233	peptidyl-prolyl cis-trans isomerase FKBP10-like	1	0.578005659393482	53.4603571509915	0.939457202505219	0.615254912998839	0.486691305488386	0	0	peptidyl-prolyl cis-trans isomerase FKBP10-like	Q2HJ89	1	5.03e-40	F36H1.1a.3	1.92e-18	Fkbp14-PD	5.99e-26	XP_030855230.1	4.28e-23	reviewed	FKB10_BOVIN	Peptidyl-prolyl cis-trans isomerase FKBP10 (PPIase FKBP10) (EC 5.2.1.8) (FK506-binding protein 10) (FKBP-10) (Rotamase)	FKBP10	Bos taurus (Bovine)	583	aorta morphogenesis [GO:0035909]; collagen fibril organization [GO:0030199]; extracellular matrix assembly [GO:0085029]; in utero embryonic development [GO:0001701]; peptidyl-lysine hydroxylation [GO:0017185]; peptidyl-proline modification [GO:0018208]; protein folding [GO:0006457]; wound healing [GO:0042060]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; aorta morphogenesis [GO:0035909]; collagen fibril organization [GO:0030199]; extracellular matrix assembly [GO:0085029]; in utero embryonic development [GO:0001701]; peptidyl-lysine hydroxylation [GO:0017185]; peptidyl-proline modification [GO:0018208]; protein folding [GO:0006457]; wound healing [GO:0042060]	GO:0001701; GO:0003755; GO:0005509; GO:0005528; GO:0005758; GO:0005783; GO:0005788; GO:0006457; GO:0016020; GO:0017185; GO:0018208; GO:0030199; GO:0035909; GO:0042060; GO:0085029
LOC105345393	peptidyl-prolyl cis-trans isomerase FKBP14	1	0.510143094089277	56.0840543406635	0.754981970013285	0.675702353634087	0.264352810734931	1.16007917382532e-243	6.20767646547318e-238	peptidyl-prolyl cis-trans isomerase FKBP14	Q5R941	1	1.12e-6	C05C8.3.2	7.82e-7	Fkbp14-PF	0.006	XP_030855230.1	2.94e-5	reviewed	FKB14_PONAB	Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (FK506-binding protein 14) (FKBP-14) (Rotamase)	FKBP14	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	211		endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005509; GO:0005788
LOC105339015	uncharacterized LOC105339015	6	0.327566264014255	2.3999853408365	0.84366576819407	0.388265443927439	0.456775481653064	5.61503808711421e-142	3.00465180071951e-136	uncharacterized LOC105339015	O80875	1	1.7	K11D12.12.1	0.064	CG6420-PB	0.9	XP_030835648.1	1.1	reviewed	SMXL7_ARATH	Protein SMAX1-LIKE 7 (AtSMXL7) (Protein D53-like 1) (AtD53-like 1) (Protein D53-like SMXL 7)	SMXL7 At2g29970 F23F1.11	Arabidopsis thaliana (Mouse-ear cress)	1002		nucleus [GO:0005634]	GO:0005634
LOC105340880	dachshund homolog 1	14	0.361486011475706	32.0034604057357	1	0.361486011475706	0.443254629520197	4.73526309871647e-22	2.53387716622797e-16	dachshund homolog 1	Q9UI36	4	1.28e-60	B0412.1a.1	1.07e-47	dac-PC	2.99e-62	XP_030837149.1	5.4e-58	reviewed	DACH1_HUMAN	Dachshund homolog 1 (Dach1)	DACH1 DACH	Homo sapiens (Human)	758	development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342]	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279
LOC105333204	uncharacterized LOC105333204	9	0.648647148177618	1.78869660785372	0.877256317689531	0.739404362325927	0.683738388756557	4.83870406308773e-180	2.58922925379075e-174	uncharacterized LOC105333204	A0QVQ8	1	0.47	F47C12.2.1	0.93	Lar-PI	4.2	XP_011663475.2	0.01	reviewed	DHA_MYCS2	Alanine dehydrogenase (EC 1.4.1.1)	ald MSMEG_2659 MSMEI_2596	Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium smegmatis)	371	alanine catabolic process [GO:0006524]; L-alanine catabolic process [GO:0042853]	cytosol [GO:0005829]; alanine dehydrogenase activity [GO:0000286]; nucleotide binding [GO:0000166]; alanine catabolic process [GO:0006524]; L-alanine catabolic process [GO:0042853]	GO:0000166; GO:0000286; GO:0005829; GO:0006524; GO:0042853
LOC105333163	tetraspanin-9	6	0.385256016243109	2.83496747021085	0.846361185983828	0.455191025561126	0.450000131106251	7.26811515229991e-140	3.8892265629169e-134	tetraspanin-9	O70352	1	5.06e-21	T23D8.2.1	3.94e-15	Tsp66E-PC	1.06e-17	XP_030844647.1	9.52e-31	reviewed	CD82_RAT	CD82 antigen (Metastasis suppressor Kangai-1 homolog) (CD antigen CD82)	Cd82 Kai1	Rattus norvegicus (Rat)	266		integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	GO:0005886; GO:0005887
LOC105320956	splicing factor U2AF 26 kDa subunit	14	0.196610884654656	19.7121235644165	1	0.196610884654656	0.352690263787483	7.36333940219618e-18	3.94018182083039e-12	splicing factor U2AF 26 kDa subunit	Q7TP17	1	1.12e-119	Y116A8C.35a.2	4.01e-89	U2af38-PB	1.45e-103	XP_789191.3	2.55e-118	reviewed	U2AF4_RAT	Splicing factor U2AF 26 kDa subunit (Liver regeneration-related protein LRRG157/LRRG158) (U2 auxiliary factor 26) (U2 small nuclear RNA auxiliary factor 1-like protein 4) (U2AF1-like 4)	U2af1l4 Cb2-806 Cb2-807	Rattus norvegicus (Rat)	220	mRNA splicing, via spliceosome [GO:0000398]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]	GO:0000398; GO:0005681; GO:0005737; GO:0016607; GO:0030628; GO:0046872; GO:0089701
LOC117680998	uncharacterized LOC117680998	2	0.210794537198378	3.13566734678088	0.587444514901712	0.358833101426859	0.131608540415411	8.30112773836992e-134	4.44199986182365e-128	uncharacterized LOC117680998	Q6R7G0	1	2.29e-37	R31.1d.1	0.21	FASN3-PC	1.5	XP_030844441.1	0.021	reviewed	Y068_OSHVF	Putative transmembrane protein ORF68	ORF68	Ostreid herpesvirus 1 (isolate France) (OsHV-1) (Pacific oyster herpesvirus)	693		host cell membrane [GO:0033644]; integral component of membrane [GO:0016021]	GO:0016021; GO:0033644
LOC105335713	actin, adductor muscle	10	0.308729729524876	70.0871150091496	0.952941176470588	0.323975642094006	0.387547243166003	8.85585587131498e-76	4.73883932358762e-70	actin, adductor muscle	Q26065	1	0	M03F4.2a.1	0	Act42A-PA	0	XP_011661664.1	0	reviewed	ACT_PLAMG	Actin, adductor muscle		Placopecten magellanicus (Sea scallop)	376		cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856
LOC105339650	golgin subfamily A member 6-like protein 22	5	0.390692336414795	14.006525091821	0.848331648129424	0.460541979397178	0.341827471251132	1.10382989278061e-173	5.90668206266048e-168	golgin subfamily A member 6-like protein 22	P19137	2	1.86e-4	K08C7.3c.1	7.29e-4	CG11498-PB	0.072	XP_030842024.1	5e-4	reviewed	LAMA1_MOUSE	Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha)	Lama1 Lama Lama-1	Mus musculus (Mouse)	3083	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retina development in camera-type eye [GO:0060041]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]	basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retina development in camera-type eye [GO:0060041]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]	GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0007411; GO:0008022; GO:0009887; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0031175; GO:0043010; GO:0043208; GO:0043256; GO:0045198; GO:0045785; GO:0045995; GO:0048514; GO:0051149; GO:0060041; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046
LOC105318603	fibronectin type III domain-containing protein 2	13	0.423192053526564	3.3868131977954	0.96551724137931	0.438306055438227	0.402222336022862	8.90476727141151e-24	4.76501220507047e-18	fibronectin type III domain-containing protein 2	H2A0L8	1	1.62e-164	C09D8.1i.1	1.44e-21	Lar-PI	7.35e-43	XP_030851900.1	1.46e-19	reviewed	FND2_PINMG	Fibronectin type III domain-containing protein 2		Margaritifera margaritifera (Freshwater pearl mussel)	624		extracellular region [GO:0005576]	GO:0005576
LOC109618627	uncharacterized LOC109618627_ncRNA	14	0.199909026540263	9.04996521364137	0.869565217391304	0.229895380521302	0.115387623903536	8.61283357149466e-7	0.460879614677536	uncharacterized LOC109618627_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105329978	uncharacterized LOC105329978	12	0.66562015106536	91.8662464542735	1	0.66562015106536	0.763033643884132	5.7135746954314e-47	3.05737952812291e-41	uncharacterized LOC105329978	Q58815	3	0.56	F55B12.9.1	2.2	mAChR-C-PA	1.8	XP_030840933.1	1.8	reviewed	GLMS_METJA	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase) (GFAT) (Glucosamine-6-phosphate synthase) (Hexosephosphate aminotransferase) (L-glutamine--D-fructose-6-phosphate amidotransferase) [Cleaved into: Mja gf6p intein]	glmS MJ1420	Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) (Methanococcus jannaschii)	1099	fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; intein-mediated protein splicing [GO:0016539]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	cytoplasm [GO:0005737]; carbohydrate derivative binding [GO:0097367]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; intein-mediated protein splicing [GO:0016539]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	GO:0003677; GO:0004360; GO:0004519; GO:0005737; GO:0006002; GO:0006047; GO:0006487; GO:0006541; GO:0016539; GO:0097367
LOC105345012	uncharacterized LOC105345012	7	0.449836482470239	15.3371137071231	0.691891891891892	0.650154291070267	0.371018168355337	3.78320842948818e-115	2.02442509628656e-109	uncharacterized LOC105345012	P32507	2	5.71e-5	F15G9.4b.1	5.41e-4	kirre-PG	2.32e-4	XP_003723404.2	6.24e-5	reviewed	NECT2_MOUSE	Nectin-2 (Herpes virus entry mediator B) (Herpesvirus entry mediator B) (HveB) (Murine herpes virus entry protein B) (mHveB) (Nectin cell adhesion molecule 2) (Poliovirus receptor homolog) (Poliovirus receptor-related protein 2) (CD antigen CD112)	Nectin2 Mph Pvr Pvrl2 Pvs	Mus musculus (Mouse)	530	acrosome assembly [GO:0001675]; adhesion of symbiont to host [GO:0044406]; cell part morphogenesis [GO:0032990]; cilium organization [GO:0044782]; coreceptor-mediated virion attachment to host cell [GO:0046814]; cytoskeleton organization [GO:0007010]; establishment of localization in cell [GO:0051649]; establishment of mitochondrion localization [GO:0051654]; fertilization [GO:0009566]; fusion of virus membrane with host plasma membrane [GO:0019064]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of immunoglobulin mediated immune response [GO:0002891]; positive regulation of mast cell activation [GO:0033005]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of viral entry into host cell [GO:0046596]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; susceptibility to T cell mediated cytotoxicity [GO:0060370]	apical junction complex [GO:0043296]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zonula adherens [GO:0005915]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; acrosome assembly [GO:0001675]; adhesion of symbiont to host [GO:0044406]; cell part morphogenesis [GO:0032990]; cilium organization [GO:0044782]; coreceptor-mediated virion attachment to host cell [GO:0046814]; cytoskeleton organization [GO:0007010]; establishment of localization in cell [GO:0051649]; establishment of mitochondrion localization [GO:0051654]; fertilization [GO:0009566]; fusion of virus membrane with host plasma membrane [GO:0019064]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of immunoglobulin mediated immune response [GO:0002891]; positive regulation of mast cell activation [GO:0033005]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of viral entry into host cell [GO:0046596]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; susceptibility to T cell mediated cytotoxicity [GO:0060370]	GO:0001675; GO:0002860; GO:0002891; GO:0005886; GO:0005911; GO:0005915; GO:0007010; GO:0007156; GO:0007286; GO:0007289; GO:0009566; GO:0009986; GO:0016021; GO:0019064; GO:0030382; GO:0032990; GO:0033005; GO:0042271; GO:0042802; GO:0042803; GO:0043296; GO:0044291; GO:0044406; GO:0044782; GO:0045954; GO:0046596; GO:0046814; GO:0050839; GO:0050862; GO:0051649; GO:0051654; GO:0060370
LOC105345004	protein PLANT CADMIUM RESISTANCE 3	1	0.456185319716773	23.7081854597358	0.99316758398178	0.45932360970527	0.762991439186821	0	0	protein PLANT CADMIUM RESISTANCE 3	Q9LQU4	1	4.85e-11	C09E10.2a.1	9.9		NA	XP_030831837.1	5.33e-40	reviewed	PCR2_ARATH	Protein PLANT CADMIUM RESISTANCE 2 (AtPCR2)	PCR2 At1g14870 F10B6.27	Arabidopsis thaliana (Mouse-ear cress)	152	response to oxidative stress [GO:0006979]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; response to oxidative stress [GO:0006979]	GO:0005886; GO:0006979; GO:0016021
LOC105330040	calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	14	0.197779403828358	2.13428840598014	0.521739130434783	0.379077190671019	0.167088503373675	3.17068199080828e-9	0.00169665729873744	calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	Q63421	1	0	T04D3.3b.1	1.54e-168	Pde1c-PK	0	NP_001091918.1	7.02e-174	reviewed	PDE1C_RAT	Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (EC 3.1.4.17)	Pde1c Pde1c2	Rattus norvegicus (Rat)	768	negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; response to calcium ion [GO:0051592]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]	cilium [GO:0005929]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; response to calcium ion [GO:0051592]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]	GO:0004114; GO:0004115; GO:0004117; GO:0005516; GO:0005764; GO:0005929; GO:0007165; GO:0007608; GO:0030552; GO:0043025; GO:0046872; GO:0047555; GO:0048101; GO:0051592; GO:0061179
LOC105349206	uncharacterized LOC105349206	9	0.771896594649634	3.55473125694037	0.935018050541516	0.825541917829917	0.817195931416824	1.02893639365593e-215	5.50592095736436e-210	uncharacterized LOC105349206	E9D269	1	0.79	T11B7.1.1	7	MED20-PA	2.8	XP_030852618.1	0.69	reviewed	DPEP1_COCPS	Putative dipeptidase CPSG_03667 (EC 3.4.13.19)	CPSG_03667	Coccidioides posadasii (strain RMSCC 757 / Silveira) (Valley fever fungus)	444	proteolysis [GO:0006508]	metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; proteolysis [GO:0006508]	GO:0006508; GO:0046872; GO:0070573
LOC105328381	transmembrane protein 45B	9	0.664203212078389	2.63540962427488	0.859205776173285	0.773043234225687	0.680278815072067	4.03051755618287e-179	2.1567621884539e-173	transmembrane protein 45B	Q497B2	1	6.34e-40	B0379.4b.1	5.3	Alk-PB	6.5	XP_001187085.3	5e-35	reviewed	TM45B_RAT	Transmembrane protein 45B	Tmem45b	Rattus norvegicus (Rat)	278		integral component of membrane [GO:0016021]	GO:0016021
LOC105322367	laccase-3	2	0.183763256063505	3.53045489076377	0.703233988585923	0.261311681525831	0.14358088818477	5.16021604848929e-146	2.76127288927501e-140	laccase-3	Q12542	1	1.02e-58	F21D5.3a.2	1.26e-83	Mco1-PC	2.65e-87	XP_030837477.1	1.7e-85	reviewed	LAC2_AGABI	Laccase-2 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 2) (Diphenol oxidase 2) (Laccase II) (Urishiol oxidase 2)	lcc2	Agaricus bisporus (White button mushroom)	520	lignin catabolic process [GO:0046274]	extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274]	GO:0005507; GO:0005576; GO:0046274; GO:0052716
LOC105334883	cysteine and tyrosine-rich protein 1	12	0.682343037226577	30.7101108020388	1	0.682343037226577	0.94219468182104	1.18947549949883e-57	6.3649785558582e-52	cysteine and tyrosine-rich protein 1	Q96J86	1	0.003	C54D1.6.1	0.001	sau-PE	1.7	XP_030851666.1	8.21e-4	reviewed	CYYR1_HUMAN	Cysteine and tyrosine-rich protein 1 (Proline-rich domain-containing protein)	CYYR1 C21orf95	Homo sapiens (Human)	154		integral component of membrane [GO:0016021]	GO:0016021
LOC105342559	hepatocyte growth factor receptor	13	0.413882396404469	2.54109384903818	1	0.413882396404469	0.411881503778919	2.60649995066059e-24	1.39475897559809e-18	hepatocyte growth factor receptor	Q07E01	1	2.03e-158	F11E6.8a.1	1.27e-68	sev-PA	1.16e-58	XP_030856331.1	1.23e-177	reviewed	MET_ORNAN	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	MET	Ornithorhynchus anatinus (Duckbill platypus)	1382	cell migration [GO:0016477]; liver development [GO:0001889]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; phagocytosis [GO:0006909]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein kinase B signaling [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	basal plasma membrane [GO:0009925]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; hepatocyte growth factor receptor activity [GO:0005008]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; liver development [GO:0001889]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; phagocytosis [GO:0006909]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein kinase B signaling [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	GO:0001889; GO:0004714; GO:0005008; GO:0005524; GO:0005887; GO:0006909; GO:0007169; GO:0007399; GO:0009925; GO:0016477; GO:0017154; GO:0030182; GO:0031016; GO:0033674; GO:0043235; GO:0050918; GO:0051897; GO:0071526; GO:2001028
LOC109620490	uncharacterized LOC109620490	9	0.71059013144778	2.97795868245999	0.956678700361011	0.74276779777749	0.833542417957402	4.18526363310524e-220	2.23956805218368e-214	uncharacterized LOC109620490	O44252	2	2.01e-10	D2096.4a.1	0.64	CG43778-PD	6.96e-11	XP_001187320.3	4.13e-21	reviewed	ROST_DROME	Protein rolling stone	rost CG9552	Drosophila melanogaster (Fruit fly)	275	myoblast fusion [GO:0007520]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; myoblast fusion [GO:0007520]	GO:0007520; GO:0016020; GO:0016021
LOC105330972	protein rolling stone-like	2	0.164550949873598	1.44699724671807	0.493214965123653	0.333629272243075	0.117462491726922	1.98010661999637e-119	1.05957089321302e-113	protein rolling stone-like	O44252	2	1.3e-8	T06C12.3.1	5.3	CG9555-PC	6.51e-18	XP_001199384.2	3.4e-13	reviewed	ROST_DROME	Protein rolling stone	rost CG9552	Drosophila melanogaster (Fruit fly)	275	myoblast fusion [GO:0007520]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; myoblast fusion [GO:0007520]	GO:0007520; GO:0016020; GO:0016021
LOC105323566	uncharacterized LOC105323566	9	0.68363456661281	1.49021804098701	0.772563176895307	0.884891471737141	0.617764013880972	1.60745914981916e-162	8.6016425074143e-157	uncharacterized LOC105323566	P43298	1	0.74	B0024.14b.1	1.5	mora-PA	2.3	XP_030851190.1	0.29	reviewed	TMK1_ARATH	Receptor protein kinase TMK1 (EC 2.7.11.1) (BARK1-like kinase 1) (Transmembrane kinase 1)	TMK1 BLK1 At1g66150 F15E12.4	Arabidopsis thaliana (Mouse-ear cress)	942	protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	GO:0004675; GO:0005524; GO:0005576; GO:0005634; GO:0005886; GO:0006468; GO:0007165; GO:0016021; GO:0106310
LOC117683259	glycoprotein 3-alpha-L-fucosyltransferase A-like	9	0.761064517888343	3.02669265977508	0.913357400722022	0.833260361482494	0.770403381283937	3.58888913635108e-203	1.92044328797455e-197	glycoprotein 3-alpha-L-fucosyltransferase A-like	Q9VUL9	2	2.77e-30	K08F8.3.2	2.35e-27	FucTA-PB	2.35e-24	XP_030849534.1	5.35e-27	reviewed	FUCTA_DROME	Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)	FucTA CG6869	Drosophila melanogaster (Fruit fly)	503	fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]	GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0036065; GO:0036071; GO:0046920
LOC105318887	uncharacterized LOC105318887	9	0.610745649695101	0.942894142477674	0.642599277978339	0.950430027896309	0.498717827999458	4.34033634063558e-131	2.32254869856483e-125	uncharacterized LOC105318887	P51131	1	0.83	C29A12.4k.1	1.7	CG33483-PB	8.7	XP_030832875.1	0.59	reviewed	CYBC_BRADU	Cytochrome b/c1 [Cleaved into: Cytochrome b; Cytochrome c1]	fbcH blr2486	Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)	687	respiratory electron transport chain [GO:0022904]	integral component of membrane [GO:0016021]; periplasmic space [GO:0042597]; plasma membrane [GO:0005886]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; respiratory electron transport chain [GO:0022904]	GO:0005886; GO:0009055; GO:0016021; GO:0020037; GO:0022904; GO:0042597; GO:0046872; GO:0070469
LOC105330561	uncharacterized LOC105330561	7	0.456767866706259	2.97677028479228	0.691891891891892	0.66017230734889	0.426910317395221	1.78164132014922e-132	9.53370523542406e-127	uncharacterized LOC105330561	Q647I9	1	1.05e-29	F28C1.3a.1	8.54e-12	RanGAP-PC	4.72e-9	XP_011674867.2	3.58e-19	reviewed	"NALP5_BOVIN"	"NACHT, LRR and PYD domains-containing protein 5 (Mater protein homolog)"	NLRP5 MATER NALP5	Bos taurus (Bovine)	1098	actin filament organization [GO:0007015]; cortical granule exocytosis [GO:0060471]; establishment of organelle localization [GO:0051656]; establishment of spindle localization [GO:0051293]; exocytosis [GO:0006887]; positive regulation of embryonic development [GO:0040019]; regulation of cell division [GO:0051302]; regulation of localization [GO:0032879]	cell cortex [GO:0005938]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; actin filament organization [GO:0007015]; cortical granule exocytosis [GO:0060471]; establishment of organelle localization [GO:0051656]; establishment of spindle localization [GO:0051293]; exocytosis [GO:0006887]; positive regulation of embryonic development [GO:0040019]; regulation of cell division [GO:0051302]; regulation of localization [GO:0032879]	GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005938; GO:0006887; GO:0007015; GO:0032879; GO:0040019; GO:0042585; GO:0048471; GO:0051293; GO:0051302; GO:0051656; GO:0060471; GO:0060473
LOC105323690	WD40 repeat-containing protein SMU1	14	0.196986633801409	5.87823124222089	0.91304347826087	0.215747265592019	0.137803131359213	7.52916816837905e-8	0.0402891812024498	WD40 repeat-containing protein SMU1	Q6NRT3	1	0	CC4.3.2	0	Smu1-PC	0	XP_030836880.1	0	reviewed	SMU1_XENLA	WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog)	smu1	Xenopus laevis (African clawed frog)	513	mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]	GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0016607; GO:0071005
LOC105329788	uncharacterized LOC105329788	5	0.398070429909804	1.41567644289055	0.520728008088979	0.76444981588504	0.290024159141158	3.39346250692619e-147	1.81586893515626e-141	uncharacterized LOC105329788	P44898	1	0.26	F10C2.3.1	5.49e-79	CG16854-PC	1.61e-97	XP_011666708.2	5.91e-20	reviewed	Y841_HAEIN	Uncharacterized protein HI_0841	HI_0841	Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)	585		plasma membrane [GO:0005886]; sulfuric ester hydrolase activity [GO:0008484]	GO:0005886; GO:0008484
LOC105348068	filamin-A	5	0.391264949265237	4.74173977862712	0.731041456016178	0.535215815799889	0.351147907183601	1.81668646925794e-178	9.72123463191676e-173	filamin-A	P21333	4	0	Y66H1B.2j.1	0	cher-PG	0	XP_030827867.1	0	reviewed	FLNA_HUMAN	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)	FLNA FLN FLN1	Homo sapiens (Human)	2647	actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]	actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glycoprotein Ib-IX-V complex [GO:1990779]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]	GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0003007; GO:0003723; GO:0005080; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005903; GO:0005911; GO:0005925; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0030018; GO:0030334; GO:0031267; GO:0031523; GO:0031532; GO:0032231; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0045022; GO:0045184; GO:0045216; GO:0045296; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051220; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0140297; GO:1900026; GO:1901381; GO:1905000; GO:1905031; GO:1990779; GO:2001046
LOC105335376	uncharacterized LOC105335376	10	0.330652778528358	5.87127171726659	0.817647058823529	0.404395484531085	0.331742539191674	4.7355754385035e-65	2.53404430174673e-59	uncharacterized LOC105335376	P13813	1	1.01e-25	C31G12.4a.1	1.13e-7	CG31998-PB	1.89e-11	XP_030828085.1	1.74e-73	reviewed	110KD_PLAKN	110 kDa antigen (PK110)		Plasmodium knowlesi	296			
LOC105339256	uncharacterized LOC105339256	4	0.211655137372367	1.44826862779932	0.28393135725429	0.745444742064216	0.127797249592906	8.58389629775468e-73	4.59331158009891e-67	uncharacterized LOC105339256	Q9LJX4	2	0.17	H30A04.1a.1	2	CG6791-PA	6.8	XP_030833552.1	0.44	reviewed	PUM5_ARATH	Pumilio homolog 5 (APUM-5) (AtPUM5)	APUM5 At3g20250 MAL21.29	Arabidopsis thaliana (Mouse-ear cress)	961	3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; drought recovery [GO:0009819]; post-transcriptional regulation of gene expression [GO:0010608]; response to osmotic stress [GO:0006970]; response to salt stress [GO:0009651]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plant-type vacuole [GO:0000325]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; drought recovery [GO:0009819]; post-transcriptional regulation of gene expression [GO:0010608]; response to osmotic stress [GO:0006970]; response to salt stress [GO:0009651]	GO:0000325; GO:0003727; GO:0003729; GO:0005737; GO:0005829; GO:0006970; GO:0009651; GO:0009819; GO:0010608; GO:0051607; GO:0061158
Hmgb1	high mobility group box 1	14	0.197598376726562	42.7399520807863	1	0.197598376726562	0.254301975359157	2.70598272542749e-13	1.44799300423805e-7	high mobility group box 1	O54879	3	4.24e-26	Y48B6A.14.2	1.21e-11	Dsp1-PE	2e-16	XP_030828041.1	1.13e-34	reviewed	HMGB3_MOUSE	High mobility group protein B3 (High mobility group protein 2a) (HMG-2a) (High mobility group protein 4) (HMG-4)	Hmgb3 Hmg2a Hmg4	Mus musculus (Mouse)	200	DNA geometric change [GO:0032392]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; regulation of transcription by RNA polymerase II [GO:0006357]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; DNA geometric change [GO:0032392]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0000400; GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0006357; GO:0008301; GO:0032392; GO:0045087; GO:0045578; GO:0045638
LOC105326883	ankyrin repeat domain-containing protein 1	6	0.321107706915733	1.7855950209546	0.641509433962264	0.500550249015702	0.387364795471916	2.1724652747726e-120	1.16250354825302e-114	ankyrin repeat domain-containing protein 1	Q02357	2	6.51e-21	B0350.2h.2	2.39e-16	mask-PF	3.8e-18	XP_797811.4	1.39e-24	reviewed	ANK1_MOUSE	Ankyrin-1 (ANK-1) (Erythrocyte ankyrin)	Ank1 Ank-1	Mus musculus (Mouse)	1862	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; inorganic cation transmembrane transport [GO:0098662]; iron ion homeostasis [GO:0055072]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]	A band [GO:0031672]; axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; M band [GO:0031430]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; transmembrane transporter binding [GO:0044325]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; erythrocyte development [GO:0048821]; inorganic cation transmembrane transport [GO:0098662]; iron ion homeostasis [GO:0055072]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]	GO:0005634; GO:0005886; GO:0006779; GO:0006888; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016020; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0030863; GO:0031430; GO:0031672; GO:0042383; GO:0043005; GO:0044325; GO:0045211; GO:0048821; GO:0051117; GO:0055072; GO:0072659; GO:0098662
LOC105326887	serine/threonine-protein kinase pim-3	10	0.286061465169517	20.3642282349155	0.929411764705882	0.307787652397581	0.341037541204084	7.76358192268491e-67	4.15435479548408e-61	serine/threonine-protein kinase pim-3	Q9PU85	1	6.43e-130	F45H7.4.2	1.24e-84	Pask-PA	1.82e-37	XP_011662304.2	8.24e-127	reviewed	PIM3_COTJA	Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (qpim)	PIM3 PIM-3	Coturnix japonica (Japanese quail) (Coturnix coturnix japonica)	323	negative regulation of apoptotic process [GO:0043066]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of apoptotic process [GO:0043066]; protein phosphorylation [GO:0006468]	GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0043066; GO:0106310
LOC105327389	cell surface hyaluronidase	12	0.772737386521953	41.0086760091654	0.96875	0.797664398990403	0.855831791312624	1.68511811811096e-52	9.0172018594612e-47	cell surface hyaluronidase	Q5FWI3	1	2.39e-106	T07C4.1.2	1.2	Trl-PH	0.33	XP_030842248.1	6.53e-39	reviewed	CEIP2_MOUSE	Cell surface hyaluronidase (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2)	Cemip2 Kiaa1412 Tmem2	Mus musculus (Mouse)	1383	angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]	cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670]	GO:0001525; GO:0004415; GO:0005509; GO:0005730; GO:0005829; GO:0005886; GO:0005887; GO:0030214; GO:0043231; GO:1903670
LOC105330884	uncharacterized LOC105330884	3	0.365558870797291	6.94213783393919	0.749482401656315	0.487748438107987	0.372174951422383	8.85290081816662e-223	4.7372580510075e-217	uncharacterized LOC105330884	A4W6Q1	1	0.31	T01D3.6a.1	0.1	Tsf1-PC	0.72	XP_030838487.1	0.17	reviewed	GSA_ENT38	Glutamate-1-semialdehyde 2,1-aminomutase (GSA) (EC 5.4.3.8) (Glutamate-1-semialdehyde aminotransferase) (GSA-AT)	hemL Ent638_0694	Enterobacter sp. (strain 638)	426	protoporphyrinogen IX biosynthetic process [GO:0006782]	cytoplasm [GO:0005737]; glutamate-1-semialdehyde 2,1-aminomutase activity [GO:0042286]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; protoporphyrinogen IX biosynthetic process [GO:0006782]	GO:0005737; GO:0006782; GO:0008483; GO:0030170; GO:0042286
LOC105324191	RNA-binding motif, single-stranded-interacting protein 3	10	0.268517831369631	14.8685151547622	0.958823529411765	0.280049271980597	0.350079980475946	1.42121081839679e-68	7.60501278610672e-63	RNA-binding motif, single-stranded-interacting protein 3	Q5RBD3	1	1.27e-86	R10E4.2f.4	1.03e-64	shep-PA	1.58e-78	XP_030846125.1	2.24e-69	reviewed	RBMS3_PONAB	RNA-binding motif, single-stranded-interacting protein 3	RBMS3	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	436		cytoplasm [GO:0005737]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:1990904
LOC105343897	melanocortin receptor 3-like	12	0.713160205193471	11.1883445776965	0.9375	0.760704218873036	0.739950756843862	1.35462109819535e-45	7.24868586613118e-40	melanocortin receptor 3-like	P47752	1	6.3e-9	F01E11.5a.1	8.02e-4	mAChR-C-PA	2.26e-13	XP_011662090.1	2.32e-10	reviewed	S1PR2_RAT	Sphingosine 1-phosphate receptor 2 (S1P receptor 2) (S1P2) (AGR16) (Endothelial differentiation G-protein coupled receptor 5) (G-protein coupled receptor H218) (Sphingosine 1-phosphate receptor Edg-5) (S1P receptor Edg-5)	S1pr2 Edg5	Rattus norvegicus (Rat)	352	actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; excitatory postsynaptic potential [GO:0060079]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of metabolic process [GO:0019222]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178]; sphingosine-1-phosphate receptor activity [GO:0038036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; excitatory postsynaptic potential [GO:0060079]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of metabolic process [GO:0019222]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]	GO:0001664; GO:0003376; GO:0004930; GO:0005178; GO:0005737; GO:0005886; GO:0007186; GO:0007189; GO:0008528; GO:0010800; GO:0014912; GO:0016021; GO:0019222; GO:0031532; GO:0038036; GO:0046847; GO:0060079; GO:0090394; GO:0098794; GO:1903142; GO:1904706
LOC105321169	uncharacterized LOC105321169	13	0.446789882365147	135.77561361622	1	0.446789882365147	0.485602949616118	2.2126015108930102e-28	1.18398076929094e-22	uncharacterized LOC105321169	H2BKS9	1	0.56	T27E9.1a.3	5.4		NA	XP_030830728.1	0.22	reviewed	CM3A_CONTS	Mu-conotoxin TsIIIA		Conus tessulatus (Tessellate cone)	67		extracellular region [GO:0005576]; ion channel inhibitor activity [GO:0008200]; sodium channel regulator activity [GO:0017080]; toxin activity [GO:0090729]	GO:0005576; GO:0008200; GO:0017080; GO:0090729
LOC105329348	tubulin alpha-1A chain	2	0.172606801741613	39.6452589090601	0.968674698795181	0.178188613738232	0.0891230586189814	9.05823379548519e-91	4.84713336983449e-85	tubulin alpha-1A chain	A5A6J1	1	0	C44B11.3.1	0	alphaTub84B-PA	0	XP_795276.3	0	reviewed	TBA1A_PANTR	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A TUBA3	Pan troglodytes (Chimpanzee)	451	microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; regulation of synapse organization [GO:0050807]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; regulation of synapse organization [GO:0050807]	GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005881; GO:0007017; GO:0031594; GO:0036464; GO:0042802; GO:0050807; GO:0055037
LOC105334467	cholecystokinin receptor type A	9	0.726282176296956	7.77311231379929	0.945848375451263	0.767863216924644	0.813560082452885	9.73506169774476e-215	5.2093093949568e-209	cholecystokinin receptor type A	O43614	2	5.56e-13	C10C6.2.1	1.76e-8	TkR86C-PA	1.23e-10	XP_030829279.1	2.08e-10	reviewed	OX2R_HUMAN	Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2)	HCRTR2	Homo sapiens (Human)	444	chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion [GO:0040011]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion [GO:0040011]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007218; GO:0007268; GO:0007631; GO:0008188; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0040011; GO:0045202; GO:0051480
LOC105334531	sarcoplasmic calcium-binding protein	3	0.322039736061653	0.881582938553777	0.411318150448585	0.782945599921704	0.212741628232569	9.8228679453058e-127	5.2562952204767e-121	sarcoplasmic calcium-binding protein	P02637	1	2.82e-59	T09A5.1b.1	0.003	CBP-PB	1.5e-7	XP_030836181.1	0.27	reviewed	SCP_MIZYE	Sarcoplasmic calcium-binding protein (SCP)		Mizuhopecten yessoensis (Japanese scallop) (Patinopecten yessoensis)	176		calcium ion binding [GO:0005509]	GO:0005509
LOC105339169	uncharacterized LOC105339169	9	0.611365551853092	1.52394013155889	0.866425992779783	0.705617741097111	0.665954602616294	2.60027479509089e-175	1.3914278450515e-169	uncharacterized LOC105339169	O75094	3	5.25e-6	K07A12.2.1	5.06e-7	sli-PE	7.83e-6	XP_030847497.1	7.19e-6	reviewed	SLIT3_HUMAN	Slit homolog 3 protein (Slit-3) (Multiple epidermal growth factor-like domains protein 5) (Multiple EGF-like domains protein 5)	SLIT3 KIAA0814 MEGF5 SLIL2 UNQ691/PRO1336	Homo sapiens (Human)	1523	aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]	extracellular space [GO:0005615]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]	GO:0003180; GO:0003181; GO:0005509; GO:0005615; GO:0005739; GO:0007411; GO:0008201; GO:0008285; GO:0010629; GO:0030308; GO:0032870; GO:0035385; GO:0048495; GO:0048846; GO:0050919; GO:0051414; GO:0060412; GO:0061364; GO:0070100
LOC105321610	structural maintenance of chromosomes protein 6	8	0.472384483259484	8.67584486095217	0.90251572327044	0.523408591207372	0.542045465263365	1.7987034784547e-154	9.62500620948938e-149	structural maintenance of chromosomes protein 6	Q6P9I7	1	0	F54D5.14.1	8.51e-100	jnj-PA	4.35e-97	XP_030832188.1	0	reviewed	SMC6_XENLA	Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (xSMC6)	smc6 smc6l1	Xenopus laevis (African clawed frog)	1128	cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]	chromosome, telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cellular senescence [GO:0090398]; DNA repair [GO:0006281]; telomere maintenance via recombination [GO:0000722]	GO:0000722; GO:0000781; GO:0005524; GO:0006281; GO:0016605; GO:0030915; GO:0090398
LOC105318512	mucin-5AC	8	0.667158919817022	7.54769957458023	0.779874213836478	0.855469905249246	0.602568919045011	7.43529886197197e-172	3.97868790343209e-166	mucin-5AC	P39217	1	0.56	C09D1.1l.1	0.43		NA	XP_001195120.2	3.32e-17	reviewed	TLPB_BACSU	Methyl-accepting chemotaxis protein TlpB	tlpB BSU31230	Bacillus subtilis (strain 168)	662	chemotaxis [GO:0006935]; signal transduction [GO:0007165]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chemotaxis [GO:0006935]; signal transduction [GO:0007165]	GO:0005886; GO:0006935; GO:0007165; GO:0016021
LOC105327958	arrestin domain-containing protein 3	4	0.183248394312902	0.97336300187707	0.315132605304212	0.581496142349358	0.122601918410225	6.94539173873003e-70	3.71653468252835e-64	arrestin domain-containing protein 3	Q6TXF1	1	6.31e-40	F40F8.8a.1	4.8e-143	CG1105-PA	6.87e-27	XP_011672389.1	4.14e-52	reviewed	ARRD3_RAT	Arrestin domain-containing protein 3 (Liver regeneration-related protein LRRG00048)	Arrdc3	Rattus norvegicus (Rat)	414	fat pad development [GO:0060613]; heat generation [GO:0031649]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein transport [GO:0015031]; skin development [GO:0043588]; temperature homeostasis [GO:0001659]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-3 adrenergic receptor binding [GO:0031699]; fat pad development [GO:0060613]; heat generation [GO:0031649]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein transport [GO:0015031]; skin development [GO:0043588]; temperature homeostasis [GO:0001659]	GO:0001659; GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0015031; GO:0031649; GO:0031651; GO:0031699; GO:0043588; GO:0051443; GO:0060613; GO:0071878; GO:0090327; GO:0120163
LOC105335166	probable ATP-dependent RNA helicase DDX4	8	0.353073850047215	3.28176020110026	0.679245283018868	0.519803168125067	0.333591099392098	3.85732151384309e-95	2.06408360062955e-89	probable ATP-dependent RNA helicase DDX4	Q4R5S7	1	0	Y54E10A.9a.2	3.06e-147	vas-PC	4.06e-150	NP_001139665.1	0	reviewed	DDX4_MACFA	Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Vasa homolog)	DDX4 QtsA-21246	Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)	725	cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	GO:0003676; GO:0003724; GO:0005524; GO:0005737; GO:0007140; GO:0007141; GO:0007283; GO:0010529; GO:0016887; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0048471; GO:0071546; GO:0071547; GO:1990511
LOC105320634	homeobox protein TGIF2	14	0.259964811710765	6.72230311214878	0.91304347826087	0.284723365207029	0.234598790173561	2.23378486142725e-12	1.19531614962861e-6	homeobox protein TGIF2	Q8C0Y1	1	5.44e-41	T28F12.2h.1	1.92e-15	vis-PA	1.57e-38	XP_011679600.1	1.19e-38	reviewed	TGIF2_MOUSE	Homeobox protein TGIF2 (5'-TG-3'-interacting factor 2) (TGF-beta-induced transcription factor 2) (TGFB-induced factor 2)	Tgif2	Mus musculus (Mouse)	237	amacrine cell differentiation [GO:0035881]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; nodal signaling pathway [GO:0038092]; positive regulation of amacrine cell differentiation [GO:1902871]; regulation of gastrulation [GO:0010470]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; amacrine cell differentiation [GO:0035881]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; nodal signaling pathway [GO:0038092]; positive regulation of amacrine cell differentiation [GO:1902871]; regulation of gastrulation [GO:0010470]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]	GO:0000122; GO:0000978; GO:0000981; GO:0005654; GO:0005813; GO:0006357; GO:0010470; GO:0030182; GO:0035881; GO:0038092; GO:0060041; GO:1902871; GO:1990837
LOC105342059	CD151 antigen	1	0.445333101224621	7.35684292350537	0.767508066046688	0.580232470413582	0.336964484304842	1.11260124374987e-308	6.88304029354803e-307	CD151 antigen	P48509	3	2.82e-22	C02F12.1a.1	1.72e-17	Tsp74F-PB	1.65e-17	XP_030829377.1	2.62e-32	reviewed	CD151_HUMAN	CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151)	CD151 TSPAN24	Homo sapiens (Human)	253	cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]	basement membrane [GO:0005604]; cell surface [GO:0009986]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]	GO:0005178; GO:0005604; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0009986; GO:0016020; GO:0016477; GO:0030335; GO:0042098; GO:0044319; GO:0045807
LOC105329605	uncharacterized LOC105329605	14	0.313470274774574	9.05320657775995	0.869565217391304	0.36049081599076	0.276070733857199	2.63441083373735e-14	1.40969431241953e-8	uncharacterized LOC105329605	Q6LVC3	1	2.3	F21F3.1.2	0.29	CG46442-PA	1.1	XP_011665347.2	1.2	reviewed	RS12_PHOPR	30S ribosomal protein S12	rpsL PBPRA0313	Photobacterium profundum (strain SS9)	124	translation [GO:0006412]	small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412]	GO:0000049; GO:0003735; GO:0006412; GO:0015935; GO:0019843
LOC105327445	sperm-specific protein PHI-2B/PHI-3	8	0.699511888207638	21.5395952452445	0.921383647798742	0.759197202901123	0.702052715368351	1.37412458213316e-200	7.35305056896111e-195	sperm-specific protein PHI-2B/PHI-3	Q3HNG7	1	5.91e-12	C18G1.5.1	9.4e-9		NA	XP_030839851.1	5.41e-8	reviewed	H18_BOVIN	Histone H1.8 (Histone H1oo) (Oocyte-specific histone H1) (Oocyte-specific linker histone H1)	H1-8 H1FOO H1OO	Bos taurus (Bovine)	343	chromosome condensation [GO:0030261]; meiotic cell cycle [GO:0051321]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; regulation of gene expression, epigenetic [GO:0040029]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; structural constituent of chromatin [GO:0030527]; chromosome condensation [GO:0030261]; meiotic cell cycle [GO:0051321]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; regulation of gene expression, epigenetic [GO:0040029]	GO:0000786; GO:0003690; GO:0005634; GO:0005694; GO:0005737; GO:0006334; GO:0030261; GO:0030527; GO:0031492; GO:0040029; GO:0045910; GO:0051321
LOC105335420	neurogenic differentiation factor 1	7	0.449835302230467	12.4211995435688	0.654054054054054	0.687764718286252	0.393201099864743	5.12101325911838e-122	2.74029516306032e-116	neurogenic differentiation factor 1	Q92886	2	7.92e-24	Y69A2AR.29.1	7.34e-19	tap-PA	5.71e-21	XP_003728087.2	5.6e-31	reviewed	NGN1_HUMAN	Neurogenin-1 (NGN-1) (Class A basic helix-loop-helix protein 6) (bHLHa6) (Neurogenic basic-helix-loop-helix protein) (Neurogenic differentiation factor 3) (NeuroD3)	NEUROG1 BHLHA6 NEUROD3 NGN NGN1	Homo sapiens (Human)	237	auditory behavior [GO:0031223]; cell fate commitment [GO:0045165]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; craniofacial suture morphogenesis [GO:0097094]; exit from mitosis [GO:0010458]; genitalia development [GO:0048806]; genitalia morphogenesis [GO:0035112]; hard palate morphogenesis [GO:1905748]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; learned vocalization behavior [GO:0098583]; mastication [GO:0071626]; negative regulation of relaxation of muscle [GO:1901078]; negative regulation of saliva secretion [GO:1905747]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; peristalsis [GO:0030432]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of muscle organ development [GO:0048634]; regulation of transcription by RNA polymerase II [GO:0006357]; thorax and anterior abdomen determination [GO:0007356]; trigeminal nerve development [GO:0021559]; vestibulocochlear nerve formation [GO:0021650]	chromatin [GO:0000785]; nucleus [GO:0005634]; perikaryon [GO:0043204]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; auditory behavior [GO:0031223]; cell fate commitment [GO:0045165]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; craniofacial suture morphogenesis [GO:0097094]; exit from mitosis [GO:0010458]; genitalia development [GO:0048806]; genitalia morphogenesis [GO:0035112]; hard palate morphogenesis [GO:1905748]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; learned vocalization behavior [GO:0098583]; mastication [GO:0071626]; negative regulation of relaxation of muscle [GO:1901078]; negative regulation of saliva secretion [GO:1905747]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; peristalsis [GO:0030432]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of muscle organ development [GO:0048634]; regulation of transcription by RNA polymerase II [GO:0006357]; thorax and anterior abdomen determination [GO:0007356]; trigeminal nerve development [GO:0021559]; vestibulocochlear nerve formation [GO:0021650]	GO:0000785; GO:0000978; GO:0000981; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0007356; GO:0007399; GO:0010458; GO:0021559; GO:0021650; GO:0030182; GO:0030432; GO:0031223; GO:0031536; GO:0035112; GO:0042472; GO:0042803; GO:0043204; GO:0045165; GO:0045666; GO:0045944; GO:0048634; GO:0048806; GO:0048839; GO:0050885; GO:0051091; GO:0070888; GO:0071626; GO:0090102; GO:0090103; GO:0097094; GO:0098583; GO:1901078; GO:1905747; GO:1905748; GO:1990837
LOC105341712	hypothetical protein	6	0.348950503671321	3.66983908275166	0.913746630727763	0.381889784253864	0.488204465106742	8.67263805235802e-152	4.64079800292119e-146	hypothetical protein	Q8L9W3	2	1.4	Y60A3A.23.1	0.33	CG10631-PA	1.5	XP_030832836.1	0.62	reviewed	ATL23_ARATH	E3 ubiquitin-protein ligase ATL23 (EC 2.3.2.27) (RING-H2 finger protein ATL23) (RING-type E3 ubiquitin transferase ATL23)	ATL23 At5g42200 MJC20.31	Arabidopsis thaliana (Mouse-ear cress)	163	cellular response to hypoxia [GO:0071456]; protein ubiquitination [GO:0016567]	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to hypoxia [GO:0071456]; protein ubiquitination [GO:0016567]	GO:0004842; GO:0016021; GO:0016567; GO:0046872; GO:0071456
LOC105322566	transmembrane channel-like protein 7	12	0.741611289081305	29.0255359955111	1	0.741611289081305	0.976378331702198	1.08421175222601e-59	5.80170382310154e-54	transmembrane channel-like protein 7	Q5YCC5	1	1.88e-132	B0416.1a.1	3.68e-28	Tmc-PD	1.9e-22	XP_030839881.1	1.22e-159	reviewed	TMC7_CHICK	Transmembrane channel-like protein 7	Tmc7	Gallus gallus (Chicken)	735		integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381]	GO:0005887; GO:0008381
LOC105336057	transient receptor potential cation channel subfamily V member 3	12	0.764236883131782	20.7946550146435	1	0.764236883131782	0.913383311161878	6.2283644895842e-56	3.33284766529242e-50	transient receptor potential cation channel subfamily V member 3	Q91ZT9	1	2.4e-22	B0350.2e.2	1.82e-16	Ank-PE	6.6e-17	XP_030838677.1	0	reviewed	ASB8_MOUSE	Ankyrin repeat and SOCS box protein 8 (ASB-8)	Asb8	Mus musculus (Mouse)	288	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]	GO:0005737; GO:0016567; GO:0035556
LOC105335107	ELAV-like protein 1	7	0.509528244121056	12.6860451456764	0.75945945945946	0.670909075888934	0.47633862438571	7.38756656999222e-148	3.9531459721354e-142	ELAV-like protein 1	O09032	2	2.11e-145	F35H8.5.1	6.07e-83	Rbp9-PH	5.21e-140	XP_030852742.1	4.66e-123	reviewed	ELAV4_RAT	ELAV-like protein 4 (Hu-antigen D) (HuD) (Paraneoplastic encephalomyelitis antigen HuD)	Elavl4 Hud	Rattus norvegicus (Rat)	385	3'-UTR-mediated mRNA stabilization [GO:0070935]; aging [GO:0007568]; associative learning [GO:0008306]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; learning [GO:0007612]; locomotory behavior [GO:0007626]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of dendrite development [GO:1900006]; regeneration [GO:0031099]; regulation of mRNA stability [GO:0043488]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]; response to cocaine [GO:0042220]; response to endoplasmic reticulum stress [GO:0034976]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysomal ribosome [GO:0042788]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; translation regulator activity [GO:0045182]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; aging [GO:0007568]; associative learning [GO:0008306]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; learning [GO:0007612]; locomotory behavior [GO:0007626]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of dendrite development [GO:1900006]; regeneration [GO:0031099]; regulation of mRNA stability [GO:0043488]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]; response to cocaine [GO:0042220]; response to endoplasmic reticulum stress [GO:0034976]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]	GO:0003729; GO:0003730; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005856; GO:0006396; GO:0006397; GO:0007399; GO:0007568; GO:0007612; GO:0007626; GO:0008143; GO:0008306; GO:0008380; GO:0016020; GO:0021895; GO:0030182; GO:0030424; GO:0030425; GO:0030426; GO:0031099; GO:0034976; GO:0035925; GO:0042220; GO:0042788; GO:0043025; GO:0043204; GO:0043488; GO:0045182; GO:0048813; GO:0070935; GO:0097158; GO:0098978; GO:0099547; GO:1900006; GO:1905870; GO:1990090
LOC105329481	troponin C	5	0.441621303840405	2.96160608909684	0.532861476238625	0.82877318690353	0.321138597584152	4.38128308678502e-163	2.34445963000336e-157	troponin C	Q9BLG0	3	4.76e-65	T21H3.3a.1	2.57e-35	Cam-PD	1.15e-35	XP_780862.4	6.33e-36	reviewed	TNNC_TODPA	Troponin C (TN-C)		Todarodes pacificus (Japanese flying squid) (Ommastrephes pacificus)	148		calcium ion binding [GO:0005509]	GO:0005509
LOC105340323	LITAF domain-containing protein	4	0.271822864963514	1.78117352569432	0.399375975039002	0.680618970475047	0.209386685065867	1.05370398527061e-118	5.63845432150186e-113	LITAF domain-containing protein	Q6GMG8	1	1.16e-22	F36G3.3.1	5.74e-18	CG32280-PD	3.69e-11	XP_030840715.1	1.36e-27	reviewed	LITAF_DANRE	Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog)	litaf zgc:91882	Danio rerio (Zebrafish) (Brachydanio rerio)	163		cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytoplasmic side of plasma membrane [GO:0009898]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0000139; GO:0003677; GO:0005634; GO:0008270; GO:0009898; GO:0098559; GO:0098560; GO:0098574
LOC105325055	collagen alpha-1(III) chain	9	0.706692306076671	1.35183341619246	0.830324909747293	0.851103342535817	0.674694232181427	1.23324602650206e-177	6.59919814749467e-172	collagen alpha-1(III) chain	Q06852	2	1.68e-5	F39B2.4b.1	0.17	Cyp310a1-PA	5.3	XP_030841014.1	0.008	reviewed	SLAP1_ACET2	Cell surface glycoprotein 1 (Outer layer protein B) (S-layer protein 1)	olpB Cthe_3078	Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) (Clostridium thermocellum)	2313	polysaccharide catabolic process [GO:0000272]	extracellular region [GO:0005576]; S-layer [GO:0030115]; carbohydrate binding [GO:0030246]; polysaccharide catabolic process [GO:0000272]	GO:0000272; GO:0005576; GO:0030115; GO:0030246
LOC105341106	netrin receptor UNC5C	6	0.335852197067024	8.33778450368385	0.924528301886792	0.363268702950047	0.44213052810142	2.05718797720135e-137	1.10081774410426e-131	netrin receptor UNC5C	Q761X5	1	1.5e-176	B0273.4b.1	2.23e-60	unc-5-PB	1.13e-52	XP_030835171.1	7.28e-75	reviewed	UNC5C_RAT	Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C)	Unc5c Unc5h3	Rattus norvegicus (Rat)	931	anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; netrin-activated signaling pathway [GO:0038007]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]	anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; netrin-activated signaling pathway [GO:0038007]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]	GO:0005042; GO:0005043; GO:0005886; GO:0006915; GO:0007411; GO:0007420; GO:0009986; GO:0015631; GO:0016021; GO:0019901; GO:0030027; GO:0030175; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0033564; GO:0038007; GO:0043025; GO:0043065; GO:0045202; GO:0061643; GO:0070161; GO:1990791
LOC105343361	sodium-coupled monocarboxylate transporter 1	6	0.539837895044831	8.05046066415513	0.964959568733154	0.559440947099531	0.713251752347533	9.99223826552059e-223	5.34692663378619e-217	sodium-coupled monocarboxylate transporter 1	Q7T384	1	1.3e-152	ZK822.5a.2	3.92e-76	CG10444-PA	7.73e-101	XP_030838764.1	6.84e-174	reviewed	SC5AC_DANRE	Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (zSMCTn) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12) (zSLC5A12)	slc5a12 smctn	Danio rerio (Zebrafish) (Brachydanio rerio)	623	sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814]	GO:0006814; GO:0015293; GO:0015355; GO:0016021
LOC105339081	transformer-2 protein homolog alpha	14	0.207478420642254	10.1152938282164	0.91304347826087	0.22723827022723	0.171221550011979	2.03010714465605e-9	0.00108632657396261	transformer-2 protein homolog alpha	P62995	1	1.1e-57	C18D11.4a.2	2.33e-35	tra2-PE	6.44e-37	XP_030849405.1	5.64e-52	reviewed	TRA2B_HUMAN	Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)	TRA2B SFRS10	Homo sapiens (Human)	288	cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing, via transesterification reactions [GO:0000375]	nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing, via transesterification reactions [GO:0000375]	GO:0000375; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005637; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0032991; GO:0036002; GO:0042802; GO:0043484; GO:0048026; GO:0071333; GO:1990403
LOC117684825	enolase-phosphatase E1-like	2	0.175784908400255	2.77033413624951	0.656309448319594	0.267838454634979	0.119010301127539	5.3199028722028e-121	2.84672258613869e-115	enolase-phosphatase E1-like	Q9D279	1	4.04e-4	T05A8.4.1	0.23	CG7120-PG	2.1	XP_030851504.1	0.32	reviewed	MISP_MOUSE	Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein)	Misp	Mus musculus (Mouse)	648	cell division [GO:0051301]; cell migration [GO:0016477]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic spindle assembly [GO:0090307]; organelle localization [GO:0051640]; regulation of protein localization to cell cortex [GO:1904776]	actin filament [GO:0005884]; cortical actin cytoskeleton [GO:0030864]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle astral microtubule end [GO:1905721]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]; actin filament binding [GO:0051015]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic spindle assembly [GO:0090307]; organelle localization [GO:0051640]; regulation of protein localization to cell cortex [GO:1904776]	GO:0000132; GO:0005884; GO:0005886; GO:0005925; GO:0016477; GO:0030864; GO:0031616; GO:0043231; GO:0051015; GO:0051301; GO:0051640; GO:0051660; GO:0090307; GO:1904776; GO:1905721
LOC105347362	sodium/hydrogen exchanger 9B2	13	0.397729987318294	10.8987396386333	0.96551724137931	0.411934629722519	0.406549612530938	5.13548217217393e-24	2.74803759418765e-18	sodium/hydrogen exchanger 9B2	Q5BKR2	2	1.53e-132	F41E7.1.1	4.58e-46	Nha1-PB	1.02e-77	XP_030835794.1	1.97e-164	reviewed	SL9B2_MOUSE	Sodium/hydrogen exchanger 9B2 (NHA-oc) (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Soditlum/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2)	Slc9b2 Nha2 Nhedc2	Mus musculus (Mouse)	547	clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]	anchoring junction [GO:0070161]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]	GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0030317; GO:0030672; GO:0031966; GO:0042802; GO:0061178; GO:0070161; GO:0072583; GO:0097228; GO:0097708; GO:2001206
LOC105328839	uncharacterized LOC105328839	8	0.766249357729138	11.9238014032101	0.836477987421384	0.916042465255135	0.69525807659942	1.27896277066578e-198	6.84383210285424e-193	uncharacterized LOC105328839	Q5U2Q4	1	0.72	Y105C5A.1.1	0.54	CG31817-PB	4	XP_030829936.1	1.5	reviewed	PAR16_RAT	Protein mono-ADP-ribosyltransferase PARP16 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 15) (Poly [ADP-ribose] polymerase 16) (PARP-16)	Parp16 Artd15	Rattus norvegicus (Rat)	322	cellular response to leukemia inhibitory factor [GO:1990830]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell death [GO:0060548]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; protein serine/threonine kinase activator activity [GO:0043539]; cellular response to leukemia inhibitory factor [GO:1990830]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cell death [GO:0060548]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]	GO:0003950; GO:0005635; GO:0005783; GO:0005789; GO:0006471; GO:0016021; GO:0019900; GO:0030968; GO:0036498; GO:0043539; GO:0060548; GO:0070213; GO:0071782; GO:0071902; GO:0140289; GO:1990404; GO:1990830
LOC105328822	afadin- and alpha-actinin-binding protein	4	0.239070353171178	8.56506316196024	0.744929797191888	0.320930044780576	0.13880756372654	5.82155145370437e-79	3.11515875528884e-73	afadin- and alpha-actinin-binding protein	H2MTR9	1	4.43e-61	M04B2.3.1	0.5	CG42818-PB	1.1	XP_030852112.1	1.08e-75	reviewed	ADIP_ORYLA	Afadin- and alpha-actinin-binding protein (ADIP) (Afadin DIL domain-interacting protein) (SSX2-interacting protein)	ssx2ip	Oryzias latipes (Japanese rice fish) (Japanese killifish)	583	cell adhesion [GO:0007155]; intraciliary transport involved in cilium assembly [GO:0035735]	adherens junction [GO:0005912]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; cell adhesion [GO:0007155]; intraciliary transport involved in cilium assembly [GO:0035735]	GO:0005737; GO:0005874; GO:0005912; GO:0007155; GO:0034451; GO:0035735; GO:0036064
LOC105345191	uncharacterized LOC105345191	8	0.495086979526814	6.30298292864942	0.817610062893082	0.605529459575104	0.503325589110944	2.17940216235994e-143	1.16621553229611e-137	uncharacterized LOC105345191	Q93075	2	3.25e-74	Y24F12A.1b.1	1.28e-42	CG3308-PA	6.27e-13	XP_030828787.1	3.9e-78	reviewed	TATD2_HUMAN	Putative deoxyribonuclease TATDN2 (EC 3.1.21.-)	TATDN2 KIAA0218	Homo sapiens (Human)	761		nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005654; GO:0046872
LOC105344034	ankyrin repeat domain-containing protein 29	14	0.198538531839845	2.65662467291469	0.608695652173913	0.32617044516546	0.140411392520725	5.6746751697941e-8	0.0303656408075818	ankyrin repeat domain-containing protein 29	Q8N6D5	2	1.11e-87	B0350.2h.2	7.97e-37	CG3104-PC	3.16e-116	XP_030839733.1	2.07e-123	reviewed	ANR29_HUMAN	Ankyrin repeat domain-containing protein 29	ANKRD29	Homo sapiens (Human)	301			
LOC105325769	disks large-associated protein 5	8	0.29800162254586	12.0439592156473	0.918238993710692	0.324536013594464	0.334840267082015	1.710603582533e-95	9.15357661842068e-90	disks large-associated protein 5	Q8K4R9	2	1.77e-38	W03A5.6b.1	8.81e-5	vlc-PB	1.11e-16	XP_030829847.1	7.18e-37	reviewed	DLGP5_MOUSE	Disks large-associated protein 5 (DAP-5) (Discs large homolog 7) (Disks large-associated protein DLG7) (Hepatoma up-regulated protein homolog) (HURP)	Dlgap5 Dlg7 Kiaa0008	Mus musculus (Mouse)	808	centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic spindle organization [GO:0007052]; regulation of mitotic cell cycle [GO:0007346]; signaling [GO:0023052]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]; microtubule binding [GO:0008017]; centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic spindle organization [GO:0007052]; regulation of mitotic cell cycle [GO:0007346]; signaling [GO:0023052]	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0007052; GO:0007059; GO:0007346; GO:0008017; GO:0023052; GO:0031616; GO:0034451; GO:0051382; GO:0051642
LOC105329277	SCO-spondin	7	0.586460858068116	3.48608304559423	0.654054054054054	0.89665503093059	0.497836361398047	1.44779551067698e-154	7.74726960127335e-149	SCO-spondin	Q2PC93	1	1.84e-104	C02B4.1.1	6.52e-72	Sema5c-PB	4.56e-40	XP_030843222.1	2.4e-146	reviewed	SSPO_CHICK	SCO-spondin	SSPO	Gallus gallus (Chicken)	5255	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	GO:0005615; GO:0007155; GO:0007399; GO:0030154; GO:0031012
LOC105329262	protein FAM183B	11	0.570207962384043	12.9598742736163	1	0.570207962384043	0.782165517765293	1.75469561959784e-63	9.3895166361176e-58	protein FAM183B	Q5NC57	2	5.93e-34	F27D9.8b.1	5	rdx-PB	4.4	XP_003728346.1	6.27e-63	reviewed	F183B_MOUSE	Protein FAM183B	Fam183b	Mus musculus (Mouse)	135		centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]	GO:0005737; GO:0005813; GO:0036064; GO:0097546
LOC105336631	T-cell acute lymphocytic leukemia protein 1-like	9	0.680952729679716	2.97785311015999	0.924187725631769	0.73681213328625506	0.753164250623234	1.46627254454421e-198	7.84614168765961e-193	T-cell acute lymphocytic leukemia protein 1-like	Q90YI8	1	2.68e-26	C43H6.8.1	8.85e-12	HLH3B-PA	2.06e-27	XP_030844277.1	1.15e-23	reviewed	TAL1_TAKRU	T-cell acute lymphocytic leukemia protein 1 (TAL-1) (FrSCL) (Stem cell protein)	tal1 scl	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	371	angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; definitive hemopoiesis [GO:0060216]; endocardium formation [GO:0060214]; erythrocyte differentiation [GO:0030218]; hemangioblast cell differentiation [GO:0060217]; hematopoietic stem cell differentiation [GO:0060218]; myeloid cell differentiation [GO:0030099]; primitive hemopoiesis [GO:0060215]; vasculogenesis [GO:0001570]	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; definitive hemopoiesis [GO:0060216]; endocardium formation [GO:0060214]; erythrocyte differentiation [GO:0030218]; hemangioblast cell differentiation [GO:0060217]; hematopoietic stem cell differentiation [GO:0060218]; myeloid cell differentiation [GO:0030099]; primitive hemopoiesis [GO:0060215]; vasculogenesis [GO:0001570]	GO:0000981; GO:0001525; GO:0001570; GO:0003677; GO:0005634; GO:0030099; GO:0030218; GO:0046983; GO:0048844; GO:0060214; GO:0060215; GO:0060216; GO:0060217; GO:0060218
LOC105323230	microsomal triglyceride transfer protein large subunit-like	3	0.401864400628177	4.7194695218071	0.870945479641132	0.461411661260086	0.487306775761034	1.46992352698102e-293	7.86567838675757e-288	microsomal triglyceride transfer protein large subunit-like	A0A0R4IVV0	1	1.21e-114	K02D7.4.1	3.64e-7	Mtp-PA	1.14e-57	XP_788526.4	4.79e-121	reviewed	MTP_DANRE	Microsomal triglyceride transfer protein large subunit	mttp mtp	Danio rerio (Zebrafish) (Brachydanio rerio)	884	cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; plasma lipoprotein particle assembly [GO:0034377]; protein secretion [GO:0009306]; sprouting angiogenesis [GO:0002040]	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lipid binding [GO:0008289]; lipid transfer activity [GO:0120013]; lipid transporter activity [GO:0005319]; phosphatidylethanolamine transfer activity [GO:1904121]; phospholipid transporter activity [GO:0005548]; cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; plasma lipoprotein particle assembly [GO:0034377]; protein secretion [GO:0009306]; sprouting angiogenesis [GO:0002040]	GO:0001579; GO:0002040; GO:0005319; GO:0005548; GO:0005783; GO:0005794; GO:0006629; GO:0006869; GO:0007586; GO:0008289; GO:0009306; GO:0015909; GO:0016323; GO:0034377; GO:0042157; GO:0042158; GO:0042632; GO:0042953; GO:0120013; GO:1904121
LOC105318379	zinc finger CCHC domain-containing protein 24	5	0.574015983572657	4.21814118526202	0.660262891809909	0.869374897018924	0.432414305117206	2.05782912141418e-220	1.1011608255017e-214	zinc finger CCHC domain-containing protein 24	Q8N2G6	1	1.89e-78	Y43E12A.2.1	6.84e-27	dec-PG	5.4	XP_030834918.1	2.09e-80	reviewed	ZCH24_HUMAN	Zinc finger CCHC domain-containing protein 24	ZCCHC24 C10orf56	Homo sapiens (Human)	241		RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0008270
LOC105318387	SPRY domain-containing SOCS box protein 3	10	0.319275810923865	10.6562414456359	0.847058823529412	0.376922832340674	0.332018967446209	4.19070975925977e-65	2.24248231785798e-59	SPRY domain-containing SOCS box protein 3	Q5M9B1	1	3.16e-32	Y46E12BL.4b.1	1.08e-17	SP555-PD	3.14e-88	XP_780661.1	2.4e-81	reviewed	SPSB3_XENLA	SPRY domain-containing SOCS box protein 3 (SSB-3)	spsb3	Xenopus laevis (African clawed frog)	360	protein ubiquitination [GO:0016567]	protein ubiquitination [GO:0016567]	GO:0016567
LOC105345576	apolipophorins	3	0.326339127971157	3.64767834672539	0.516908212560387	0.631328967196538	0.267620204067576	1.52139085960162e-159	8.14108420099705e-154	apolipophorins	Q9U943	2	1.62e-121	C04F6.1.1	1.71e-13	Apoltp-PC	3.45e-98	XP_030851924.1	1.42e-103	reviewed	APLP_LOCMI	Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]		Locusta migratoria (Migratory locust)	3380	Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]	GO:0005319; GO:0005576; GO:0008289; GO:0016055
LOC105344169	sodium/calcium exchanger 3	1	0.40945188585839	6.28779580995773	0.96280129056747	0.425271434375686	0.629242991103993	0	0	sodium/calcium exchanger 3	P70549	1	1.04e-95	ZC168.1.1	3.54e-122	Calx-PD	5.29e-92	XP_794875.3	0	reviewed	"NAC3_RAT"	Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3)	Slc8a3 Ncx3	Rattus norvegicus (Rat)	927	calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]; telencephalon development [GO:0021537]	anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202]; calcium:cation antiporter activity [GO:0015368]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808]; telencephalon development [GO:0021537]	GO:0002244; GO:0005432; GO:0005516; GO:0005739; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006814; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015368; GO:0015491; GO:0016020; GO:0016528; GO:0021537; GO:0030001; GO:0030424; GO:0030425; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0042995; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0060402; GO:0070161; GO:0070588; GO:0071320; GO:0071456; GO:0071901; GO:0098703; GO:0098794; GO:0098815; GO:0099055; GO:0099580; GO:1905060; GO:1990034
LOC105336654	cholesterol 25-hydroxylase-like	9	0.629009672572555	2.10076278395833	0.924187725631769	0.680608122275773	0.724868739986292	5.29345101842943e-191	2.83256798756974e-185	cholesterol 25-hydroxylase-like	O95992	1	7.9e-25	F35C8.5.1	3.76e-13	CG10362-PA	4.5	XP_011681783.1	3.08e-21	reviewed	CH25H_HUMAN	Cholesterol 25-hydroxylase (EC 1.14.99.38) (Cholesterol 25-monooxygenase) (h25OH)	CH25H	Homo sapiens (Human)	272	B cell chemotaxis [GO:0035754]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; negative regulation of fusion of virus membrane with host plasma membrane [GO:1903914]; response to type I interferon [GO:0034340]; sterol biosynthetic process [GO:0016126]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; C-4 methylsterol oxidase activity [GO:0000254]; cholesterol 25-hydroxylase activity [GO:0001567]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; steroid hydroxylase activity [GO:0008395]; B cell chemotaxis [GO:0035754]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; negative regulation of fusion of virus membrane with host plasma membrane [GO:1903914]; response to type I interferon [GO:0034340]; sterol biosynthetic process [GO:0016126]	GO:0000254; GO:0001567; GO:0005506; GO:0005789; GO:0005829; GO:0006629; GO:0008203; GO:0008395; GO:0016020; GO:0016021; GO:0016126; GO:0016491; GO:0034340; GO:0035754; GO:1903914
LOC105322782	beta-1,3-galactosyltransferase brn	12	0.701819615646806	8.1759471000875	0.9375	0.748607590023259	0.766162828552755	3.71963614100615e-47	1.99040705614152e-41	beta-1,3-galactosyltransferase brn	Q24157	2	7.2e-46	T12G3.8a.1	2.59e-30	brn-PA	9.34e-47	XP_001179708.3	1.23e-35	reviewed	BRN_DROME	Beta-1,3-galactosyltransferase brn (EC 2.4.1.62) (Brainiac protein) (Neurogenic secreted-signaling protein brn)	brn CG4934	Drosophila melanogaster (Fruit fly)	325	border follicle cell migration [GO:0007298]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; insect visual primordium formation [GO:0001744]; maintenance of polarity of follicular epithelium [GO:0042248]; morphogenesis of follicular epithelium [GO:0016333]; Notch signaling pathway [GO:0007219]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell-cell adhesion [GO:0007299]; protein glycosylation [GO:0006486]	Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity [GO:0046981]; ganglioside galactosyltransferase activity [GO:0047915]; glycosyltransferase activity [GO:0016757]; UDP-glycosyltransferase activity [GO:0008194]; border follicle cell migration [GO:0007298]; germarium-derived egg chamber formation [GO:0007293]; glycosphingolipid biosynthetic process [GO:0006688]; insect visual primordium formation [GO:0001744]; maintenance of polarity of follicular epithelium [GO:0042248]; morphogenesis of follicular epithelium [GO:0016333]; Notch signaling pathway [GO:0007219]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell-cell adhesion [GO:0007299]; protein glycosylation [GO:0006486]	GO:0000139; GO:0001744; GO:0005795; GO:0006486; GO:0006688; GO:0007219; GO:0007293; GO:0007298; GO:0007299; GO:0008194; GO:0016021; GO:0016333; GO:0016757; GO:0030707; GO:0042248; GO:0046981; GO:0047915
LOC105349151	tctex1 domain-containing protein 1	9	0.69527466298516	2.20516038381079	0.884476534296029	0.786086047538323	0.740526173238651	3.49515062315799e-195	1.87028305965682e-189	tctex1 domain-containing protein 1	Q66IC8	1	3.13e-28	D1009.5.1	8.68e-9	CG14763-PC	1.5e-10	XP_011677266.1	3.99e-24	reviewed	DYLT5_DANRE	Dynein light chain Tctex-type 5 (Tctex1 domain-containing protein 1)	dynlt5 tctex1d1 zgc:101774	Danio rerio (Zebrafish) (Brachydanio rerio)	173	cilium assembly [GO:0060271]; microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein intermediate chain binding [GO:0045505]; cilium assembly [GO:0060271]; microtubule-based movement [GO:0007018]	GO:0005737; GO:0005868; GO:0007018; GO:0045505; GO:0060271
LOC105325415	tektin-2	11	0.511437907300218	14.0567678682522	1	0.511437907300218	0.682036444749716	1.55081747382796e-55	8.29854836785134e-50	tektin-2	Q9UIF3	1	4.81e-172	R02E12.4.1	1.45e-17	CG3085-PB	1.05e-67	XP_030838502.1	5.59e-172	reviewed	TEKT2_HUMAN	Tektin-2 (Tektin-t) (Testicular tektin) (Testicular tektin B1-like protein) (TEKTB1) (Tektin-B1)	TEKT2	Homo sapiens (Human)	430	cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]	axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]	GO:0005634; GO:0005815; GO:0005879; GO:0015630; GO:0030317; GO:0031514; GO:0036159; GO:0060271; GO:0060294
LOC105325420	uncharacterized LOC105325420	4	0.316089337888372	5.54732495479862	0.888455538221529	0.355773951863822	0.380962480186074	6.81195742702372e-217	3.64513291485981e-211	uncharacterized LOC105325420	P9WIZ4	1	0.35	F07C3.4.1	0.93	CG3106-PB	0.25	XP_030838471.1	4.2	reviewed	MNTH_MYCTO	Divalent metal cation transporter MntH (Mramp)	mntH MT0951	Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)	428		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metal ion transmembrane transporter activity [GO:0046873]; symporter activity [GO:0015293]	GO:0005886; GO:0015293; GO:0016021; GO:0046872; GO:0046873
LOC109619157	protein fem-1 homolog A-A	8	0.42740839745865	4.87595564263261	0.80188679245283	0.533003413301376	0.469804087851732	8.13176154682962e-134	4.35137065780091e-128	protein fem-1 homolog A-A	Q7T3P8	2	1.46e-18	F35D6.1a.1	4.07e-11	CG6966-PC	1.73e-13	XP_030849782.1	5.54e-15	reviewed	FEM1C_DANRE	Protein fem-1 homolog C (FEM1c) (FEM1-gamma)	fem1c	Danio rerio (Zebrafish) (Brachydanio rerio)	618	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]	Cul2-RING ubiquitin ligase complex [GO:0031462]; ubiquitin ligase complex [GO:0000151]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]	GO:0000151; GO:0006511; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756
LOC109619155	uncharacterized LOC109619155	3	0.379057612580416	1.78688133421732	0.641131815044859	0.591231949008636	0.33356917374792	2.56513883940512e-199	1.3726263140764e-193	uncharacterized LOC109619155	Q9Y6H6	1	5.9	M176.7.2	0.76	Amph-PC	2.5	XP_030833009.1	1.2	reviewed	KCNE3_HUMAN	Potassium voltage-gated channel subfamily E member 3 (MinK-related peptide 2) (Minimum potassium ion channel-related peptide 2) (Potassium channel subunit beta MiRP2)	KCNE3	Homo sapiens (Human)	103	cellular chloride ion homeostasis [GO:0030644]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential [GO:1905025]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; potassium ion export across plasma membrane [GO:0097623]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sodium ion transport [GO:0006814]; ventricular cardiac muscle cell action potential [GO:0086005]	basolateral part of cell [GO:1990794]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; cellular chloride ion homeostasis [GO:0030644]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential [GO:1905025]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; potassium ion export across plasma membrane [GO:0097623]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sodium ion transport [GO:0006814]; ventricular cardiac muscle cell action potential [GO:0086005]	GO:0005249; GO:0005737; GO:0005886; GO:0006814; GO:0015459; GO:0016021; GO:0030425; GO:0030644; GO:0031982; GO:0032809; GO:0043204; GO:0044325; GO:0045121; GO:0060307; GO:0086005; GO:0086011; GO:0086091; GO:0097623; GO:0098915; GO:1902260; GO:1903765; GO:1903817; GO:1905025; GO:1990794
LOC105319801	uncharacterized LOC105319801	2	0.248769111163698	3.44164043411816	0.716550412175016	0.347176007349692	0.199261195592828	2.94796734077538e-203	1.57748090778763e-197	uncharacterized LOC105319801	Q03280	1	1.5		NA	sano-PE	0.78	XP_030829517.1	6.4	reviewed	TOM1_YEAST	E3 ubiquitin-protein ligase TOM1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TOM1) (Suppressor of snRNA protein 2) (Temperature-dependent organization in mitotic nucleus protein 1)	TOM1 SSR2 YDR457W D8035.1	Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)	3268	cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; nucleus organization [GO:0006997]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; nucleus organization [GO:0006997]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361]; ubiquitin-dependent protein catabolic process [GO:0006511]	GO:0000209; GO:0000278; GO:0000447; GO:0000448; GO:0000472; GO:0000480; GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006511; GO:0006913; GO:0006997; GO:0008361; GO:0016567; GO:0043161; GO:0051028; GO:0061630
LOC105347430	protein nanos	8	0.735102012462794	19.0424199577285	0.817610062893082	0.899086307550648	0.66048899081359	1.46870945503722e-188	7.85918179066057e-183	protein nanos	P60321	1	3.32e-17	Y53C12B.3a.2	3.5e-5	nos-PB	1.07e-12	NP_001073023.1	1.07e-16	reviewed	"NANO2_HUMAN"	Nanos homolog 2 (NOS-2)	"NANOS2 NOS2"	Homo sapiens (Human)	138	germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]	GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007283; GO:0008270; GO:0017148; GO:0030718; GO:0045835; GO:0048471; GO:0048477; GO:1900153
LOC105340088	uncharacterized LOC105340088	2	0.229823045012518	12.2475984164546	0.881293595434369	0.260779207069176	0.266896955914063	7.02004711372379e-274	3.75648337093051e-268	uncharacterized LOC105340088	Q6U7I1	1	0.32	C50E10.4a.1	1.7	d4-PB	0.83	XP_030829645.1	0.64	reviewed	UBP7_CHICK	Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7)	USP7	Gallus gallus (Chicken)	1101	histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; protein deubiquitination [GO:0016579]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; protein deubiquitination [GO:0016579]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]	GO:0004197; GO:0004843; GO:0005634; GO:0005694; GO:0005829; GO:0006511; GO:0016579; GO:0016605; GO:0031647; GO:0035616; GO:0051090
LOC105340092	teratocarcinoma-derived growth factor 1	6	0.553513373860341	23.9273363294436	0.986522911051213	0.561075031973187	0.72024104391029	5.98192753007012e-225	3.20097727676076e-219	teratocarcinoma-derived growth factor 1	P51865	1	1.01e-18	ZC116.3.1	6.6e-4	slow-PB	0.001	XP_787941.2	3.29e-18	reviewed	TDGF1_MOUSE	Teratocarcinoma-derived growth factor (Cripto growth factor) (Epidermal growth factor-like Cripto protein)	Tdgf1 Cripto	Mus musculus (Mouse)	171	anatomical structure development [GO:0048856]; anterior/posterior axis specification [GO:0009948]; anterior/posterior axis specification, embryo [GO:0008595]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; cardiac muscle cell differentiation [GO:0055007]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; fibroblast proliferation [GO:0048144]; gastrulation [GO:0007369]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; morphogenesis of a branching structure [GO:0001763]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nodal signaling pathway [GO:0038092]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction [GO:0009966]; vasculogenesis [GO:0001570]	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; activin receptor binding [GO:0070697]; coreceptor activity [GO:0015026]; growth factor activity [GO:0008083]; nodal binding [GO:0038100]; signaling receptor binding [GO:0005102]; type I activin receptor binding [GO:0070698]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; anterior/posterior axis specification [GO:0009948]; anterior/posterior axis specification, embryo [GO:0008595]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; cardiac muscle cell differentiation [GO:0055007]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; fibroblast proliferation [GO:0048144]; gastrulation [GO:0007369]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; morphogenesis of a branching structure [GO:0001763]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nodal signaling pathway [GO:0038092]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction [GO:0009966]; vasculogenesis [GO:0001570]	GO:0001568; GO:0001570; GO:0001701; GO:0001763; GO:0001954; GO:0005102; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0007368; GO:0007369; GO:0007507; GO:0008083; GO:0008284; GO:0008595; GO:0009948; GO:0009952; GO:0009966; GO:0009986; GO:0010762; GO:0015026; GO:0016324; GO:0017147; GO:0019897; GO:0030154; GO:0030335; GO:0030512; GO:0031225; GO:0038092; GO:0038100; GO:0043406; GO:0045121; GO:0045944; GO:0048144; GO:0048146; GO:0048471; GO:0048856; GO:0055007; GO:0070697; GO:0070698
LOC105327868	uncharacterized LOC105327868	1	0.406005922077884	7.0561907405408	0.880622509014993	0.461044224876804	0.46033903570229	0	0	uncharacterized LOC105327868	B2GB76	1	0.26	K03H1.5.1	2.8	Rim-PY	8.8	XP_030831971.1	0.34	reviewed	MRAY_LIMF3	Phospho-N-acetylmuramoyl-pentapeptide-transferase (EC 2.7.8.13) (UDP-MurNAc-pentapeptide phosphotransferase)	mraY LAF_0572	Limosilactobacillus fermentum (strain NBRC 3956 / LMG 18251) (Lactobacillus fermentum)	319	cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimelyl-D-alanyl-D-alanine:undecaprenyl-phosphate transferase activity [GO:0051992]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]	GO:0005886; GO:0007049; GO:0008360; GO:0008963; GO:0009252; GO:0016021; GO:0046872; GO:0051301; GO:0051992; GO:0071555
LOC105337948	transcriptional regulator Myc-A	14	0.203005849247595	7.54846548847568	0.782608695652174	0.259396362927482	0.128419834433254	2.0850026197163e-7	0.111570158183115	transcriptional regulator Myc-A	Q17103	1	2.03e-40	T19B10.11.1	1.77e-7	Myc-PA	4.2e-10	NP_999744.1	7.33e-31	reviewed	MYC_ASTRU	Myc protein (c-myc)	MYC	Asterias rubens (Common European starfish) (Asterias vulgaris)	407		nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]	GO:0000981; GO:0003677; GO:0005634; GO:0046983
LOC105337948	transcriptional regulator Myc-A	3	0.322388705574115	10.5169618204788	0.966183574879227	0.333672310269209	0.516073616380093	1.11350829193992e-308	1.03956788869757e-305	transcriptional regulator Myc-A	Q17103	1	2.03e-40	T19B10.11.1	1.77e-7	Myc-PA	4.2e-10	NP_999744.1	7.33e-31	reviewed	MYC_ASTRU	Myc protein (c-myc)	MYC	Asterias rubens (Common European starfish) (Asterias vulgaris)	407		nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]	GO:0000981; GO:0003677; GO:0005634; GO:0046983
LOC105340469	actin	10	0.4124812668994	170.606102388021	0.958823529411765	0.430195186336798	0.522453389917037	8.14142986881084e-102	4.35654425423963e-96	actin	O17320	1	0	T04C12.5.3	0	Act5C-PE	0	XP_030852862.1	0	reviewed	ACT_CRAGI	Actin		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	376		cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005856
LOC105333818	ATP-dependent RNA helicase dbp2	14	0.203612810182432	18.5208025300418	0.956521739130435	0.212867937917997	0.199547099227765	9.61757611851448e-11	5.14644192162605e-5	ATP-dependent RNA helicase dbp2	Q61656	2	0	F58E10.3a.5	0	CG10077-PD	0	XP_780035.1	0	reviewed	DDX5_MOUSE	Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68)	Ddx5 Tnz2	Mus musculus (Mouse)	614	alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; nuclear androgen receptor binding [GO:0050681]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; transcription coregulator activity [GO:0003712]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]	GO:0000122; GO:0000380; GO:0000381; GO:0000956; GO:0001837; GO:0003712; GO:0003723; GO:0003724; GO:0003730; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0006606; GO:0007623; GO:0009299; GO:0016607; GO:0016887; GO:0019899; GO:0030509; GO:0030520; GO:0030521; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045069; GO:0045445; GO:0045667; GO:0045893; GO:0046332; GO:0048306; GO:0050681; GO:0060765; GO:0061614; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1903800; GO:1990841; GO:1990904; GO:2001014
LOC105320035	tektin-4	11	0.531323655025102	18.4705211011731	0.978723404255319	0.542874169264778	0.670641412763794	1.24212550891078e-54	6.6467129682223e-49	tektin-4	Q5PPV2	1	9.24e-166	R02E12.4.1	1.67e-34	CG32820-PB	4.58e-76	NP_999787.1	0	reviewed	TEKT4_XENLA	Tektin-4	tekt4	Xenopus laevis (African clawed frog)	446	cell projection organization [GO:0030030]; cilium movement involved in cell motility [GO:0060294]	axonemal microtubule [GO:0005879]; motile cilium [GO:0031514]; cell projection organization [GO:0030030]; cilium movement involved in cell motility [GO:0060294]	GO:0005879; GO:0030030; GO:0031514; GO:0060294
LOC105323555	tubulin polymerization-promoting protein family member 3	11	0.533217663353415	21.7341805343413	0.957446808510638	0.556916226169122	0.636066859035949	6.83938618688408e-52	3.65981026369116e-46	tubulin polymerization-promoting protein family member 3	Q9CRB6	1	6e-23	C32E8.3.1	1.05e-15	ringer-PB	2.84e-14	XP_782492.2	5.27e-19	reviewed	TPPP3_MOUSE	Tubulin polymerization-promoting protein family member 3	Tppp3	Mus musculus (Mouse)	176	decidualization [GO:0046697]; embryo implantation [GO:0007566]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]	microtubule [GO:0005874]; microtubule bundle [GO:0097427]; perinuclear region of cytoplasm [GO:0048471]; tubulin binding [GO:0015631]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]	GO:0001578; GO:0005874; GO:0007566; GO:0015631; GO:0032273; GO:0046697; GO:0046785; GO:0048471; GO:0097427
LOC105318577	transcriptional regulator ATRX	8	0.395766797885053	3.61591028253791	0.729559748427673	0.542473455721753	0.398977647246477	1.15781422978676e-113	6.19555656872731e-108	transcriptional regulator ATRX	Q10002	2	1.06e-99	T05H10.2.2	9.33e-101	Gdap1-PB	0.017	XP_030838408.1	1.5e-138	reviewed	APN1_CAEEL	Apurinic-apyrimidinic endonuclease (AP endonuclease) (EC 3.1.21.-)	apn-1 T05H10.2	Caenorhabditis elegans	396	base-excision repair [GO:0006284]	mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]	GO:0003677; GO:0003906; GO:0005634; GO:0005739; GO:0006284; GO:0008081; GO:0008270; GO:0008311; GO:0017005
LOC105333580	5-phosphohydroxy-L-lysine phospho-lyase	3	0.550343217944005	5.64780534151387	0.948930296756384	0.579961689309719	0.688145038293951	0	0	5-phosphohydroxy-L-lysine phospho-lyase	Q8TBG4	1	0	T01B11.2a.2	1.22e-141	CG8745-PA	0	XP_793741.4	0	reviewed	AT2L1_HUMAN	Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)	ETNPPL AGXT2L1	Homo sapiens (Human)	499		mitochondrial matrix [GO:0005759]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005759; GO:0008483; GO:0030170; GO:0050459
LOC105335481	uncharacterized LOC105335481	4	0.225992447636466	1.73720913702454	0.329173166926677	0.686545776943008	0.134042728609199	2.72624197762455e-76	1.45883389216272e-70	uncharacterized LOC105335481	Q9C9U8	1	0.006	F12A10.5.1	0.047	CG5890-PD	0.32	XP_011679771.2	0.072	reviewed	CML26_ARATH	Probable calcium-binding protein CML26 (Calmodulin-like protein 26)	CML26 At1g73630 F25P22.4	Arabidopsis thaliana (Mouse-ear cress)	163		cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005737
LOC117686524	angiotensin-converting enzyme-like	6	0.569031066341313	4.2090980226231	0.940700808625337	0.604901219520422	0.725346465791638	1.42032717188829e-226	7.60028432294797e-221	angiotensin-converting enzyme-like	Q6Q4G4	1	0	C42D8.5a.2	1.75e-59	Ance-PC	0	XP_003724612.2	0	reviewed	ACE_THETS	Angiotensin-converting enzyme (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (TtACE)	ACE	Theromyzon tessulatum (Duck leech)	616	proteolysis [GO:0006508]	extracellular space [GO:0005615]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; proteolysis [GO:0006508]	GO:0004180; GO:0005615; GO:0006508; GO:0008237; GO:0008241; GO:0016020; GO:0046872
LOC105325327	dual oxidase 2	10	0.257582941992973	13.2469566747959	0.923529411764706	0.278911465852263	0.374919819021322	2.38140493486101e-73	1.2743088318836e-67	dual oxidase 2	Q8HZK2	2	0	F56C11.1.1	0	Duox-PC	0	XP_030832128.1	0	reviewed	DUOX2_PIG	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox)	DUOX2	Sus scrofa (Pig)	1545	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590]	anchoring junction [GO:0070161]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NADH oxidase H202-forming activity [GO:0106293]; NADPH oxidase H202-forming activity [GO:0106294]; peroxidase activity [GO:0004601]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590]	GO:0004601; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006590; GO:0006952; GO:0006979; GO:0016175; GO:0016324; GO:0019221; GO:0020037; GO:0042335; GO:0042446; GO:0042554; GO:0042744; GO:0043020; GO:0045177; GO:0050665; GO:0051591; GO:0070161; GO:0106293; GO:0106294
LOC105320873	sodium-dependent neutral amino acid transporter B(0)AT3-like	5	0.405421822490484	63.3646315082138	1	0.405421822490484	0.72959046509179	0	0	sodium-dependent neutral amino acid transporter B(0)AT3-like	O88576	1	0	T23G5.5.1	1.9e-119	CG10804-PC	0	XP_030831959.1	3.69e-136	reviewed	S6A18_MOUSE	Sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3)	Slc6a18 Xt2 Xtrp2	Mus musculus (Mouse)	615	amino acid transmembrane transport [GO:0003333]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neutral amino acid transmembrane transporter activity [GO:0015175]; symporter activity [GO:0015293]; amino acid transmembrane transport [GO:0003333]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	GO:0003333; GO:0005886; GO:0005887; GO:0006836; GO:0015175; GO:0015293; GO:0016324; GO:0031526; GO:0035725
LOC105345029	uncharacterized LOC105345029	2	0.168446005815371	1.28122275678005	0.433861762840837	0.388248101682023	0.113914632782817	7.85323023677042e-116	4.20232632553774e-110	uncharacterized LOC105345029	P0DI02	1	2.7	ZC262.3a.1	2.1		NA	XP_030831830.1	2.5	reviewed	FBK10_ARATH	F-box/kelch-repeat protein At1g24800	At1g24800 F5A9.18	Arabidopsis thaliana (Mouse-ear cress)	433			
LOC109619311	uncharacterized LOC109619311_ncRNA	11	0.507104273765653	43.1658857177856	0.978723404255319	0.518128279717081	0.660114842117664	8.48747820189382e-54	4.541717485659e-48	uncharacterized LOC109619311_ncRNA		NA	NA		NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LOC105345813	CCAAT/enhancer-binding protein gamma	2	0.169847896362029	3.47484017846787	0.674191502853519	0.2519282661427	0.175955012538944	3.35835489783719e-179	1.79708257267186e-173	CCAAT/enhancer-binding protein gamma	Q03484	1	6.69e-12	ZK909.4.1	1.17e-6	slbo-PB	1.49e-6	XP_003725328.3	1.39e-12	reviewed	CEBPD_RAT	CCAAT/enhancer-binding protein delta (C/EBP delta) (Transcription factor CELF)	Cebpd Celf	Rattus norvegicus (Rat)	268	fat cell differentiation [GO:0045444]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear development [GO:0048839]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; fat cell differentiation [GO:0045444]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear development [GO:0048839]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]	GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0002244; GO:0003677; GO:0005634; GO:0006357; GO:0042802; GO:0043565; GO:0045444; GO:0045595; GO:0045669; GO:0045892; GO:0045944; GO:0048839; GO:0090575; GO:1990837
